WO2010018853A1 - Pyridyl-triazolopyrimidine derivative or salt thereof, and harmful organism control agent comprising the same - Google Patents
Pyridyl-triazolopyrimidine derivative or salt thereof, and harmful organism control agent comprising the same Download PDFInfo
- Publication number
- WO2010018853A1 WO2010018853A1 PCT/JP2009/064275 JP2009064275W WO2010018853A1 WO 2010018853 A1 WO2010018853 A1 WO 2010018853A1 JP 2009064275 W JP2009064275 W JP 2009064275W WO 2010018853 A1 WO2010018853 A1 WO 2010018853A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- compound
- optionally substituted
- reaction
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Definitions
- the present invention relates to a pest control agent containing a novel pyridyl-triazolopyrimidine derivative or a salt thereof as an active ingredient.
- Patent Document 1 discloses the use of a triazolopyrimidine derivative having a specific chemical structure as a nematicide. However, these compounds differ in chemical structure from the compounds of the present invention.
- Patent Document 2 discloses a method for inhibiting or treating cancerous tumor cell proliferation and related diseases by administering an effective amount of a triazolopyrimidine derivative to a mammal. However, there is no description of the compounds of the present invention and the use of the compounds of the present invention as pest control agents.
- the present inventors have made various studies on pyridyl-triazolopyrimidine derivatives in order to find better pest control agents. As a result, it was found that the novel pyridyl-triazolopyrimidine derivative has a very high control effect against pests at a low dosage, and also has safety against crops, pest natural enemies or mammals. The present invention has been completed.
- R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, cyano, aryl , A heterocyclic group which may be substituted with alkyl, CH ⁇ NOR 2 , CH ⁇ NNR 4 R 5 , COR 2 , COOR 2 , OR 2 , S (O) n R 3 , NR 4 R 5 or CONR 4 R 5 X is alkyl, alkenyl, alkynyl, aryl, heterocyclic group, halogen atom, haloalkyl, cyano, nitro, NR 4 R 5 , CONR 4 R 5 , S (O) n R 3 , OR 2 , COR 2 or COOR 2 ; A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5
- M is an integer of 1 to 4; n is an integer of 0 to 2], or a salt thereof.
- the present invention also relates to a pest control agent comprising a pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof as an active ingredient.
- the pest control agent comprising the pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof as an active ingredient has a very high control effect against pests with a low dose.
- each X may be the same or different.
- the halogen atom in the formula (I) or the halogen atom as a substituent include each atom of fluorine, chlorine, bromine or iodine.
- the number of halogen atoms as a substituent may be 1 or 2 or more, and in the case of 2 or more, each halogen atom may be the same or different. Further, the halogen atom may be substituted at any position.
- the alkyl in the formula (I) may be linear or branched, and specific examples thereof include C 1 such as methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, hexyl. -6 and so on.
- Examples of cycloalkyl in formula (I) include C 3-6 such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
- the alkenyl in the formula (I) may be linear or branched, and specific examples thereof include vinyl, 1-propenyl, allyl, isopropenyl, 1-butenyl, 1,3-butadienyl, -C 2-6 such as hexenyl.
- the alkynyl in the formula (I) may be linear or branched, and specific examples thereof include ethynyl, 2-butynyl, 2-pentynyl, 3-methyl-1-butynyl, 2-pentene- Examples thereof include C 2-6 such as 4-ynyl and 3-hexynyl.
- Examples of the aryl in the formula (I) include C 6-10 aryl such as phenyl and naphthyl.
- the heterocyclic group in the formula (I) includes a condensed heterocyclic group in addition to a monocyclic heterocyclic group.
- the monocyclic heterocyclic group includes, for example, a 3-membered heterocyclic group such as oxiranyl; furyl, tetrahydrofuryl, thienyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, dioxolanyl, oxazolyl, oxazolinyl, isoxazolyl, thiazolyl, thiazolinyl, isothiazolyl, imidazolyl, imidazolinyl 5-membered heterocyclic groups such as imidazolidinyl, oxazolidinyl, oxazolidinyl, thiazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, triazolyl, oxadiazolyl, thiadiazol
- a 5- or 6-membered heterocyclic group containing 1 to 4 atoms of at least one atom selected from the group consisting of O, S and N is desirable.
- the condensed heterocyclic group include benzofuranyl, isobenzofuranyl, dihydrobenzofuranyl, dihydroisobenzofuranyl, benzothienyl, isobenzothienyl, dihydrobenzothienyl, dihydroisobenzothienyl, tetrahydrobenzothienyl, indolyl, isoindolyl, Benzoxazolyl, benzothiazolyl, indazolyl, benzimidazolyl, benzodioxolanyl, benzodioxanyl, chromenyl, chromanyl, isochromanyl, chromonyl, chromanonyl, quinolyl, isoquinolyl, cin
- the salt of the pyridyl-triazolopyrimidine derivative of the formula (I) includes any agriculturally acceptable salt.
- examples thereof include ammonium salts such as dimethylammonium salt and triethylammonium salt; hydrochloride Inorganic acid salts such as perchlorate, sulfate and nitrate; organic acid salts such as acetate and methanesulfonate.
- the pyridyl-triazolopyrimidine derivative of the formula (I) may have isomers such as optical isomers and geometric isomers, but the present invention includes both isomers and isomer mixtures. It is. In the present specification, unless otherwise specified, isomers are described as a mixture. The present invention also includes various isomers other than those described above within the scope of technical common sense in the technical field. Depending on the type of isomer, there may be a chemical structure different from that of the formula (I). However, since those skilled in the art can fully recognize that they are related to isomers, the scope of the present invention. It is clear that it is within.
- the pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof can be produced according to the following production methods [1] to [9] and usual salt production methods, and is also produced according to the synthesis examples described later. be able to. Manufacturing method [1]
- R 1a is optionally substituted by by alkyl which may be, cycloalkyl which may be substituted by A 1, alkenyl which may be substituted by A 1, A 1 substituted by A 1 alkynyl, A heterocyclic group which may be substituted with aryl or alkyl;
- a 1 is a halogen atom, OR 2a , S (O) n R 3 , NR 4 R 5a , cyano, alkyl, cycloalkyl, aryl, heterocyclic group , SCH 2 COOR 2a , NHNR 4 R 5a or —CH (CN) 2 ;
- R 2a is a hydrogen atom, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, acetyl, benzyl or aryl;
- R 5a is a hydrogen atom , alkyl, cycloalkyl, haloalkyl, COR
- the compound of the formula (II) and the compound of the formula (III) are condensed to obtain the ⁇ , ⁇ -unsaturated ketone derivative of the formula (IV), the reaction of the formula (IV)
- the latter reaction consists of condensing the compound with the compound of formula (V) to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-1).
- the compound of formula (III) can be used at a ratio of 0.8 to 5 equivalents, preferably 1 to 3.5 equivalents, per 1 mol of the compound of formula (II).
- This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction.
- alcohols such as methanol, ethanol, propanol and butanol
- aromatic hydrocarbons such as benzene, toluene and xylene
- pentane, hexane, heptane Aliphatic hydrocarbons such as petroleum ether, ligroin and petroleum benzine
- ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane
- esters such as methyl acetate and ethyl acetate
- acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone
- sulfoxides such as dimethyl sulfoxide
- sulfones such as sulfolane
- hexamethyl phosphorami Phosphoric acid amides such as;
- the compound of formula (V) can be used in a proportion of 0.8 to 10 equivalents, preferably 1 to 2.5 equivalents, relative to 1 mol of the compound of formula (IV).
- This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction, for example, carboxylic acids such as acetic acid and propionic acid; alcohols such as methanol, ethanol, propanol and butanol; aromatic carbonization such as benzene, toluene and xylene.
- Hydrogen aliphatic hydrocarbons such as pentane, hexane, heptane, petroleum ether, ligroin, petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran, dioxane; esters such as methyl acetate and ethyl acetate Nitriles such as acetonitrile and propionitrile; acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone; sulfoxides such as dimethyl sulfoxide; sulfolane and the like Examples include sulfones; phosphoric acid amides such as hexamethylphosphoramide; halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane; and mixed solvents thereof. Acids are
- Y is a halogen atom
- R 3 X and m are as defined above.
- Examples of the halogen atom for Y include fluorine, chlorine, bromine and iodine atoms.
- the production method [2] includes a reaction in the first half to obtain an ⁇ , ⁇ -unsaturated ketone derivative of the formula (VII) by reacting a compound of the formula (II), carbon disulfide and a compound of the formula (VI).
- the latter reaction consists of condensing the compound of formula (VII) with the compound of formula (V) to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-2).
- carbon disulfide and the compound of formula (VI) are used in an amount of 0.8 to 5 equivalents, preferably 1 to 3 equivalents, per 1 mol of the compound of formula (II). it can.
- the compound of formula (VII) can be produced by reacting in the presence of a base and a solvent.
- the base include alkali metal hydrides such as sodium hydride and potassium hydride; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metals such as sodium and potassium; sodium methoxide and sodium Ethoxide, alkali metal alkoxides such as potassium tertiary butoxide; and the like.
- the base can be used in an amount of 1 to 10 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (II).
- the solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the first half of the production method [1].
- the reaction temperature is usually 0 to 100 ° C., preferably 10 to 50 ° C.
- the reaction time is usually 6 to 48 hours.
- the compound of the formula (V) can be used in a proportion of 0.8 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of the formula (VII).
- This reaction can be performed in the presence of a base and a solvent, if necessary.
- the base examples include alkali metal hydrides such as sodium hydride and potassium hydride; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metals such as sodium and potassium; sodium methoxide and sodium Alkali metal alkoxides such as ethoxide and potassium tertiary butoxide; alkali metal carbonates such as sodium carbonate and potassium carbonate; alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate; such as triethylamine and pyridine Organic bases; and the like.
- the base can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (V).
- the solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the first half of the production method [1].
- the reaction temperature is usually 100 to 200 ° C.
- the reaction time is usually 0.1 to 10 hours. Manufacturing method [3]
- R 3 , X and m are as described above, and na is an integer of 1 to 2.
- the oxidizing agent used in the above reaction examples include hydrogen peroxide, peracetic acid, m-chloroperbenzoic acid, and the like.
- the solvent may be any solvent that is inert to the reaction, for example, halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane; ketones such as acetone and dimethyl ethyl ketone; Mention may be made of ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; carboxylic acids such as acetic acid and propionic acid; and mixed solvents thereof.
- the oxidizing agent can be used in a ratio of 1 to 3 equivalents per 1 mol of the compound of the formula (I-2).
- the reaction temperature is usually room temperature to reflux temperature.
- the reaction time is usually 1 to 24 hours. Manufacturing method [4]
- R 1b is optionally substituted by by alkyl which may be, cycloalkyl which may be substituted by A 1, alkenyl which may be substituted by A 1, A 1 substituted by A 1 alkynyl, A halogen atom, cyano, aryl, an optionally substituted heterocyclic group, OR 2a or NR 4 R 5a ; R 2a , R 4 , R 5a , A 1 , X and m are as defined above.
- the compound of the formula (I-3) is reacted with a nucleophile in the presence of a solvent to thereby react [1,2,4] triazolo [1,5- a] Pyrimidine derivatives can be produced.
- nucleophile examples include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal mercaptides such as sodium methyl mercaptan; primary or secondary amines such as methylamine, dimethylamine and piperidine; And organometallic reagents such as bromide, ethylmagnesium bromide, and phenylmagnesium bromide; fluorinating agents such as potassium fluoride, cesium fluoride, and tetrabutylammonium fluoride;
- the nucleophilic reagent can be used in a ratio of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (I-3).
- Any solvent may be used as long as it is inert to the reaction.
- alcohols such as methanol, ethanol, propanol and butanol
- aromatic hydrocarbons such as benzene, toluene and xylene
- Aliphatic ethers such as petroleum ether, ligroin and petroleum benzine
- ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane
- esters such as methyl acetate and ethyl acetate
- acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone
- sulfoxides such as dimethyl sulfoxide; and mixed solvents thereof.
- the reaction temperature is usually ⁇ 100 to
- R 8 is alkyl; R 1a , X and m are as described above.
- the compound of formula (VIII) can be used in a proportion of 0.8 equivalent to large excess, preferably 1 to 10 equivalents, relative to 1 mol of the compound of formula (II).
- the compound of formula (IX) can be produced by reacting in the presence of a base and a solvent.
- the base include those similar to the reaction in the first half of the above production method [2].
- the base can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to the compound of formula (II). Any solvent may be used as long as it is inert to the reaction.
- alcohols such as methanol, ethanol, propanol and butanol
- aromatic hydrocarbons such as benzene, toluene and xylene
- pentane, hexane, heptane Aliphatic hydrocarbons such as petroleum ether, ligroin and petroleum benzine
- ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane
- N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl Acid amides such as pyrrolidinone
- sulfoxides such as dimethyl sulfoxide
- sulfones such as sulfolane
- halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, 1,2-dichloroethane; and a mixed solvent thereof.
- You can gel, among others ethers are
- the compound of the formula (V) can be used in a proportion of 0.8 to 10 equivalents, preferably 1 to 2.5 equivalents, relative to 1 mol of the compound of the formula (IX).
- the compound of formula (I-5) can be produced in the presence of a solvent.
- the solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the latter half of the above production method [1]. Among them, carboxylic acids are preferable.
- Formula (IX) is a liquid at normal temperature
- the reaction in the latter half of the production method [5] can be carried out without isolating the compound.
- the reaction temperature is usually 50 to 150 ° C., desirably 80 to 120 ° C.
- the reaction time is usually 0.5 to 100 hours. Manufacturing method [6]
- R 1c is a halogen atom
- R 9 and R 10 are each independently alkyl
- X, Y, and m are as described above.
- Examples of the halogen atom for R 1c include fluorine, chlorine and bromine atoms.
- the compound of the formula (I-6) can be produced by the reactions (a) to (e) above. Each reaction is described in detail below.
- the compound of the formula (XII) can be produced by reacting the compound of the formula (X) with the compound of the formula (XI) in the presence of a base and a solvent.
- the compound of the formula (XI) can be used in a proportion of 0.8 equivalent to a large excess, desirably 1 to 30 equivalent, relative to 1 mol of the compound of the formula (X).
- Examples of the base include those similar to the reaction in the first half of the above production method [2].
- the base can be used at a ratio of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (X).
- the solvent may be any solvent as long as it is inert to the reaction, and examples thereof include those similar to the reaction in the first half of the above production method [5]. Among them, ethers are desirable.
- the reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C.
- the reaction time is usually 0.1 to 24 hours.
- the compound of the formula (XIII) can be produced by hydrolyzing the compound of the formula (XII) in the presence of a base and water.
- the base include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
- the base can be used in a proportion of 1 equivalent to a large excess with respect to the compound of the formula (XII).
- the reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C.
- the reaction time is usually 0.1 to 24 hours.
- the compound of formula (XIV) can be produced by reacting the compound of formula (XIII) with a halogenating agent in the presence of a solvent.
- a halogenating agent include thionyl chloride and oxalyl dichloride.
- the halogenating agent can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (XIII).
- the solvent may be any solvent that is inert to the reaction, and examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane.
- the reaction temperature is usually 0 to 100 ° C., preferably 10 to 50 ° C.
- the reaction time is usually 0.1 to 24 hours.
- (d) 4,5-dihydro-5-oxo [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (XV) is a compound of formula (XIV) and a compound of formula (V) Can be produced by condensation.
- the compound of the formula (V) can be used in a ratio of 0.8 to 10 equivalents, desirably 1 to 2.5 equivalents, relative to 1 mol of the compound of the formula (XIV).
- This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction. For example, the same reaction as in the first half of the above production method [5] can be mentioned, but acid amides are particularly desirable.
- the reaction temperature is usually 0 to 150 ° C., preferably 20 to 100 ° C.
- the reaction time is usually 0.5 to 100 hours.
- the 5-halo [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-6) is produced by reacting the compound of compound (XV) with a halogenating agent.
- a halogenating agent include thionyl chloride, phosphorus oxychloride, phosphorus oxybromide and the like.
- the halogenating agent can be used in a proportion of 1 to 20 equivalents, preferably 1 to 8 equivalents, relative to 1 mol of the compound of the formula (XV). This reaction can be performed in the presence of a solvent, if necessary.
- the solvent may be any solvent that is inert to the reaction, and examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, 1,2-dichloroethane.
- the reaction temperature is usually 0 to 150 ° C., preferably 20 to 100 ° C.
- the reaction time is usually 0.1 to 24 hours.
- R 9 , R 1a , X and m are as described above.
- the compound of formula (X) is reacted with the compound of formula (XVI) to obtain the compound of formula (IX), and the compound of formula (IX) and formula (V)
- the latter reaction consists of condensing the compound to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-5).
- the compound of the formula (XVI) can be used in a proportion of 0.8 equivalent to a large excess, preferably 1 to 10 equivalents, relative to 1 mol of the compound of the formula (X).
- the compound of formula (IX) can be produced in the presence of a base and a solvent.
- the base include those similar to the reaction in the first half of the above production method [5].
- the base can be used at a ratio of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (X).
- the solvent may be any solvent as long as it is inert to the reaction, and examples thereof include those similar to the reaction in the first half of the above production method [5].
- the reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C.
- the reaction time is usually 0.1 to 24 hours.
- the reaction in the latter half of the production process [7] can be carried out in the same manner as the reaction in the latter half of the production process [5]. Manufacturing method [8]
- R 11 and R 12 are each independently hydrogen, alkyl or cycloalkyl; X, Y and m are as described above.
- the compound of the formula (I-7) and the halogenating agent are reacted in the presence of a solvent and a small amount of a radical initiator to thereby produce [1,2,4 of the formula (I-8).
- a triazolo [1,5-a] pyrimidine derivative can be produced. This reaction can be performed under light irradiation as needed.
- halogenating agent examples include N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide and the like.
- the halogenating agent can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to the compound of formula (I-7).
- radical initiator examples include benzoyl peroxide and azobisisobutyronitrile. Any solvent may be used as long as it is inert to the reaction.
- examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane.
- the reaction temperature is usually 0 to 100 ° C., preferably 10 to 80 ° C.
- the reaction time is usually 0.1 to 24 hours. Manufacturing method [9]
- R 13 is optionally substituted by by alkyl which may be, cycloalkyl which may be substituted by A 1, alkenyl which may be substituted by A 1, A 1 substituted by A 1 alkynyl, A heterocyclic group which may be substituted with a halogen atom, cyano, aryl or alkyl, OR 14 , SR 14 or NR 15 R 16 , wherein R 14 , R 15 and R 16 may each independently be substituted with A 1 ; alkyl, cycloalkyl which may be substituted by A 1, is substituted with an alkenyl or A 1 may be substituted by A 1 be also good alkynyl; R 11, R 12, A 1, X and m are described above It is as follows.
- the compound of the formula (I-8) is reacted with a nucleophile in the presence of a solvent to give [1,2,4] triazolo [1,5- a] Pyrimidine derivatives can be produced.
- nucleophiles examples include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal haloalkoxides such as sodium trifluoromethyl ethoxide; alkali metal mercaptides such as sodium methyl mercaptan; methylamine and dimethylamine Primary or secondary amines such as pyridine, piperidine, morpholine; organometallic reagents such as methylmagnesium bromide, ethylmagnesium bromide, phenylmagnesium bromide; fluorine such as potassium fluoride, cesium fluoride, tetrabutylammonium fluoride A cyanating agent such as potassium cyanide and sodium cyanide; and the like.
- alkali metal alkoxides such as sodium methoxide and sodium ethoxide
- alkali metal haloalkoxides such as sodium trifluoromethyl ethoxide
- the nucleophilic reagent can be used in a ratio of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of the formula (I-8).
- the solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction of the above production method [4].
- the reaction temperature is usually ⁇ 100 to 50 ° C., desirably ⁇ 70 to 20 ° C.
- the reaction time is usually 6 to 48 hours.
- X a is alkyl, aryl, halogen atom, haloalkyl, cyano, nitro, OR 2b , COR 2b or COOR 2b ;
- R 2b is alkyl, alkenyl, alkynyl, haloalkyl, cyanoalkyl, alkoxyalkyl, acetyl, Benzyl or aryl;
- m is as described above), and one or more methods are appropriately selected from the same methods as those described in Synthesis Examples 1 to 13 below.
- the methyl group at the 5-position on the triazolopyrimidine ring can be appropriately converted to another substituent selected from R 1 .
- the following formula (I-11) which can be produced by the production method [1], the production method [4] or the production method [5] or the same method as in Synthesis Examples 14 (1) to (4) described later;
- X b is alkyl, halogen atom, haloalkyl, cyano, OR 2a , COOR 2a acetyl, S (O) n R 3a , NR 4 R 5a or CONR 4 R 5b ;
- R 3a is alkyl R 1a , R 2a , R 4 , R 5a , m and n are as described above), and the synthesis examples 18 (1), 18 (2), and 18 A specific substituent on the pyridine ring can be appropriately converted to another substituent selected from X by appropriately selecting and executing one or more methods from the same methods as in Example 19.
- the compound represented by the formula (I-12) may be selected from X by selecting a specific substituent on the pyridine ring by a known substituent conversion reaction in addition to the method similar to the synthesis example described later. Can be appropriately converted to the above substituent.
- the desirable mode of the pest control agent containing the compound of the present invention is described below.
- the pest control agent containing the compound of the present invention includes, for example, various pest control agents that are problematic in the field of agriculture and horticulture, that is, agricultural and horticultural pest control agents, and pest control agents that parasitize animals, that is, animal parasitics. It is particularly useful as a biocontrol agent.
- Pesticides for agricultural and horticultural use are useful, for example, as insecticides, acaricides, nematicides or soil insecticides.
- Plant parasitic mites such as rustic mites, mites, aphids such as peach aphids and cotton aphids; diamondback moths, weevil, scallops, codling moths, ball worms, tobacco worms, mai moths, yellow moths, prickly winged clams, Colorado Agricultural pests such as leaf beetle, cucumber beetle, ball weevil, leafhoppers, leafhoppers, scale insects, stink bugs, whitefly, thrips, grasshoppers, fly flies, scarab beetles, tamanayaga, kaburagaga, ants, etc .; Plant parasitic nematodes such as cucumbers, cyst nematodes, nesting nematodes, rice scented nematodes, strawberry nem
- the agricultural and horticultural pest control agent containing the compound of the present invention is particularly effective for controlling plant parasitic mites, agricultural pests, plant parasitic nematodes and the like. Among them, it is most useful as an insecticidal or acaricidal agent because it exhibits a further excellent effect in controlling plant parasitic mites and agricultural pests. Moreover, the agricultural and horticultural pesticide containing the compound of the present invention is also effective for controlling various resistant pests against drugs such as organic phosphorus agents, carbamate agents, and synthetic pyrethroid agents.
- the compound of the present invention has excellent osmotic transfer properties, soil harmful insects, mites, nematodes by treating agricultural and horticultural pesticides containing the compound of the present invention on the soil It is possible to control pests on the foliage at the same time as the control of gastropods and isopods.
- Another desirable embodiment of the pest control agent containing the compound of the present invention is a farm that comprehensively controls the aforementioned plant parasitic mites, agricultural pests, plant parasitic nematodes, gastropods, soil pests, etc. Examples include horticultural pest control agents.
- the agricultural and horticultural pest control agent containing the compound of the present invention is usually a powder, granule, granule wettable powder, wettable powder, aqueous suspension, by mixing the compound with various agricultural adjuvants, Used in various forms such as oil suspensions, aqueous solvents, emulsions, solutions, pastes, aerosols, microdispersions, etc. It can be in any formulation form.
- Adjuvants used in the formulation include solid carriers such as diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaolin, bentonite, kaolinite, sericite, clay, sodium carbonate, sodium bicarbonate, sodium sulfate, zeolite, starch; water , Toluene, xylene, solvent naphtha, dioxane, acetone, isophorone, methyl isobutyl ketone, chlorobenzene, cyclohexane, dimethyl sulfoxide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone, alcohol, etc.
- solid carriers such as diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaolin, bentonite, kaolinite, sericite, clay, sodium carbonate, sodium bicarbonate, sodium sulfate, zeolite,
- Solvent fatty acid salt, benzoate, alkylsulfosuccinate, dialkylsulfosuccinate, polycarboxylate, alkylsulfate, alkylsulfate, alkylarylsulfate, alkyldiglycolethersulfate, al Cole sulfate ester salt, alkyl sulfonate salt, alkyl aryl sulfonate salt, aryl sulfonate salt, lignin sulfonate salt, alkyl diphenyl ether disulfonate salt, polystyrene sulfonate salt, alkyl phosphate ester salt, alkyl aryl phosphate salt, styryl Aryl phosphate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl aryl ether sulfate, polyoxyethylene alkyl aryl ether sulfate, polyoxyethylene alkyl ether
- each component of these adjuvants can be used by appropriately selecting one or two or more types without departing from the object of the present invention.
- auxiliary agents they can be appropriately selected from those known in the art.
- various commonly used adjuvants such as extenders, thickeners, anti-settling agents, antifreeze agents, dispersion stabilizers, safeners, and antifungal agents can be used.
- the compounding ratio of the compound of the present invention and various adjuvants is 0.001: 99.999 to 95: 5, preferably 0.005: 99.995 to 90:10.
- a diluent such as water
- various spreading agents surfactants, vegetable oils, mineral oils, etc.
- the active ingredient concentration is preferably 0.5 to 500,000 ppm, and the application amount per unit area is 0.05 to 50,000 g, preferably 1 to 30,000 g of the compound of the present invention per hectare.
- application of the agricultural and horticultural pest control agent which is another desirable embodiment of the pest control agent containing the compound of the present invention, is performed according to the application of the pest control agent.
- the present invention also includes a method for controlling pests by such an application method, particularly a method for controlling plant parasitic mites, agricultural pests, and plant parasitic nematodes.
- Application of various preparations or dilutions of agricultural and horticultural pesticides containing the compound of the present invention is usually performed by a commonly used application method, that is, spraying (for example, spraying, spraying, misting, atomizing, It can be carried out by powder application, water surface application, etc.), soil application (mixing, irrigation, etc.), surface application (application, powder coating, coating, etc.), immersion poison bait, etc. It is also possible to feed livestock with the above-mentioned active ingredient mixed with feed to inhibit the occurrence and growth of harmful insects, particularly harmful insects, in the excreta. It can also be applied by the so-called ultra-low concentration low volume method. In this method, it is possible to contain 100% of the active ingredient.
- the agricultural and horticultural pest control agent containing the compound of the present invention can be mixed or used in combination with other agricultural chemicals, fertilizers, safeners, etc.
- Other agrochemicals include herbicides, insecticides, acaricides, nematicides, soil insecticides, fungicides, antiviral agents, attractants, antibiotics, plant hormones, plant growth regulators, etc. It is done.
- a mixed pest control composition in which the compound of the present invention and one or more active compound compounds of other agricultural chemicals are used in combination or in combination is preferred in terms of application range, timing of chemical treatment, control activity, etc. It is possible to improve.
- the compound of the present invention and the other active ingredient compounds of other agricultural chemicals may be prepared separately and mixed at the time of spraying, or both may be used together.
- the present invention includes such a composition for controlling mixed pests.
- the mixing ratio between the compound of the present invention and the active ingredient compound of other agricultural chemicals cannot be defined unconditionally due to differences in weather conditions, formulation form, application time, application location, type of pests and occurrence, etc., but generally from 1: 300 to 300: 1, preferably 1: 100 to 100: 1.
- the appropriate amount to be applied is 0.1 to 50,000 g, preferably 1 to 30,000 g as the total amount of active ingredient compounds per hectare.
- the present invention also includes a method for controlling pests by a method for applying such a composition for controlling mixed pests.
- Organometallic compounds such as fenbutatin oxide and cyhexatin; Fenvalerate, permethrin, cypermethrin, deltamethrin, cyhalothrin, tefluthrin, etofenprox, flufenprox, cyfluthrin , Fenpropathrin, flucytrinate, fluvalinate, cycloprothrin, lambda-cyhalothrin, pyrethrin, esfenvalerate, Tetramethrin, resmethrin, protrifenbute, bifenthrin, zeta-cypermethrin, acrinathrin, alpha-cypermethri n), allethrin, gamma-cyhalothrin, theta-cypermethrin, tau-fluvalinate, tralomethrin, profluthrin
- Pyridine compounds such as pyridalyl, flonicamid and the like; Tetronic acid compounds such as spirodiclofen; Strobilurin-based compounds such as fluacrypyrim; Pyridinamine compounds such as flufenerim; Dinitro compounds; organic sulfur compounds; urea compounds; triazine compounds; hydrazone compounds; and other compounds such as buprofezin, hexythiazox, amitraz, chlordimeform, silafluofen ), Triazamate, pymetrozine, pyrimidifen, chlorfenapyr, indoxacarb, acequinocyl, etoxazole, cyromazine, 1,3-dichloropropene (1,3-dichloropropene), diafenthiuron, benclothiaz, bifenazate, spiromesifen, spirotetramat, propargi Propargite, clofentezine, metaflum
- Bacillus thuringienses aizawai, Bacillus thuringienses kurstaki, Bacillus thuringienses israelensis, Bacillus thuringienses japonensis, Bacillus thuringienses tenebrionis, crystalline protein toxins produced by Bacillus thuringienses, entomopathogenic fungi, nematode pathogenic fungi, etc.
- Microbial pesticides such as: avermectin, emamectin-benzoate, milbemectin, milbemycin, spinosad, ivermectin, lepimectin, DE-175, abamectin and antibiotics such as abamectin and emamectin; semi-synthetic antibiotics; natural products such as azadirachtin and rotenone; repellents such as deet;
- bactericidal active ingredient compounds in the above-mentioned other agricultural chemicals include, for example, mepanipyrim, pyrimethanil, cyprodinil Anilinopyrimidine compounds such as ferimzone; Tria such as 5-chloro-6- (2,4,6-trifluorophenyl) -7- (4-methylpiperidin-1-yl) [1,2,4] triazolo [1,5-a] pyrimidine Zolopyrimidine compounds; Pyridinamine compounds such as fluazinam; Triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, microbutanil, cyproconazole cyproconazole), tebuconazole, hexaconazole, furconazole-cis, prochloraz, metconazole, ep
- Quinoxaline compounds such as quinomethionate; Dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, metiram, propineb, thiram; Organochlorine compounds such as fthalide, chlorothalonil, quintozene; Imidazole compounds such as benomyl, thiophanate-methyl, carbendazim, thiabendazole, fuberiazole, cyazofamid; Cyanoacetamide compounds such as cymoxanil; Metalaxyl, metalaxyl-M, mefenoxam, oxadixyl, offurace, benalaxyl, benalaxyl-M, also known as kiralaxyl, chiax ), Phenylamide compounds such as furalaxyl, cyprofuram;
- Sulfenic acid compounds such as dichlofluanid; Copper-based compounds such as cupric hydroxide and oxine copper; Isoxazole compounds such as hymexazol; Fosetyl aluminum (fosetyl-Al), tolclofos-methyl, edifenphos, iprobenfos, S-benzyl O, O-diisopropyl phosphorothioate, O-ethyl S, S-diphenyl phosphorodithioate, aluminum Organophosphorus compounds such as ethyl hydrogen phosphonate; N-halogenothioalkyl compounds such as captan, captafol, folpet; Dicarboximide compounds such as procymidone, iprodione, vinclozolin;
- Benzanilide compounds such as flutolanil, mepronil, zoxamid, tiadinil; Carboxin (carboxin), oxycarboxin, thifluzamide, penthiopyrad, boscalid, isothianil, bixafen, 3- (difluoromethyl) -1-methyl-N- [(1RS, 4SR, 9RS) -1,2,3,4-Tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] pyrazole-4-carboxamide and 3- (difluoromethyl) -1-methyl- Of a mixture of N-[(1RS, 4SR, 9SR) -1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] pyrazole-4-carboxamide (isopyrazam) Such anilide compounds; Piperazine compounds such as triforine; Pyridine compounds such as pyrif
- Organotin compounds such as fentin hydroxide and fentin acetate; Urea-based compounds such as pencycuron; Synamic acid compounds such as dimethomorph and flumorph; Phenyl carbamate compounds such as dietofencarb; Cyanopyrrole compounds such as fludioxonil and fenpiclonil; Azoxystrobin, kresoxim-methyl, metominofen, trifloxystrobin, picoxystrobin, oryzastrobin, dimoxystrobin Strobilurin-based compounds such as pyraclostrobin, fluoxastrobin, fluacrypyrin;
- Oxazolidinone compounds such as famoxadone; Thiazole carboxamide compounds such as ethaboxam; Silylamide compounds such as silthiopham; Iprovalicarb, Benthiavalicarb-isopropyl, methyl [S- (R, S)]-[3- (N-isopropoxycarbonylvalinyl) -amino] -3- (4-chloro Aminoacid amide carbamate compounds such as -phenyl) propionate (valiphenal); Imidazolidine compounds such as fenamidone; Hydroxyanilide compounds such as fenhexamid; Benzenesulfonamide compounds such as flusulfamide; Oxime ether compounds such as cyflufenamid; Phenoxyamide compounds such as fenoxanil; Antibiotics such as validamycin, kasugamycin, polyoxins; Guanidine compounds such as iminoctadine and dodine
- animal parasite control agents include ectoparasites that parasitize on the body surface of the host animal (back, armpit, lower abdomen, inner thigh, etc.) and the host animal body (stomach, intestinal tract, lung, heart, liver). , Vascular, subcutaneous, lymphoid tissue, etc.) are effective in controlling endoparasites, and in particular, are effective in controlling ectoparasites.
- ectoparasites examples include animal parasitic mites and fleas. There are so many of these types that it is difficult to list them all.
- the animal parasitic mites for example Boophilus microplus (Boophilus microplus), Rhipicephalus sanguineus (Rhipicephalus sanguineus), Haemaphysalis longicornis (Haemaphysalis longicornis), Haemaphysalis flava (Haemaphysalis flava), Adenophora chima tick (Haemaphysalis campanulata), Isukachimadani (Haemaphysalis concinna), Yamatochimadani (Haemaphysalis japonica), H.
- kitaokai Haemaphysalis kitaokai
- Iyasuchimadani Haemaphysalis ias
- Ixodes ovatus Ixodes ovatus
- I. nipponensis Ixodes nipponensis
- Schulze ticks Ixodes persulcatus
- Takasago testudinarium Amblyomma testudinarium
- Ootogechimadani Haemaphysalis megaspinosa
- tick such as Dermacentor reticulatus , Dermacentor taiwanesis ; duck ( Dermanyssus gallinae ); Shidani (Ornithonyssus sylviarum), Torisashidani, such as Southern tri sand mite (Ornithonyssus bursa); Nan iodine tsutsugamushi (Eutromb
- chiggers such as Miyagawa Tama chiggers (Helenicula miyagawai); Inutsumedani (Cheyletiella yasguri), rabbit Tsumedani (Cheyletiella parasitivorax), Nekotsumedani (Cheyletiella blakei) Tsumedani, such as; rabbits 9,000 mite (Psoroptes cuniculi), Ushishokuhidani (Chorioptes bovis), dog ear mites (Otodectes cynotis), mange mites (Sar coptes scabiei ), mite mites like Notoedres
- fleas examples include ectoparasite worms belonging to the order Flea ( Siphonaptera ), and more specifically fleas belonging to the family Flea family ( Pulicidae ), Nagano family ( Ceratephyllus ) and the like.
- fleas belonging to the family flea family include, for example, dog fleas ( Ctenocephalides canis ), cat fleas ( Ctenocephalides felis ), human fleas ( Purex irritans ), elephant fleas ( Echidnophaga gallinacea ), keops mouse fleas ( Xenopsylla cheopis ) Leptopsylla segnis ), European mud minnow ( Nosopsyllus fasciatus ), and Yamato mud mink ( Monopsyllus anisus ).
- the animal parasite control agent containing the compound of the present invention is effective for controlling fleas belonging to the family Flea, particularly dog fleas, cat fleas and the like.
- ectoparasites include, for example, lice such as bovine lice, foal lice, sheep lice, bovine white lice, head lice; lice such as dog lice; blood-sucking dipterous pests such as bovine abs, quail sharks, .
- endoparasites include nematodes such as lungworms, benthic worms, tuberous worms, gastric parasites, roundworms, and filamentous worms; Tapeworms such as real tapeworms, multi-headed tapeworms, single-banded tapeworms, multi-banded tapeworms; Japanese schistosomiasis, fluke like liver fluke; coccidium, malaria parasite, intestinal granulocyst, toxoplasma, chestnut Protozoa such as Ptosporidium, and the like.
- nematodes such as lungworms, benthic worms, tuberous worms, gastric parasites, roundworms, and filamentous worms
- Tapeworms such as real tapeworms, multi-headed tapeworms, single-banded tapeworms, multi-banded tapeworms
- Japanese schistosomiasis fluke like liver fluke
- Examples of host animals include various pet animals, livestock, poultry, etc., and more specifically dogs, cats, mice, rats, hamsters, guinea pigs, squirrels, rabbits, ferrets, birds (eg, pigeons, parrots, (E.g., nine-bird, bird, parakeet, juvenile pine, canary, etc.), cattle, horses, pigs, sheep, ducks, chickens, etc.
- the animal parasite control agent containing the compound of the present invention is effective for controlling pests parasitic on pet animals or livestock, particularly ectoparasites.
- pet animals or domestic animals it is particularly effective for dogs, cats, cows or horses.
- the compound of the present invention When used as an animal parasite control agent, it may be used as it is. In addition, it can be used in the form of various forms such as powders, granules, tablets, powders, capsules, liquids, emulsions, aqueous suspensions, oily suspensions and the like together with appropriate auxiliary agents. In addition to the above-mentioned preparation forms, any preparation forms used in the normal field can be used as long as the object of the present invention is met. Examples of the adjuvant used in the preparation include anionic surfactants and nonionic surfactants exemplified as the above-mentioned preparation adjuvants for agricultural and horticultural pest control agents; positive agents such as cetyltrimethylammonium bromide.
- Ionic surfactants water, acetone, acetonitrile, N-methylacetamide, N, N-dimethylacetamide, N, N-dimethylformamide, 2-pyrrolidone, N-methyl-2-pyrrolidone, kerosene, triacetin, methanol, Ethanol, isopropanol, benzyl alcohol, ethylene glycol, propylene glycol, polyethylene glycol, liquid polyoxyethylene glycol, butyl diglycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, diethylene glycol monoethyl Solvents such as ether, diethylene glycol normal butyl ether, dipropylene glycol monomethyl ether, dipropylene glycol normal butyl ether; oxidations such as butylhydroxyanisole, butylhydroxytoluene, ascorbic acid, sodium metabisulfite, propyl gallate, sodium thiosulfate Inhibitors; Film
- each component of these adjuvants can be used by appropriately selecting one or two or more types without departing from the object of the present invention.
- it can be used by appropriately selecting from those known in the field, and further, selected from various adjuvants used in the above-mentioned agricultural and horticultural fields. You can also
- the compounding ratio of the compound of the present invention and various adjuvants is usually about 0.1: 99.9 to 90:10. In actual use of these preparations, use them as they are, or dilute them to a predetermined concentration with a diluent such as water, and add various spreading agents (surfactants, vegetable oils, mineral oils, etc.) as necessary. Can be used.
- Administration of the compound of the present invention to the host animal is performed orally or parenterally.
- the oral administration method include a method of administering tablets, liquid agents, capsules, wafers, biscuits, minced meat, and other feeds containing the compound of the present invention.
- the compound of the present invention is prepared into an appropriate preparation and then taken into the body by intravenous administration, intramuscular administration, intradermal administration, subcutaneous administration, etc .; spot-on For example, a method of administering to the body surface by treatment, pour-on treatment, spray treatment, etc .; a method of embedding a resin piece containing the compound of the present invention under the skin of a host animal, and the like.
- the dose of the compound of the present invention to the host animal varies depending on the administration method, administration purpose, disease symptoms, etc., but is usually a ratio of 0.01 mg to 100 g, preferably 0.1 mg to 10 g, per 1 kg body weight of the host animal. Is suitable for administration.
- the present invention includes a method for controlling pests according to the administration method or dosage as described above, particularly a method for controlling ectoparasites or endoparasites.
- the present invention includes a prophylactic or therapeutic agent for parasitic animal diseases containing the compound of the present invention as an active ingredient, and a method for preventing or treating parasitic animal diseases.
- the present invention includes a composition for controlling mixed pests in which various components as described above are mixed or used together, and a method for controlling pests using the composition, particularly a method for controlling ectoparasites or endoparasites. Is also included.
- X is alkyl, alkenyl, alkynyl, aryl, halogen atom, haloalkyl, cyano, nitro, NR 4 R 5 , S (O) n R 3 , OR 2 , COR 2 or COOR 2 A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 ,
- R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, substituted with alkyl
- An optionally heterocyclic group CH ⁇ NOR 2 , CH ⁇ NNR 4 R 5 , COR 2 , COOR 2 , OR 2 , S (O) n R 3 , NR 4 R 5 or CONR 4 R 5 ; Alkyl, aryl, halogen atom, haloalkyl or OR 2 ;
- A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , alkyl, cycloalkyl, heterocycle A group, NHNR 4 R 5 , COOR 2 or nitro;
- R 2 is a hydrogen atom, alkyl, haloalkyl or cyanoalkyl;
- R 3
- A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro;
- R 5 is haloalkyl, COR
- (5) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (1), wherein X is OR 2 .
- Synthesis example 1 Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 18)
- 2-acetyl-3-chloro-5- (trifluoromethyl) pyridine 1.0 g
- N, N-dimethylacetamide dimethylacetal 715 mg
- Synthesis example 3 Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-dimethoxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 7) 7 -[3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine in a mixed solution of 220 mg and methanol Paratoluenesulfonic acid was added and heated to reflux for 7 hours.
- the mixture was neutralized by adding a saturated aqueous sodium hydrogen carbonate solution, extracted twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate.
- Synthesis example 4 Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 36) 7 A mixed solution of 710 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 10 ml of methanol was ice-cooled. 164 mg of sodium borohydride was added and stirred for 30 minutes.
- Synthesis example 5 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methanesulfonyloxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 51)
- Synthesis 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxymethyl [1,2,4] triazolo [1,5-a] pyrimidine 136 mg, triethylamine 0.23 ml and chloroform 5 ml of the mixed solution was ice-cooled, 0.05 ml of methanesulfonyl chloride was added, and the mixture was stirred for 1 hour under ice-cooling.
- Synthesis example 7 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (oxiran-2-yl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 1) 21) Synthesis 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine 200 mg, trimethyl sulfoiodide 110 mg of potassium tert-butoxide was added to a mixed solution of 215 mg of xsonium and 5 ml of dimethyl sulfoxide, and stirred at room temperature for 20 hours.
- Synthesis example 8 Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid (Compound No. 48) 7 A mixed solution of 1.0 g of 10- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 10 ml of acetone was added to ice. After cooling, 3 ml of Jones reagent was slowly added dropwise, and the mixture was stirred for 1 hour under ice cooling.
- the reaction solution was returned to room temperature, and the precipitated solid was filtered to obtain a filtrate containing 2-fluoro-3-iodo-5- (trifluoromethyl) pyridine.
- a filtrate containing 2-fluoro-3-iodo-5- (trifluoromethyl) pyridine.
- 22.3 g of sodium cyanide and 6.7 g of tetrabutylammonium bromide were added and stirred at 50 ° C. for 6 hours.
- the reaction solution was poured into 4,000 ml of water, and the precipitated solid was filtered.
- reaction mixture was acidified with 1N hydrochloric acid, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and evaporated under reduced pressure to remove crude 1-cyclopropyl-3- [ 3-Iodo-5- (trifluoromethyl) pyridin-2-yl] propane-1,3-dione was obtained as a liquid.
- Test Example 1 Effect test on peach aphid Japanese radish leaves were inserted into a test tube containing water, and about 20 first-instar larvae were released on the leaves. The next day, after counting the number of larvae parasitic on the radish leaves, the parasitic radish leaves were immersed in a chemical solution adjusted to a concentration of 200 ppm of the present compound for about 10 seconds. After the chemical solution was air-dried, it was left in a constant temperature room at 25 ° C. with illumination. Five days after the treatment, the viability of the peach aphid was determined, and the mortality rate was determined by the following formula. The detached insects and abnormal insects were regarded as dead insects. When the compound Nos.
- Death rate (%) (1 ⁇ (number of surviving insects / number of treated insects)) ⁇ 100
- Test Example 2 Effect test on green planthopper Rice seedlings were immersed in a chemical solution adjusted to have a concentration of the present compound of 200 ppm for about 10 seconds. After the chemical solution was air-dried, the root was wrapped with wet absorbent cotton and placed in a test tube. Ten 10-year-old larvae of the green planthopper were released into this, and the tube mouth was covered with gauze and left in a constant temperature room at 25 ° C. Five days after the insect release, the dead planthopper was judged to be alive or dead, and the mortality rate was determined by the following formula. Compound No.
- Test Example 3 Effect test on silver leaf whitefly A potted cucumber seedling infested with silver leaf whitefly 1-2 larvae was sprayed with a chemical solution adjusted to a concentration of 200 ppm of the compound of the present invention using a hand spray. After the chemical solution was air-dried, it was left in a constant temperature room at 25 ° C. with illumination. Seven days after the treatment, the number of old larvae was examined, and the control efficiency (%) was determined by the following formula. Compound No.
- Control efficiency (%) (1 ⁇ (Ta ⁇ Cb) / (Tb ⁇ Ca)) ⁇ 100
- Ta old larvae after treatment in treated cucumber seedlings
- Tb Number of 1-2 instar larvae before treatment in treated cucumber seedlings
- Ca number of old larvae after treatment in untreated cucumber seedlings
- Cb Number of 1-2 instar larvae before treatment in untreated cucumber seedlings
- Test Example 4 Medicinal Efficacy Test Using Dogs against Phytophyllum Tick
- a dog (beagle, 8 months old) was administered a gelatin capsule containing 10 mg / kg body weight of the compound of the present invention.
- about 50 young mites were collected from the ear of the dog. Let go through and artificially infest. After the treatment, observe the number of infestations, the number of drops, and the life and death of the fallen spider mites. As a result, the compound of the present invention drops or kills the parasitic spider mite.
- Test Example 5 Medicinal Efficacy Test Using a Dog against a Cat Flea A gelatin capsule containing 10 mg / kg body weight of the compound of the present invention was administered to a dog (beagle, 8 months old), and immediately after that about 100 cat flea non-blood-sucking adults were covered in the back Let go on and let it infest. The compound of the present invention exhibits a hatching-inhibiting effect on the treated eggs of treated adults. Test Example 5 Drug efficacy test using dogs against cat fleas
- Formulation Example 1 (1) Compound of the present invention 20 parts by weight (2) Clay 70 parts by weight (3) White carbon 5 parts by weight (4) Sodium polycarboxylate 3 parts by weight (5) Sodium alkylnaphthalene sulfonate 2 parts by weight or more To make a wettable powder.
- Formulation Example 2 (1) Compound of the present invention 5 parts by weight (2) Talc 60 parts by weight (3) Calcium carbonate 34.5 parts by weight (4) Liquid paraffin 0.5 parts by weight or more are uniformly mixed to obtain a powder.
- Formulation Example 3 (1) Compound of the present invention 20 parts by weight (2) N, N-dimethylacetamide 20 parts by weight (3) Polyoxyethylene tristyryl phenyl ether 10 parts by weight (4) Calcium dodecylbenzenesulfonate 2 parts by weight (5) Xylene 48 A mixture of more than parts by weight is uniformly mixed and dissolved to obtain an emulsion.
- Formulation Example 4 (1) Clay 68 parts by weight (2) Sodium lignin sulfonate 2 parts by weight (3) Polyoxyethylene alkylaryl sulfate 5 parts by weight (4) White carbon 25 parts by weight A mixture of each component and the present compound Mix at a weight ratio of 4: 1 to make a wettable powder.
- Formulation Example 5 (1) Compound of the present invention 50 parts by weight (2) Sodium alkylnaphthalene sulfonate formaldehyde condensate 2 parts by weight (3) Silicone oil 0.2 parts by weight (4) Water 47.8 parts by weight or more uniformly mixed (5) 5 parts by weight of sodium polycarboxylate (6) 42.8 parts by weight of anhydrous sodium sulfate are further added to the crushed stock solution, and the mixture is uniformly mixed, granulated and dried to obtain a granulated wettable powder.
- Formulation Example 6 (1) Compound of the present invention 5 parts by weight (2) Polyoxyethylene octylphenyl ether 1 part by weight (3) Polyoxyethylene alkyl ether phosphate 0.1 part by weight (4) Granular calcium carbonate 93.9 parts by weight (1 ) To (3) are mixed uniformly in advance and diluted with an appropriate amount of acetone, and then sprayed onto (4) to remove acetone and form granules.
- Formulation Example 7 (1) Compound of the present invention 2.5 parts by weight (2) N, N-dimethylacetamide 2.5 parts by weight (3) Soybean oil 95.0 parts by weight or more are uniformly mixed and dissolved to give a trace amount of spray ( ultra low volume formulation).
- Formulation Example 8 (1) Compound of the present invention 40 parts by weight (2) Polyoxyethylene tristyryl phenyl ether potassium phosphate 4 parts by weight (3) Silicone oil 0.2 part by weight (4) Xanthan gum 0.1 part by weight (5) Ethylene glycol 5 Part by weight (6) Water 50.7 parts by weight or more are uniformly mixed and pulverized to obtain an aqueous suspension.
- Formulation Example 9 (1) Compound of the present invention 10 parts by weight (2) 80 parts by weight of diethylene glycol monoethyl ether (3) Polyoxyethylene alkyl ether 10 parts by weight or more of ingredients are mixed uniformly to obtain an aqueous solution.
- novel pyridyl-triazolopyrimidine derivatives or salts thereof of the present invention are useful as pest control agents.
- the entire contents of the specification, claims, and abstract of Japanese Patent Application No. 2008-208708, filed on August 13, 2008, are incorporated herein as the disclosure of the specification of the present invention. Is.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Disclosed is a novel harmful organism control agent.
The harmful organism control agent comprises a pyridyl-triazolopyrimidine derivative represented by formula (I) [wherein R1 represents an optionally substituted alkyl, an optionally substituted cycloalkyl, an optionally substituted alkenyl, an optionally substituted alkynyl, a halogen atom, a cyano, an aryl, an optionally alkyl-substituted heterocyclic group, CH=NOR2, CH=NNR4R5, COR2, COOR2, OR2, S(O)nR3, NR4R5 or CONR4R5; X represents an alkyl, an alkenyl, an alkynyl, an aryl, a heterocyclic group, a halogen atom, a haloalkyl, a cyano, a nitro, NR4R5, CONR4R5, S(O)nR3, OR2, COR2 or COOR2; m represents an integer of 1 to 4; and n represents an integer of 0 to 2] or a salt thereof as an active ingredient.
Description
本発明は、新規なピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する有害生物防除剤に関する。
The present invention relates to a pest control agent containing a novel pyridyl-triazolopyrimidine derivative or a salt thereof as an active ingredient.
特許文献1には、特定の化学構造を有するトリアゾロピリミジン誘導体の殺線虫剤としての使用について開示がある。しかしながら、それらの化合物は、本発明化合物とは化学構造が異なる。また、特許文献2には、トリアゾロピリミジン誘導体の有効量を哺乳動物に投与する癌性腫瘍細胞の増殖及び関連疾患を阻害又は治療する方法について開示がある。しかしながら、そこには、本発明化合物及び本発明化合物の有害生物防除剤としての使用については記載されていない。
Patent Document 1 discloses the use of a triazolopyrimidine derivative having a specific chemical structure as a nematicide. However, these compounds differ in chemical structure from the compounds of the present invention. Patent Document 2 discloses a method for inhibiting or treating cancerous tumor cell proliferation and related diseases by administering an effective amount of a triazolopyrimidine derivative to a mammal. However, there is no description of the compounds of the present invention and the use of the compounds of the present invention as pest control agents.
長年にわたり、多数の有害生物防除剤が使用されているが、効力が不十分、有害生物が抵抗性を獲得しその使用が制限される等、種々の課題を有するものが少なくない。従って、かかる欠点の少ない新規な有害生物防除剤、例えば、農園芸分野で問題となる各種有害生物や、動物に寄生する有害生物を防除できる有害生物防除剤の開発が望まれている。
Over the years, many pest control agents have been used, but many have various problems such as insufficient efficacy, pests gaining resistance and their use being restricted. Therefore, development of a new pest control agent with few such disadvantages, for example, a pest control agent capable of controlling various pests that are problematic in the field of agriculture and horticulture and pests parasitic on animals is desired.
本発明者らは、より優れた有害生物防除剤を見出すべく、ピリジル-トリアゾロピリミジン誘導体につき種々検討した。その結果、新規なピリジル-トリアゾロピリミジン誘導体が、低薬量で有害生物に対して極めて高い防除効果を有し、且つ、作物、有害生物の天敵或は哺乳動物に対する安全性を併せ持つことを見出し、本発明を完成した。
The present inventors have made various studies on pyridyl-triazolopyrimidine derivatives in order to find better pest control agents. As a result, it was found that the novel pyridyl-triazolopyrimidine derivative has a very high control effect against pests at a low dosage, and also has safety against crops, pest natural enemies or mammals. The present invention has been completed.
すなわち本発明は、式(I):
That is, the present invention relates to the formula (I):
〔式中、R1はAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、Aで置換されてもよいアルキニル、ハロゲン原子、シアノ、アリール、アルキルで置換されてもよい複素環基、CH=NOR2、CH=NNR4R5、COR2、COOR2、OR2、S(O)nR3、NR4R5又はCONR4R5であり;Xはアルキル、アルケニル、アルキニル、アリール、複素環基、ハロゲン原子、ハロアルキル、シアノ、ニトロ、NR4R5、CONR4R5、S(O)nR3、OR2、COR2又はCOOR2であり;Aはハロゲン原子、OR2、S(O)nR3、OS(O)nR3、NR4R5、シアノ、アルキル、シクロアルキル、アリール、複素環基、SCH2COOR2、NHNR4R5、COOR2、ニトロ又は-CH(CN)2であり;R2は水素原子、アルキル、アルケニル、アルキニル、ハロアルキル、シアノアルキル、アルコキシアルキル、アセチル、ベンジル又はアリールであり;R3はアルキル又はアセチルであり;R4は水素原子又はアルキルであり;R5は水素原子、アルキル、シクロアルキル、ハロアルキル、COR2、COOR2、S(O)nR3、CH2CH2OR2又はCH2CNであり;mは1~4の整数であり;nは0~2の整数である〕で表されるピリジル-トリアゾロピリミジン誘導体又はその塩に関する。
また、本発明は、式(I)のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分とする有害生物防除剤に関する。 [Wherein R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, cyano, aryl , A heterocyclic group which may be substituted with alkyl, CH═NOR 2 , CH═NNR 4 R 5 , COR 2 , COOR 2 , OR 2 , S (O) n R 3 , NR 4 R 5 or CONR 4 R 5 X is alkyl, alkenyl, alkynyl, aryl, heterocyclic group, halogen atom, haloalkyl, cyano, nitro, NR 4 R 5 , CONR 4 R 5 , S (O) n R 3 , OR 2 , COR 2 or COOR 2 ; A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , cyano, alkyl, cycloalkyl, aryl, heterocyclic group, SCH 2 COOR 2 , NHNR 4 R 5 , C OOR 2 , nitro or —CH (CN) 2 ; R 2 is a hydrogen atom, alkyl, alkenyl, alkynyl, haloalkyl, cyanoalkyl, alkoxyalkyl, acetyl, benzyl or aryl; R 3 is alkyl or acetyl R 4 is a hydrogen atom or alkyl; R 5 is a hydrogen atom, alkyl, cycloalkyl, haloalkyl, COR 2 , COOR 2 , S (O) n R 3 , CH 2 CH 2 OR 2 or CH 2 CN. M is an integer of 1 to 4; n is an integer of 0 to 2], or a salt thereof.
The present invention also relates to a pest control agent comprising a pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof as an active ingredient.
また、本発明は、式(I)のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分とする有害生物防除剤に関する。 [Wherein R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, cyano, aryl , A heterocyclic group which may be substituted with alkyl, CH═NOR 2 , CH═NNR 4 R 5 , COR 2 , COOR 2 , OR 2 , S (O) n R 3 , NR 4 R 5 or CONR 4 R 5 X is alkyl, alkenyl, alkynyl, aryl, heterocyclic group, halogen atom, haloalkyl, cyano, nitro, NR 4 R 5 , CONR 4 R 5 , S (O) n R 3 , OR 2 , COR 2 or COOR 2 ; A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , cyano, alkyl, cycloalkyl, aryl, heterocyclic group, SCH 2 COOR 2 , NHNR 4 R 5 , C OOR 2 , nitro or —CH (CN) 2 ; R 2 is a hydrogen atom, alkyl, alkenyl, alkynyl, haloalkyl, cyanoalkyl, alkoxyalkyl, acetyl, benzyl or aryl; R 3 is alkyl or acetyl R 4 is a hydrogen atom or alkyl; R 5 is a hydrogen atom, alkyl, cycloalkyl, haloalkyl, COR 2 , COOR 2 , S (O) n R 3 , CH 2 CH 2 OR 2 or CH 2 CN. M is an integer of 1 to 4; n is an integer of 0 to 2], or a salt thereof.
The present invention also relates to a pest control agent comprising a pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof as an active ingredient.
前記式(I)のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分とする有害生物防除剤は、低薬量で有害生物に対して極めて高い防除効果を有する。
The pest control agent comprising the pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof as an active ingredient has a very high control effect against pests with a low dose.
式(I)中のmが2~4の整数である場合は、各Xは同一であっても相異なってもよい。
式(I)中のハロゲン原子又は置換基としてのハロゲン原子としては、フッ素、塩素、臭素又はヨウ素の各原子が挙げられる。置換基としてのハロゲン原子の数は1又は2以上であってよく、2以上の場合、各ハロゲン原子は同一でも相異なってもよい。また、ハロゲン原子の置換位置はいずれの位置でもよい。
式(I)中のアルキルとしては、直鎖状又は分枝状のいずれでもよく、その具体例としては、メチル、エチル、プロピル、イソプロピル、ブチル、tert-ブチル、ペンチル、ヘキシルのようなC1-6のものなどが挙げられる。
式(I)中のシクロアルキルとしては、シクロプロピル、シクロブチル、シクロペンチル、シクロヘキシルのようなC3-6のものなどが挙げられる。 When m in the formula (I) is an integer of 2 to 4, each X may be the same or different.
Examples of the halogen atom in the formula (I) or the halogen atom as a substituent include each atom of fluorine, chlorine, bromine or iodine. The number of halogen atoms as a substituent may be 1 or 2 or more, and in the case of 2 or more, each halogen atom may be the same or different. Further, the halogen atom may be substituted at any position.
The alkyl in the formula (I) may be linear or branched, and specific examples thereof include C 1 such as methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, hexyl. -6 and so on.
Examples of cycloalkyl in formula (I) include C 3-6 such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
式(I)中のハロゲン原子又は置換基としてのハロゲン原子としては、フッ素、塩素、臭素又はヨウ素の各原子が挙げられる。置換基としてのハロゲン原子の数は1又は2以上であってよく、2以上の場合、各ハロゲン原子は同一でも相異なってもよい。また、ハロゲン原子の置換位置はいずれの位置でもよい。
式(I)中のアルキルとしては、直鎖状又は分枝状のいずれでもよく、その具体例としては、メチル、エチル、プロピル、イソプロピル、ブチル、tert-ブチル、ペンチル、ヘキシルのようなC1-6のものなどが挙げられる。
式(I)中のシクロアルキルとしては、シクロプロピル、シクロブチル、シクロペンチル、シクロヘキシルのようなC3-6のものなどが挙げられる。 When m in the formula (I) is an integer of 2 to 4, each X may be the same or different.
Examples of the halogen atom in the formula (I) or the halogen atom as a substituent include each atom of fluorine, chlorine, bromine or iodine. The number of halogen atoms as a substituent may be 1 or 2 or more, and in the case of 2 or more, each halogen atom may be the same or different. Further, the halogen atom may be substituted at any position.
The alkyl in the formula (I) may be linear or branched, and specific examples thereof include C 1 such as methyl, ethyl, propyl, isopropyl, butyl, tert-butyl, pentyl, hexyl. -6 and so on.
Examples of cycloalkyl in formula (I) include C 3-6 such as cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
式(I)中のアルケニルとしては、直鎖状又は分枝状のいずれでもよく、その具体例としては、ビニル、1-プロペニル、アリル、イソプロペニル、1-ブテニル、1,3-ブタジエニル、1-ヘキセニルのようなC2-6のものなどが挙げられる。
式(I)中のアルキニルとしては、直鎖状又は分枝状のいずれでもよく、その具体例としては、エチニル、2-ブチニル、2-ペンチニル、3-メチル-1-ブチニル、2-ペンテン-4-イニル、3-ヘキシニルのようなC2-6のものなどが挙げられる。
式(I)中のアリールとしては、例えばフェニル、ナフチル等のC6-10アリールが挙げられる。 The alkenyl in the formula (I) may be linear or branched, and specific examples thereof include vinyl, 1-propenyl, allyl, isopropenyl, 1-butenyl, 1,3-butadienyl, -C 2-6 such as hexenyl.
The alkynyl in the formula (I) may be linear or branched, and specific examples thereof include ethynyl, 2-butynyl, 2-pentynyl, 3-methyl-1-butynyl, 2-pentene- Examples thereof include C 2-6 such as 4-ynyl and 3-hexynyl.
Examples of the aryl in the formula (I) include C 6-10 aryl such as phenyl and naphthyl.
式(I)中のアルキニルとしては、直鎖状又は分枝状のいずれでもよく、その具体例としては、エチニル、2-ブチニル、2-ペンチニル、3-メチル-1-ブチニル、2-ペンテン-4-イニル、3-ヘキシニルのようなC2-6のものなどが挙げられる。
式(I)中のアリールとしては、例えばフェニル、ナフチル等のC6-10アリールが挙げられる。 The alkenyl in the formula (I) may be linear or branched, and specific examples thereof include vinyl, 1-propenyl, allyl, isopropenyl, 1-butenyl, 1,3-butadienyl, -C 2-6 such as hexenyl.
The alkynyl in the formula (I) may be linear or branched, and specific examples thereof include ethynyl, 2-butynyl, 2-pentynyl, 3-methyl-1-butynyl, 2-pentene- Examples thereof include C 2-6 such as 4-ynyl and 3-hexynyl.
Examples of the aryl in the formula (I) include C 6-10 aryl such as phenyl and naphthyl.
式(I)中の複素環基としては、単環式複素環基の他、縮合複素環基が含まれる。単環式複素環基としては、例えばオキシラニルのような3員複素環基;フリル、テトラヒドロフリル、チエニル、ピロリル、ピロリニル、ピロリジニル、ジオキソラニル、オキサゾリル、オキサゾリニル、イソキサゾリル、チアゾリル、チアゾリニル、イソチアゾリル、イミダゾリル、イミダゾリニル、イミダゾリジニル、オキサゾリジニル、チアゾリジニル、ピラゾリル、ピラゾリニル、ピラゾリジニル、トリアゾリル、オキサジアゾリル、チアジアゾリル、テトラゾリルなどの5員複素環基;ピラニル、ピリジル、ピペリジニル、ジオキサニル、オキサジニル、モルホリニル、チアジニル、ピリダジニル、ピリミジニル、ピラジニル、ピペラジニル、トリアジニルなどの6員複素環基が挙げられる。これら単環式複素環基の中では、O、S及びNからなる群より選ばれる少なくとも1種の原子を1~4含有する5若しくは6員複素環基が望ましい。縮合複素環基としては、例えばベンゾフラニル、イソベンゾフラニル、ジヒドロベンゾフラニル、ジヒドロイソベンゾフラニル、ベンゾチエニル、イソベンゾチエニル、ジヒドロベンゾチエニル、ジヒドロイソベンゾチエニル、テトラヒドロベンゾチエニル、インドリル、イソインドリル、ベンゾオキサゾリル、ベンゾチアゾリル、インダゾリル、ベンズイミダゾリル、ベンゾジオキソラニル、ベンゾジオキサニル、クロメニル、クロマニル、イソクロマニル、クロモニル、クロマノニル、キノリル、イソキノリル、シンノリニル、フタラジニル、キナゾリニル、キノキサリニル、インドリジニル、キノリジニル、イミダゾピリジル、ナフチリジニル、プテリジニル、ジヒドロベンゾオキサジニル、ジヒドロベンゾオキサゾリノニル、ジヒドロベンゾオキサジノニル、ベンゾチオキサニルなどが挙げられる。これら縮合複素環基の中では、O、S及びNからなる群より選ばれる少なくとも1種の原子を1~4含有する8~10員縮合複素環基が望ましい。
The heterocyclic group in the formula (I) includes a condensed heterocyclic group in addition to a monocyclic heterocyclic group. The monocyclic heterocyclic group includes, for example, a 3-membered heterocyclic group such as oxiranyl; furyl, tetrahydrofuryl, thienyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, dioxolanyl, oxazolyl, oxazolinyl, isoxazolyl, thiazolyl, thiazolinyl, isothiazolyl, imidazolyl, imidazolinyl 5-membered heterocyclic groups such as imidazolidinyl, oxazolidinyl, oxazolidinyl, thiazolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl; And 6-membered heterocyclic groups such as triazinyl. Among these monocyclic heterocyclic groups, a 5- or 6-membered heterocyclic group containing 1 to 4 atoms of at least one atom selected from the group consisting of O, S and N is desirable. Examples of the condensed heterocyclic group include benzofuranyl, isobenzofuranyl, dihydrobenzofuranyl, dihydroisobenzofuranyl, benzothienyl, isobenzothienyl, dihydrobenzothienyl, dihydroisobenzothienyl, tetrahydrobenzothienyl, indolyl, isoindolyl, Benzoxazolyl, benzothiazolyl, indazolyl, benzimidazolyl, benzodioxolanyl, benzodioxanyl, chromenyl, chromanyl, isochromanyl, chromonyl, chromanonyl, quinolyl, isoquinolyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, indolizinyl, quinolizylyl , Naphthyridinyl, pteridinyl, dihydrobenzoxazinyl, dihydrobenzoxazolinonyl, dihydride Benzoxadiazoles nonyl, benzothiadiazole oxa sulfonyl and the like. Among these condensed heterocyclic groups, 8- to 10-membered condensed heterocyclic groups containing 1 to 4 at least one atom selected from the group consisting of O, S and N are desirable.
前記式(I)のピリジル-トリアゾロピリミジン誘導体の塩としては、農業上許容されるものであればあらゆるものが含まれるが、例えば、ジメチルアンモニウム塩、トリエチルアンモニウム塩のようなアンモニウム塩;塩酸塩、過塩素酸塩、硫酸塩、硝酸塩のような無機酸塩;酢酸塩、メタンスルホン酸塩のような有機酸塩などが挙げられる。
The salt of the pyridyl-triazolopyrimidine derivative of the formula (I) includes any agriculturally acceptable salt. Examples thereof include ammonium salts such as dimethylammonium salt and triethylammonium salt; hydrochloride Inorganic acid salts such as perchlorate, sulfate and nitrate; organic acid salts such as acetate and methanesulfonate.
前記式(I)のピリジル-トリアゾロピリミジン誘導体には、光学異性体、幾何異性体のような異性体が存在する場合があるが、本発明には各異性体及び異性体混合物の双方が含まれる。本願明細書においては、特に言及しない限り、異性体は混合物として記載する。尚、本発明には、当該技術分野における技術常識の範囲内において、前記したもの以外の各種異性体も含まれる。また、異性体の種類によっては、前記式(I)とは異なる化学構造となる場合があるが、当業者であればそれらが異性体の関係にあることが十分認識できる為、本発明の範囲内であることは明らかである。
The pyridyl-triazolopyrimidine derivative of the formula (I) may have isomers such as optical isomers and geometric isomers, but the present invention includes both isomers and isomer mixtures. It is. In the present specification, unless otherwise specified, isomers are described as a mixture. The present invention also includes various isomers other than those described above within the scope of technical common sense in the technical field. Depending on the type of isomer, there may be a chemical structure different from that of the formula (I). However, since those skilled in the art can fully recognize that they are related to isomers, the scope of the present invention. It is clear that it is within.
前記式(I)のピリジル-トリアゾロピリミジン誘導体又その塩は、以下の製法〔1〕~〔9〕並びに、通常の塩の製造方法に従って製造することができ、また、後記合成例に従って製造することができる。
製法〔1〕 The pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof can be produced according to the following production methods [1] to [9] and usual salt production methods, and is also produced according to the synthesis examples described later. be able to.
Manufacturing method [1]
製法〔1〕 The pyridyl-triazolopyrimidine derivative of the formula (I) or a salt thereof can be produced according to the following production methods [1] to [9] and usual salt production methods, and is also produced according to the synthesis examples described later. be able to.
Manufacturing method [1]
製法〔1〕中、R1aはA1で置換されてもよいアルキル、A1で置換されてもよいシクロアルキル、A1で置換されてもよいアルケニル、A1で置換されてもよいアルキニル、アリール又はアルキルで置換されてもよい複素環基であり;A1は、ハロゲン原子、OR2a、S(O)nR3、NR4R5a、シアノ、アルキル、シクロアルキル、アリール、複素環基、SCH2COOR2a、NHNR4R5a又は-CH(CN)2であり;R2aは水素原子、アルキル、アルケニル、アルキニル、ハロアルキル、アルコキシアルキル、アセチル、ベンジル又はアリールであり;R5aは水素原子、アルキル、シクロアルキル、ハロアルキル、COR2a、COOR2a又はS(O)nR3であり;R6及びR7は各々独立にアルキルであり;R3、R4、X、m及びnは前述の通りである。
PRODUCTION PROCESS [1], R 1a is optionally substituted by by alkyl which may be, cycloalkyl which may be substituted by A 1, alkenyl which may be substituted by A 1, A 1 substituted by A 1 alkynyl, A heterocyclic group which may be substituted with aryl or alkyl; A 1 is a halogen atom, OR 2a , S (O) n R 3 , NR 4 R 5a , cyano, alkyl, cycloalkyl, aryl, heterocyclic group , SCH 2 COOR 2a , NHNR 4 R 5a or —CH (CN) 2 ; R 2a is a hydrogen atom, alkyl, alkenyl, alkynyl, haloalkyl, alkoxyalkyl, acetyl, benzyl or aryl; R 5a is a hydrogen atom , alkyl, cycloalkyl, haloalkyl, COR 2a, be COOR 2a or S (O) n R 3; R 6 and R 7 each independently is alkyl; R 3, R 4, X , m Fine n are as defined above.
製法〔1〕は、式(II)の化合物と、式(III)の化合物を縮合して、式(IV)のα,β-不飽和ケトン誘導体を得る前半の反応と、式(IV)の化合物と式(V)の化合物を縮合して、式(I-1)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を得る後半の反応とから成る。
In the production method [1], the compound of the formula (II) and the compound of the formula (III) are condensed to obtain the α, β-unsaturated ketone derivative of the formula (IV), the reaction of the formula (IV) The latter reaction consists of condensing the compound with the compound of formula (V) to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-1).
製法〔1〕前半の反応において、式(III)の化合物は、式(II)の化合物1モルに対して0.8~5当量、望ましくは1~3.5当量の割合で使用できる。本反応は、必要に応じて、溶媒の存在下で行うことができる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えばメタノール、エタノール、プロパノール、ブタノールなどのアルコール類;ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ペンタン、ヘキサン、ヘプタン、石油エーテル、リグロイン、石油ベンジンなどの脂肪族炭化水素類;ジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類;酢酸メチル、酢酸エチルなどのエステル類;アセトニトリル、プロピオニトリルなどのニトリル類;N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチルピロリジノンなどの酸アミド類;ジメチルスルホキシドなどのスルホキシド類;スルホランなどのスルホン類;ヘキサメチルホスホルアミドなどのリン酸アミド類;クロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類;及びこれらの混合溶媒を挙げることができる。反応温度は通常80~200℃、望ましくは100~150℃である。反応時間は通常2~48時間である。
Production Method [1] In the first half of the reaction, the compound of formula (III) can be used at a ratio of 0.8 to 5 equivalents, preferably 1 to 3.5 equivalents, per 1 mol of the compound of formula (II). This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction. For example, alcohols such as methanol, ethanol, propanol and butanol; aromatic hydrocarbons such as benzene, toluene and xylene; pentane, hexane, heptane, Aliphatic hydrocarbons such as petroleum ether, ligroin and petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; esters such as methyl acetate and ethyl acetate; acetonitrile, propionitrile and the like Nitriles; acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone; sulfoxides such as dimethyl sulfoxide; sulfones such as sulfolane; hexamethyl phosphorami Phosphoric acid amides such as; may be mentioned, and a mixed solvent thereof; chloroform, dichloromethane, carbon tetrachloride, halogenated hydrocarbons such as 1,2-dichloroethane. The reaction temperature is usually from 80 to 200 ° C, preferably from 100 to 150 ° C. The reaction time is usually 2 to 48 hours.
製法〔1〕後半の反応において、式(V)の化合物は、式(IV)の化合物1モルに対して、0.8~10当量、望ましくは1~2.5当量の割合で使用できる。本反応は、必要に応じて、溶媒の存在下で行うことができる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えば酢酸、プロピオン酸などのカルボン酸類;メタノール、エタノール、プロパノール、ブタノールなどのアルコール類;ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ペンタン、ヘキサン、ヘプタン、石油エーテル、リグロイン、石油ベンジンなどの脂肪族炭化水素類;ジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類;酢酸メチル、酢酸エチルなどのエステル類;アセトニトリル、プロピオニトリルなどのニトリル類;N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチルピロリジノンなどの酸アミド類;ジメチルスルホキシドなどのスルホキシド類;スルホランなどのスルホン類;ヘキサメチルホスホルアミドなどのリン酸アミド類;クロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類;及びこれらの混合溶媒を挙げることができるが、中でもカルボン酸類が望ましい。反応温度は通常50~150℃、望ましくは80~120℃である。反応時間は通常0.5~100時間である。
製法〔2〕 Production Method [1] In the latter half of the reaction, the compound of formula (V) can be used in a proportion of 0.8 to 10 equivalents, preferably 1 to 2.5 equivalents, relative to 1 mol of the compound of formula (IV). This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction, for example, carboxylic acids such as acetic acid and propionic acid; alcohols such as methanol, ethanol, propanol and butanol; aromatic carbonization such as benzene, toluene and xylene. Hydrogen: aliphatic hydrocarbons such as pentane, hexane, heptane, petroleum ether, ligroin, petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran, dioxane; esters such as methyl acetate and ethyl acetate Nitriles such as acetonitrile and propionitrile; acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone; sulfoxides such as dimethyl sulfoxide; sulfolane and the like Examples include sulfones; phosphoric acid amides such as hexamethylphosphoramide; halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane; and mixed solvents thereof. Acids are desirable. The reaction temperature is usually 50 to 150 ° C., desirably 80 to 120 ° C. The reaction time is usually 0.5 to 100 hours.
Manufacturing method [2]
製法〔2〕 Production Method [1] In the latter half of the reaction, the compound of formula (V) can be used in a proportion of 0.8 to 10 equivalents, preferably 1 to 2.5 equivalents, relative to 1 mol of the compound of formula (IV). This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction, for example, carboxylic acids such as acetic acid and propionic acid; alcohols such as methanol, ethanol, propanol and butanol; aromatic carbonization such as benzene, toluene and xylene. Hydrogen: aliphatic hydrocarbons such as pentane, hexane, heptane, petroleum ether, ligroin, petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran, dioxane; esters such as methyl acetate and ethyl acetate Nitriles such as acetonitrile and propionitrile; acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone; sulfoxides such as dimethyl sulfoxide; sulfolane and the like Examples include sulfones; phosphoric acid amides such as hexamethylphosphoramide; halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane; and mixed solvents thereof. Acids are desirable. The reaction temperature is usually 50 to 150 ° C., desirably 80 to 120 ° C. The reaction time is usually 0.5 to 100 hours.
Manufacturing method [2]
製法〔2〕中、Yはハロゲン原子であり、R3、X及びmは前述の通りである。Yのハロゲン原子としてはフッ素、塩素、臭素又は沃素の各原子が挙げられる。
PRODUCTION PROCESS [2], Y is a halogen atom, R 3, X and m are as defined above. Examples of the halogen atom for Y include fluorine, chlorine, bromine and iodine atoms.
製法〔2〕は、式(II)の化合物と、二硫化炭素と、式(VI)の化合物とを反応させ、式(VII)のα,β-不飽和ケトン誘導体を得る前半の反応と、式(VII)の化合物と式(V)の化合物を縮合し、式(I-2)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を得る後半の反応とから成る。
The production method [2] includes a reaction in the first half to obtain an α, β-unsaturated ketone derivative of the formula (VII) by reacting a compound of the formula (II), carbon disulfide and a compound of the formula (VI). The latter reaction consists of condensing the compound of formula (VII) with the compound of formula (V) to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-2).
製法〔2〕前半の反応において、二硫化炭素及び式(VI)の化合物は、各々式(II)の化合物1モルに対して0.8~5当量、望ましくは1~3当量の割合で使用できる。本反応において、式(VII)の化合物は、塩基及び溶媒の存在下で反応させることにより製造することができる。塩基としては、例えば水素化ナトリウム、水素化カリウムのようなアルカリ金属水素化物;水酸化ナトリウム、水酸化カリウムのようなアルカリ金属水酸化物;ナトリウム、カリウムのようなアルカリ金属;ナトリウムメトキシド、ナトリウムエトキシド、カリウム第3級ブトキシドのようなアルカリ金属アルコキシド;などを挙げることができる。塩基は、式(II)の化合物1モルに対して1~10当量、望ましくは1~3当量の割合で使用できる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔1〕前半の反応と同様のものを挙げることができる。反応温度は通常0~100℃、望ましくは10~50℃である。反応時間は通常6~48時間である。
Production method [2] In the first half of the reaction, carbon disulfide and the compound of formula (VI) are used in an amount of 0.8 to 5 equivalents, preferably 1 to 3 equivalents, per 1 mol of the compound of formula (II). it can. In this reaction, the compound of formula (VII) can be produced by reacting in the presence of a base and a solvent. Examples of the base include alkali metal hydrides such as sodium hydride and potassium hydride; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metals such as sodium and potassium; sodium methoxide and sodium Ethoxide, alkali metal alkoxides such as potassium tertiary butoxide; and the like. The base can be used in an amount of 1 to 10 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (II). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the first half of the production method [1]. The reaction temperature is usually 0 to 100 ° C., preferably 10 to 50 ° C. The reaction time is usually 6 to 48 hours.
製法〔2〕後半の反応において、式(V)の化合物は、式(VII)の化合物1モルに対して0.8~5当量、望ましくは1~3当量の割合で使用できる。本反応は、必要に応じて、塩基及び溶媒の存在下で行うことができる。塩基としては、例えば水素化ナトリウム、水素化カリウムのようなアルカリ金属水素化物;水酸化ナトリウム、水酸化カリウムのようなアルカリ金属水酸化物;ナトリウム、カリウムのようなアルカリ金属;ナトリウムメトキシド、ナトリウムエトキシド、カリウム第3級ブトキシドのようなアルカリ金属アルコキシド;炭酸ナトリウム、炭酸カリウムのようなアルカリ金属炭酸塩;重炭酸ナトリウム、重炭酸カリウムのようなアルカリ金属重炭酸塩;トリエチルアミン、ピリジンのような有機塩基;などを挙げることができる。塩基は、式(V)の化合物1モルに対して1~5当量、望ましくは1~3当量の割合で使用できる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔1〕前半の反応と同様のものを挙げることができる。反応温度は通常100~200℃である。反応時間は通常0.1~10時間である。
製法〔3〕 Production method [2] In the latter half of the reaction, the compound of the formula (V) can be used in a proportion of 0.8 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of the formula (VII). This reaction can be performed in the presence of a base and a solvent, if necessary. Examples of the base include alkali metal hydrides such as sodium hydride and potassium hydride; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metals such as sodium and potassium; sodium methoxide and sodium Alkali metal alkoxides such as ethoxide and potassium tertiary butoxide; alkali metal carbonates such as sodium carbonate and potassium carbonate; alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate; such as triethylamine and pyridine Organic bases; and the like. The base can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (V). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the first half of the production method [1]. The reaction temperature is usually 100 to 200 ° C. The reaction time is usually 0.1 to 10 hours.
Manufacturing method [3]
製法〔3〕 Production method [2] In the latter half of the reaction, the compound of the formula (V) can be used in a proportion of 0.8 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of the formula (VII). This reaction can be performed in the presence of a base and a solvent, if necessary. Examples of the base include alkali metal hydrides such as sodium hydride and potassium hydride; alkali metal hydroxides such as sodium hydroxide and potassium hydroxide; alkali metals such as sodium and potassium; sodium methoxide and sodium Alkali metal alkoxides such as ethoxide and potassium tertiary butoxide; alkali metal carbonates such as sodium carbonate and potassium carbonate; alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate; such as triethylamine and pyridine Organic bases; and the like. The base can be used in an amount of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (V). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the first half of the production method [1]. The reaction temperature is usually 100 to 200 ° C. The reaction time is usually 0.1 to 10 hours.
Manufacturing method [3]
製法〔3〕中、R3、X及びmは前述の通りであり、naは1~2の整数である。
In the production method [3], R 3 , X and m are as described above, and na is an integer of 1 to 2.
製法〔3〕では、式(I-2)の化合物と酸化剤とを溶媒の存在下で反応させることにより、式(I-3)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を製造することができる。
In the production method [3], the compound of formula (I-2) and an oxidizing agent are reacted in the presence of a solvent to thereby react [1,2,4] triazolo [1,5-a of formula (I-3). Pyrimidine derivatives can be produced.
上記反応で使用する酸化剤としては、例えば、過酸化水素、過酢酸、m-クロロ過安息香酸などを挙げることができる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えばクロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類;アセトン、ジメチルエチルケトンなどのケトン類;ジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類;酢酸、プロピオン酸などのカルボン酸類;及びこれらの混合溶媒を挙げることができる。酸化剤は、式(I-2)の化合物1モルに対して1~3当量の割合で使用できる。反応温度は通常、室温~還流温度である。反応時間は通常1~24時間である。
製法〔4〕 Examples of the oxidizing agent used in the above reaction include hydrogen peroxide, peracetic acid, m-chloroperbenzoic acid, and the like. The solvent may be any solvent that is inert to the reaction, for example, halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane; ketones such as acetone and dimethyl ethyl ketone; Mention may be made of ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; carboxylic acids such as acetic acid and propionic acid; and mixed solvents thereof. The oxidizing agent can be used in a ratio of 1 to 3 equivalents per 1 mol of the compound of the formula (I-2). The reaction temperature is usually room temperature to reflux temperature. The reaction time is usually 1 to 24 hours.
Manufacturing method [4]
製法〔4〕 Examples of the oxidizing agent used in the above reaction include hydrogen peroxide, peracetic acid, m-chloroperbenzoic acid, and the like. The solvent may be any solvent that is inert to the reaction, for example, halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane; ketones such as acetone and dimethyl ethyl ketone; Mention may be made of ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; carboxylic acids such as acetic acid and propionic acid; and mixed solvents thereof. The oxidizing agent can be used in a ratio of 1 to 3 equivalents per 1 mol of the compound of the formula (I-2). The reaction temperature is usually room temperature to reflux temperature. The reaction time is usually 1 to 24 hours.
Manufacturing method [4]
製法〔4〕中、R1bはA1で置換されてもよいアルキル、A1で置換されてもよいシクロアルキル、A1で置換されてもよいアルケニル、A1で置換されてもよいアルキニル、ハロゲン原子、シアノ、アリール、アルキルで置換されてもよい複素環基、OR2a又はNR4R5aであり;R2a、R4、R5a、A1、X及びmは前述の通りである。
PRODUCTION PROCESS [4], R 1b is optionally substituted by by alkyl which may be, cycloalkyl which may be substituted by A 1, alkenyl which may be substituted by A 1, A 1 substituted by A 1 alkynyl, A halogen atom, cyano, aryl, an optionally substituted heterocyclic group, OR 2a or NR 4 R 5a ; R 2a , R 4 , R 5a , A 1 , X and m are as defined above.
製法〔4〕では、式(I-3)の化合物と求核試薬とを溶媒の存在下で反応させることにより、式(I-4)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を製造することができる。
In the production method [4], the compound of the formula (I-3) is reacted with a nucleophile in the presence of a solvent to thereby react [1,2,4] triazolo [1,5- a] Pyrimidine derivatives can be produced.
求核試薬としては、例えばナトリウムメトキシド、ナトリウムエトキシドのようなアルカリ金属アルコキシド;ナトリウムメチルメルカプタンようなアルカリ金属メルカプチド;メチルアミン、ジメチルアミン、ピペリジンのような1級又は2級アミン類;メチルマグネシウムブロマイド、エチルマグネシウムブロマイド、フェニルマグネシウムブロマイドのような有機金属試薬;フッ化カリウム、フッ化セシウム、テトラブチルアンモニウムフルオライドのようなフッ素化剤;などを挙げることができる。求核試薬は、式(I-3)の化合物1モルに対して1~5当量、望ましくは1~3当量の割合で使用できる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えばメタノール、エタノール、プロパノール、ブタノールなどのアルコール類;ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ペンタン、ヘキサン、ヘプタン、石油エーテル、リグロイン、石油ベンジンなどの脂肪族炭化水素類;ジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類;酢酸メチル、酢酸エチルなどのエステル類;アセトニトリル、プロピオニトリルなどのニトリル類;N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチルピロリジノンなどの酸アミド類;ジメチルスルホキシドなどのスルホキシド類;及びこれらの混合溶媒を挙げることができる。反応温度は通常-100~50℃、望ましくは-70~30℃である。反応時間は通常1分~48時間である。
製法〔5〕 Examples of the nucleophile include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal mercaptides such as sodium methyl mercaptan; primary or secondary amines such as methylamine, dimethylamine and piperidine; And organometallic reagents such as bromide, ethylmagnesium bromide, and phenylmagnesium bromide; fluorinating agents such as potassium fluoride, cesium fluoride, and tetrabutylammonium fluoride; The nucleophilic reagent can be used in a ratio of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (I-3). Any solvent may be used as long as it is inert to the reaction. For example, alcohols such as methanol, ethanol, propanol and butanol; aromatic hydrocarbons such as benzene, toluene and xylene; pentane, hexane and heptane Aliphatic ethers such as petroleum ether, ligroin and petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; esters such as methyl acetate and ethyl acetate; acetonitrile, propionitrile and the like Nitriles; acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone; sulfoxides such as dimethyl sulfoxide; and mixed solvents thereof. The reaction temperature is usually −100 to 50 ° C., desirably −70 to 30 ° C. The reaction time is usually 1 minute to 48 hours.
Manufacturing method [5]
製法〔5〕 Examples of the nucleophile include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal mercaptides such as sodium methyl mercaptan; primary or secondary amines such as methylamine, dimethylamine and piperidine; And organometallic reagents such as bromide, ethylmagnesium bromide, and phenylmagnesium bromide; fluorinating agents such as potassium fluoride, cesium fluoride, and tetrabutylammonium fluoride; The nucleophilic reagent can be used in a ratio of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of formula (I-3). Any solvent may be used as long as it is inert to the reaction. For example, alcohols such as methanol, ethanol, propanol and butanol; aromatic hydrocarbons such as benzene, toluene and xylene; pentane, hexane and heptane Aliphatic ethers such as petroleum ether, ligroin and petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; esters such as methyl acetate and ethyl acetate; acetonitrile, propionitrile and the like Nitriles; acid amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidinone; sulfoxides such as dimethyl sulfoxide; and mixed solvents thereof. The reaction temperature is usually −100 to 50 ° C., desirably −70 to 30 ° C. The reaction time is usually 1 minute to 48 hours.
Manufacturing method [5]
製法〔5〕中、R8はアルキルであり;R1a、X及びmは前述の通りである。
In the production process [5], R 8 is alkyl; R 1a , X and m are as described above.
製法〔5〕は、式(II)の化合物と、式(VIII)の化合物とを反応させ、式(IX)の化合物を得る前半の反応と、式(IX)の化合物と式(V)の化合物を縮合し、式(I-5)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を得る後半の反応とから成る。
In the production method [5], the reaction of the first half to obtain the compound of the formula (IX) by reacting the compound of the formula (II) with the compound of the formula (VIII), the compound of the formula (IX) and the compound of the formula (V) The latter reaction consists of condensing the compound to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-5).
製法〔5〕前半の反応において、式(VIII)の化合物は、式(II)の化合物1モルに対して0.8当量~大過剰量、望ましくは1~10当量の割合で使用できる。本反応において、式(IX)の化合物は、塩基及び溶媒の存在下で反応させることにより製造することができる。塩基としては、例えば前記製法〔2〕前半の反応と同様のものなどを挙げることができる。塩基は、式(II)の化合物に対して1~5当量、望ましくは1~2当量の割合で使用できる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えばメタノール、エタノール、プロパノール、ブタノールなどのアルコール類;ベンゼン、トルエン、キシレンなどの芳香族炭化水素類;ペンタン、ヘキサン、ヘプタン、石油エーテル、リグロイン、石油ベンジンなどの脂肪族炭化水素類;ジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、テトラヒドロフラン、ジオキサンなどのエーテル類;N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチルピロリジノンなどの酸アミド類;ジメチルスルホキシドなどのスルホキシド類;スルホランなどのスルホン類;クロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類;及びこれらの混合溶媒を挙げることができるが、中でもエーテル類が望ましい。反応温度は通常0~70℃、望ましくは10~50℃である。反応時間は通常0.1~24時間である。
Process [5] In the first half of the reaction, the compound of formula (VIII) can be used in a proportion of 0.8 equivalent to large excess, preferably 1 to 10 equivalents, relative to 1 mol of the compound of formula (II). In this reaction, the compound of formula (IX) can be produced by reacting in the presence of a base and a solvent. Examples of the base include those similar to the reaction in the first half of the above production method [2]. The base can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to the compound of formula (II). Any solvent may be used as long as it is inert to the reaction. For example, alcohols such as methanol, ethanol, propanol and butanol; aromatic hydrocarbons such as benzene, toluene and xylene; pentane, hexane, heptane, Aliphatic hydrocarbons such as petroleum ether, ligroin and petroleum benzine; ethers such as diethyl ether, dipropyl ether, dibutyl ether, tetrahydrofuran and dioxane; N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl Acid amides such as pyrrolidinone; sulfoxides such as dimethyl sulfoxide; sulfones such as sulfolane; halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, 1,2-dichloroethane; and a mixed solvent thereof. You can gel, among others ethers are preferred. The reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C. The reaction time is usually 0.1 to 24 hours.
製法〔5〕後半の反応において、式(V)の化合物は、式(IX)の化合物1モルに対して0.8~10当量、望ましくは1~2.5当量の割合で使用できる。本反応において、式(I-5)の化合物は、溶媒の存在下で製造することができる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔1〕後半の反応と同様のものを挙げることができるが、中でもカルボン酸類が望ましい。なお、式(IX)が、常温で液体である場合、製法〔5〕前半の反応後、当該化合物を単離することなく、引き続き、製法〔5〕後半の反応を行うことができる。反応温度は通常50~150℃、望ましくは80~120℃である。反応時間は通常0.5~100時間である。
製法〔6〕 Production Method [5] In the latter half of the reaction, the compound of the formula (V) can be used in a proportion of 0.8 to 10 equivalents, preferably 1 to 2.5 equivalents, relative to 1 mol of the compound of the formula (IX). In this reaction, the compound of formula (I-5) can be produced in the presence of a solvent. The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the latter half of the above production method [1]. Among them, carboxylic acids are preferable. In addition, when Formula (IX) is a liquid at normal temperature, after the reaction in the first half of the production method [5], the reaction in the latter half of the production method [5] can be carried out without isolating the compound. The reaction temperature is usually 50 to 150 ° C., desirably 80 to 120 ° C. The reaction time is usually 0.5 to 100 hours.
Manufacturing method [6]
製法〔6〕 Production Method [5] In the latter half of the reaction, the compound of the formula (V) can be used in a proportion of 0.8 to 10 equivalents, preferably 1 to 2.5 equivalents, relative to 1 mol of the compound of the formula (IX). In this reaction, the compound of formula (I-5) can be produced in the presence of a solvent. The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction in the latter half of the above production method [1]. Among them, carboxylic acids are preferable. In addition, when Formula (IX) is a liquid at normal temperature, after the reaction in the first half of the production method [5], the reaction in the latter half of the production method [5] can be carried out without isolating the compound. The reaction temperature is usually 50 to 150 ° C., desirably 80 to 120 ° C. The reaction time is usually 0.5 to 100 hours.
Manufacturing method [6]
製法〔6〕中、R1cはハロゲン原子であり;R9及びR10は各々独立にアルキルであり;X、Y及びmは前述の通りである。R1cのハロゲン原子としてはフッ素、塩素又は臭素の各原子が挙げられる。
In the production process [6], R 1c is a halogen atom; R 9 and R 10 are each independently alkyl; X, Y, and m are as described above. Examples of the halogen atom for R 1c include fluorine, chlorine and bromine atoms.
製法〔6〕では、上記(a)~(e)の反応によって、式(I-6)の化合物を製造できる。個々の反応については、以下に詳述する。
In the production method [6], the compound of the formula (I-6) can be produced by the reactions (a) to (e) above. Each reaction is described in detail below.
(a) 式(XII)の化合物は、式(X)の化合物と式(XI)の化合物とを塩基及び溶媒の存在下で反応させることにより製造することができる。式(XI)の化合物は、式(X)の化合物1モルに対して0.8当量~大過剰量、望ましくは1~30当量の割合で使用できる。塩基としては、例えば前記製法〔2〕前半の反応と同様のものなどを挙げることができる。塩基は、式(X)の化合物1モルに対して1~5当量、望ましくは1~2当量の割合で使用できる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔5〕前半の反応と同様のものを挙げることができるが、中でもエーテル類が望ましい。反応温度は通常0~70℃、望ましくは10~50℃である。反応時間は通常0.1~24時間である。
(a) The compound of the formula (XII) can be produced by reacting the compound of the formula (X) with the compound of the formula (XI) in the presence of a base and a solvent. The compound of the formula (XI) can be used in a proportion of 0.8 equivalent to a large excess, desirably 1 to 30 equivalent, relative to 1 mol of the compound of the formula (X). Examples of the base include those similar to the reaction in the first half of the above production method [2]. The base can be used at a ratio of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (X). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include those similar to the reaction in the first half of the above production method [5]. Among them, ethers are desirable. The reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C. The reaction time is usually 0.1 to 24 hours.
(b) 式(XIII)の化合物は、式(XII)の化合物を塩基及び水の存在下で加水分解させることにより製造することができる。塩基としては、例えば水酸化ナトリウム、水酸化カリウムのようなアルカリ金属水酸化物を挙げることができる。塩基は、式(XII)の化合物に対して1当量~大過剰量の割合で使用できる。反応温度は通常0~70℃、望ましくは10~50℃である。反応時間は通常0.1~24時間である。
(b) The compound of the formula (XIII) can be produced by hydrolyzing the compound of the formula (XII) in the presence of a base and water. Examples of the base include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide. The base can be used in a proportion of 1 equivalent to a large excess with respect to the compound of the formula (XII). The reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C. The reaction time is usually 0.1 to 24 hours.
(c) 式(XIV)の化合物は、式(XIII)の化合物とハロゲン化剤とを溶媒の存在下で反応させることにより製造することができる。ハロゲン化剤としては、塩化チオニル、二塩化オキサリルなどを挙げることができる。ハロゲン化剤は、式(XIII)の化合物1モルに対して1~5当量、望ましくは1~2当量の割合で使用できる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えばクロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類を挙げることができる。反応温度は通常0~100℃、望ましくは10~50℃である。反応時間は通常0.1~24時間である。
(c) The compound of formula (XIV) can be produced by reacting the compound of formula (XIII) with a halogenating agent in the presence of a solvent. Examples of the halogenating agent include thionyl chloride and oxalyl dichloride. The halogenating agent can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (XIII). The solvent may be any solvent that is inert to the reaction, and examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane. The reaction temperature is usually 0 to 100 ° C., preferably 10 to 50 ° C. The reaction time is usually 0.1 to 24 hours.
(d) 式(XV)の4,5-ジヒドロ-5-オキソ[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体は、式(XIV)の化合物と式(V)の化合物とを縮合することにより製造することができる。式(V)の化合物は、式(XIV)の化合物1モルに対して0.8~10当量、望ましくは1~2.5当量の割合で使用できる。本反応は、必要に応じて、溶媒の存在下で行うことができる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔5〕前半の反応と同様のものを挙げることができるが、中でも酸アミド類が望ましい。反応温度は通常0~150℃、望ましくは20~100℃である。反応時間は通常0.5~100時間である。
(d) 4,5-dihydro-5-oxo [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (XV) is a compound of formula (XIV) and a compound of formula (V) Can be produced by condensation. The compound of the formula (V) can be used in a ratio of 0.8 to 10 equivalents, desirably 1 to 2.5 equivalents, relative to 1 mol of the compound of the formula (XIV). This reaction can be performed in the presence of a solvent, if necessary. Any solvent may be used as long as it is inert to the reaction. For example, the same reaction as in the first half of the above production method [5] can be mentioned, but acid amides are particularly desirable. The reaction temperature is usually 0 to 150 ° C., preferably 20 to 100 ° C. The reaction time is usually 0.5 to 100 hours.
(e) 式(I-6)の5-ハロ[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体は、化合物(XV)の化合物とハロゲン化剤とを反応させることにより製造することができる。ハロゲン化剤としては、塩化チオニル、オキシ塩化リン、オキシ臭化リンなどを挙げることができる。ハロゲン化剤は、式(XV)の化合物1モルに対して1~20当量、望ましくは1~8当量の割合で使用できる。本反応は、必要に応じて、溶媒の存在下で行うことができる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えばクロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類が挙げられる。反応温度は通常0~150℃、望ましくは20~100℃である。反応時間は通常0.1~24時間である。
製法〔7〕 (e) The 5-halo [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-6) is produced by reacting the compound of compound (XV) with a halogenating agent. be able to. Examples of the halogenating agent include thionyl chloride, phosphorus oxychloride, phosphorus oxybromide and the like. The halogenating agent can be used in a proportion of 1 to 20 equivalents, preferably 1 to 8 equivalents, relative to 1 mol of the compound of the formula (XV). This reaction can be performed in the presence of a solvent, if necessary. The solvent may be any solvent that is inert to the reaction, and examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, 1,2-dichloroethane. The reaction temperature is usually 0 to 150 ° C., preferably 20 to 100 ° C. The reaction time is usually 0.1 to 24 hours.
Manufacturing method [7]
製法〔7〕 (e) The 5-halo [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-6) is produced by reacting the compound of compound (XV) with a halogenating agent. be able to. Examples of the halogenating agent include thionyl chloride, phosphorus oxychloride, phosphorus oxybromide and the like. The halogenating agent can be used in a proportion of 1 to 20 equivalents, preferably 1 to 8 equivalents, relative to 1 mol of the compound of the formula (XV). This reaction can be performed in the presence of a solvent, if necessary. The solvent may be any solvent that is inert to the reaction, and examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, 1,2-dichloroethane. The reaction temperature is usually 0 to 150 ° C., preferably 20 to 100 ° C. The reaction time is usually 0.1 to 24 hours.
Manufacturing method [7]
製法〔7〕中、R9、R1a、X及びmは前述の通りである。
In the production method [7], R 9 , R 1a , X and m are as described above.
製法〔7〕は、式(X)の化合物と、式(XVI)の化合物とを反応させ、式(IX)の化合物を得る前半の反応と、式(IX)の化合物と式(V)の化合物を縮合し、式(I-5)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を得る後半の反応とから成る。
In the production method [7], the compound of formula (X) is reacted with the compound of formula (XVI) to obtain the compound of formula (IX), and the compound of formula (IX) and formula (V) The latter reaction consists of condensing the compound to obtain the [1,2,4] triazolo [1,5-a] pyrimidine derivative of formula (I-5).
製法〔7〕前半の反応において、式(XVI)の化合物は、式(X)の化合物1モルに対して0.8当量~大過剰量、望ましくは1~10当量の割合で使用できる。本反応において、式(IX)の化合物は塩基及び溶媒の存在下で製造することができる。塩基としては、例えば前記製法〔5〕前半の反応と同様のものなどを挙げることができる。塩基は、式(X)の化合物1モルに対して1~5当量、望ましくは1~2当量の割合で使用できる。溶媒としては反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔5〕前半の反応と同様のものを挙げることができるが、中でもエーテル類が望ましい。反応温度は通常0~70℃、望ましくは10~50℃である。反応時間は、通常0.1~24時間である。
製法〔7〕後半の反応は、前記した製法〔5〕後半の反応と同様に行うことができる。製法〔8〕 Production Method [7] In the first half of the reaction, the compound of the formula (XVI) can be used in a proportion of 0.8 equivalent to a large excess, preferably 1 to 10 equivalents, relative to 1 mol of the compound of the formula (X). In this reaction, the compound of formula (IX) can be produced in the presence of a base and a solvent. Examples of the base include those similar to the reaction in the first half of the above production method [5]. The base can be used at a ratio of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (X). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include those similar to the reaction in the first half of the above production method [5]. Among them, ethers are desirable. The reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C. The reaction time is usually 0.1 to 24 hours.
The reaction in the latter half of the production process [7] can be carried out in the same manner as the reaction in the latter half of the production process [5]. Manufacturing method [8]
製法〔7〕後半の反応は、前記した製法〔5〕後半の反応と同様に行うことができる。製法〔8〕 Production Method [7] In the first half of the reaction, the compound of the formula (XVI) can be used in a proportion of 0.8 equivalent to a large excess, preferably 1 to 10 equivalents, relative to 1 mol of the compound of the formula (X). In this reaction, the compound of formula (IX) can be produced in the presence of a base and a solvent. Examples of the base include those similar to the reaction in the first half of the above production method [5]. The base can be used at a ratio of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to 1 mol of the compound of the formula (X). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include those similar to the reaction in the first half of the above production method [5]. Among them, ethers are desirable. The reaction temperature is usually 0 to 70 ° C., preferably 10 to 50 ° C. The reaction time is usually 0.1 to 24 hours.
The reaction in the latter half of the production process [7] can be carried out in the same manner as the reaction in the latter half of the production process [5]. Manufacturing method [8]
製法〔8〕中、R11及びR12は各々独立に水素、アルキル又はシクロアルキルであり;X、Y及びmは前述の通りである。
In the production process [8], R 11 and R 12 are each independently hydrogen, alkyl or cycloalkyl; X, Y and m are as described above.
製法〔8〕では、式(I-7)の化合物とハロゲン化剤とを、溶媒と少量のラジカル開始剤の存在下で反応させることにより、式(I-8)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を製造することができる。本反応は、必要に応じ、光照射下で行うことができる。
In the production method [8], the compound of the formula (I-7) and the halogenating agent are reacted in the presence of a solvent and a small amount of a radical initiator to thereby produce [1,2,4 of the formula (I-8). ] A triazolo [1,5-a] pyrimidine derivative can be produced. This reaction can be performed under light irradiation as needed.
ハロゲン化剤としては、例えばN-クロロスクシンイミド、N-ブロモスクシンイミド、N-ヨードスクシンイミドなどを挙げることができる。ハロゲン化剤は、式(I-7)の化合物に対して1~5当量、望ましくは1~2当量の割合で使用できる。ラジカル開始剤としては、例えば過酸化ベンゾイル、アゾビスイソブチロニトリルなどを挙げることができる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えばクロロホルム、ジクロロメタン、四塩化炭素、1,2-ジクロロエタンなどのハロゲン化炭化水素類;などが挙げられる。反応温度は通常0~100℃、望ましくは10~80℃である。反応時間は、通常0.1~24時間である。
製法〔9〕 Examples of the halogenating agent include N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide and the like. The halogenating agent can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to the compound of formula (I-7). Examples of the radical initiator include benzoyl peroxide and azobisisobutyronitrile. Any solvent may be used as long as it is inert to the reaction. Examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane. The reaction temperature is usually 0 to 100 ° C., preferably 10 to 80 ° C. The reaction time is usually 0.1 to 24 hours.
Manufacturing method [9]
製法〔9〕 Examples of the halogenating agent include N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide and the like. The halogenating agent can be used in a proportion of 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to the compound of formula (I-7). Examples of the radical initiator include benzoyl peroxide and azobisisobutyronitrile. Any solvent may be used as long as it is inert to the reaction. Examples thereof include halogenated hydrocarbons such as chloroform, dichloromethane, carbon tetrachloride, and 1,2-dichloroethane. The reaction temperature is usually 0 to 100 ° C., preferably 10 to 80 ° C. The reaction time is usually 0.1 to 24 hours.
Manufacturing method [9]
製法〔9〕中、R13はA1で置換されてもよいアルキル、A1で置換されてもよいシクロアルキル、A1で置換されてもよいアルケニル、A1で置換されてもよいアルキニル、ハロゲン原子、シアノ、アリール、アルキルで置換されてもよい複素環基、OR14、SR14又はNR15R16であり、R14、R15及びR16は各々独立にA1で置換されてもよいアルキル、A1で置換されてもよいシクロアルキル、A1で置換されてもよいアルケニル又はA1で置換されてもよいアルキニルであり;R11、R12、A1、X及びmは前述の通りである。
PRODUCTION PROCESS [9], R 13 is optionally substituted by by alkyl which may be, cycloalkyl which may be substituted by A 1, alkenyl which may be substituted by A 1, A 1 substituted by A 1 alkynyl, A heterocyclic group which may be substituted with a halogen atom, cyano, aryl or alkyl, OR 14 , SR 14 or NR 15 R 16 , wherein R 14 , R 15 and R 16 may each independently be substituted with A 1 ; alkyl, cycloalkyl which may be substituted by A 1, is substituted with an alkenyl or A 1 may be substituted by A 1 be also good alkynyl; R 11, R 12, A 1, X and m are described above It is as follows.
製法〔9〕では、式(I-8)の化合物と求核試薬とを溶媒の存在下で反応させることにより、式(I-9)の[1,2,4]トリアゾロ[1,5-a]ピリミジン誘導体を製造することができる。
In the production method [9], the compound of the formula (I-8) is reacted with a nucleophile in the presence of a solvent to give [1,2,4] triazolo [1,5- a] Pyrimidine derivatives can be produced.
求核試薬としては、例えばナトリウムメトキシド、ナトリウムエトキシドのようなアルカリ金属アルコキシド;ナトリウムトリフルオロメチルエトキシドのようなアルカリ金属ハロアルコキシド;ナトリウムメチルメルカプタンのようなアルカリ金属メルカプチド;メチルアミン、ジメチルアミン、ピペリジン、モルホリンのような1級又は2級アミン類;メチルマグネシウムブロマイド、エチルマグネシウムブロマイド、フェニルマグネシウムブロマイドのような有機金属試薬;フッ化カリウム、フッ化セシウム、テトラブチルアンモニウムフルオライドのようなフッ素化剤;シアン化カリウム、シアン化ナトリウムのようなシアノ化剤;などを挙げることができる。求核試薬は、式(I-8)の化合物1モルに対して1~5当量、望ましくは1~3当量の割合で使用できる。溶媒としては、反応に不活性な溶媒であればいずれのものでもよく、例えば前記製法〔4〕の反応と同様のものを挙げることができる。反応温度は通常-100~50℃、望ましくは-70~20℃である。反応時間は通常6~48時間である。
Examples of nucleophiles include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal haloalkoxides such as sodium trifluoromethyl ethoxide; alkali metal mercaptides such as sodium methyl mercaptan; methylamine and dimethylamine Primary or secondary amines such as pyridine, piperidine, morpholine; organometallic reagents such as methylmagnesium bromide, ethylmagnesium bromide, phenylmagnesium bromide; fluorine such as potassium fluoride, cesium fluoride, tetrabutylammonium fluoride A cyanating agent such as potassium cyanide and sodium cyanide; and the like. The nucleophilic reagent can be used in a ratio of 1 to 5 equivalents, preferably 1 to 3 equivalents, relative to 1 mol of the compound of the formula (I-8). The solvent may be any solvent as long as it is inert to the reaction, and examples thereof include the same ones as in the reaction of the above production method [4]. The reaction temperature is usually −100 to 50 ° C., desirably −70 to 20 ° C. The reaction time is usually 6 to 48 hours.
また、前記した製法〔1〕、製法〔4〕、製法〔5〕又は製法〔7〕或は後記合成例1(1)~(2)と同様の方法によって製造できる下記式(I-10);
Further, the following formula (I-10) which can be produced by the same production method as described in the above production method [1], production method [4], production method [5] or production method [7] or Synthesis Example 1 (1) to (2) described later ;
(式中、Xaはアルキル、アリール、ハロゲン原子、ハロアルキル、シアノ、ニトロ、OR2b、COR2b又はCOOR2bであり;R2bはアルキル、アルケニル、アルキニル、ハロアルキル、シアノアルキル、アルコキシアルキル、アセチル、ベンジル又はアリールであり;mは前述の通りである)で表される化合物を出発物質とし、後記の合成例1~合成例13と同様の方法から1つ又は2つ以上の方法を適宜選択し実行することで、トリアゾロピリミジン環上の5位のメチル基を、R1から選ばれる他の置換基に適宜変換することができる。また、前記した製法〔1〕、製法〔4〕又は製法〔5〕或は後記合成例14(1)~(4)と同様の方法によって製造できる下記式(I-11);
Wherein X a is alkyl, aryl, halogen atom, haloalkyl, cyano, nitro, OR 2b , COR 2b or COOR 2b ; R 2b is alkyl, alkenyl, alkynyl, haloalkyl, cyanoalkyl, alkoxyalkyl, acetyl, Benzyl or aryl; m is as described above), and one or more methods are appropriately selected from the same methods as those described in Synthesis Examples 1 to 13 below. By performing, the methyl group at the 5-position on the triazolopyrimidine ring can be appropriately converted to another substituent selected from R 1 . In addition, the following formula (I-11) which can be produced by the production method [1], the production method [4] or the production method [5] or the same method as in Synthesis Examples 14 (1) to (4) described later;
(式中、Xa及びmは前述の通りである)で表される化合物を出発物質とし、後記の合成例14(5)又は合成例15と同様の方法で、トリアゾロピリミジン環上の5位の1-ヒドロキシエチル基を、R1から選ばれる他の置換基に適宜変換することができる。
(Wherein, X a and m are as described above), and 5 5 on the triazolopyrimidine ring is prepared in the same manner as in Synthesis Example 14 (5) or Synthesis Example 15 described later. The 1-hydroxyethyl group at the position can be appropriately converted to another substituent selected from R 1 .
また、前記した製法〔1〕、製法〔4〕、製法〔5〕、製法〔7〕又は製法〔9〕或は後記の合成例1(1)~(2)、合成例14(1)~(2)、合成例14(1)~(5)、合成例16(1)~(5)又は合成例17(1)~(2)と同様の方法によって製造できる下記式(I-12);
Further, the above-mentioned production method [1], production method [4], production method [5], production method [7] or production method [9], or Synthesis Examples 1 (1) to (2), Synthesis Example 14 (1) to (2), Synthesis Example 14 (1) to (5), Synthesis Example 16 (1) to (5) or Synthesis Example 17 (1) to (2) or the following formula (I-12) ;
(式中、Xbはアルキル、ハロゲン原子、ハロアルキル、シアノ、OR2a、COOR2a、アセチル、S(O)nR3a、NR4R5a又はCONR4R5bであり;R3aはアルキルであり;R1a、R2a、R4、R5a、m及びnは前述の通りである)で表される化合物を出発物質とし、後記の合成例18(1)、合成例18(2)、合成例19と同様の方法から1つ又は2つ以上の方法を適宜選択し実行することで、ピリジン環上の特定の置換基を、Xから選ばれる他の置換基に適宜変換することができる。さらに、前記式(I-12)で表される化合物は、後記合成例と同様の方法以外に、公知の置換基変換反応によっても、ピリジン環上の特定の置換基を、Xから選ばれる他の置換基に適宜変換することができる。
Wherein X b is alkyl, halogen atom, haloalkyl, cyano, OR 2a , COOR 2a acetyl, S (O) n R 3a , NR 4 R 5a or CONR 4 R 5b ; R 3a is alkyl R 1a , R 2a , R 4 , R 5a , m and n are as described above), and the synthesis examples 18 (1), 18 (2), and 18 A specific substituent on the pyridine ring can be appropriately converted to another substituent selected from X by appropriately selecting and executing one or more methods from the same methods as in Example 19. Further, the compound represented by the formula (I-12) may be selected from X by selecting a specific substituent on the pyridine ring by a known substituent conversion reaction in addition to the method similar to the synthesis example described later. Can be appropriately converted to the above substituent.
本発明化合物を含有する有害生物防除剤の望ましい態様について以下に記述する。本発明化合物を含有する有害生物防除剤は、例えば農園芸分野で問題となる各種有害生物の防除剤、即ち農園芸用有害生物防除剤や、動物に寄生する有害生物の防除剤、即ち動物寄生生物防除剤として特に有用である。
The desirable mode of the pest control agent containing the compound of the present invention is described below. The pest control agent containing the compound of the present invention includes, for example, various pest control agents that are problematic in the field of agriculture and horticulture, that is, agricultural and horticultural pest control agents, and pest control agents that parasitize animals, that is, animal parasitics. It is particularly useful as a biocontrol agent.
農園芸用有害生物防除剤としては、例えば、殺虫、殺ダニ、殺線虫又は殺土壌害虫剤として有用であるが、具体的には、ナミハダニ、ニセナミハダニ、カンザワハダニ、ミカンハダニ、リンゴハダニ、チャノホコリダニ、ミカンサビダニ、ネダニなどのような植物寄生性ダニ類;モモアカアブラムシ、ワタアブラムシのようなアブラムシ類;コナガ、ヨトウムシ、ハスモンヨトウ、コドリンガ、ボールワーム、タバコバッドワーム、マイマイガ、コブノメイガ、チャノコカクモンハマキ、コロラドハムシ、ウリハムシ、ボールウィービル、ウンカ類、ヨコバイ類、カイガラムシ類、カメムシ類、コナジラミ類、アザミウマ類、バッタ類、ハナバエ類、コガネムシ類、タマナヤガ、カブラヤガ、アリ類などのような農業害虫類;ネコブセンチュウ類、シストセンチュウ類、ネグサレセンチュウ類、イネシンガレセンチュウ、イチゴメセンチュウ、マツノザイセンチュウなどのような植物寄生性線虫類;ナメクジ、マイマイなどのような腹足類;ダンゴムシ、ワラジムシのような等脚類などのような土壌害虫類;イエダニ、ゴキブリ類、イエバエ、アカイエカなどのような衛生害虫類;バクガ、アズキゾウムシ、コクヌストモドキ、ゴミムシダマシ類などのような貯穀害虫類;イガ、ヒメカツオブシムシ、シロアリ類などのような衣類、家屋害虫類;ケナガコナダニ、コナヒョウダニ、ミナミツメダニなどのような屋内塵性ダニ類;などの防除に有効である。本発明化合物を含有する農園芸用有害生物防除剤は、植物寄生性ダニ類、農業害虫類、植物寄生性線虫類などの防除に特に有効である。その中でも、植物寄生性ダニ類、農業害虫類の防除にさらに優れた効果を示すため、殺虫又は殺ダニ剤として最も有用である。また、本発明化合物を含有する農園芸用有害生物防除剤は、有機リン剤、カーバメート剤、合成ピレスロイド剤などの薬剤に対する各種抵抗性害虫の防除にも有効である。さらに本発明化合物は、優れた浸透移行性を有していることから、本発明化合物を含有する農園芸用有害生物防除剤を土壌に処理することによって土壌有害昆虫類、ダニ類、線虫類、腹脚類、等脚類の防除と同時に茎葉部の害虫類をも防除することができる。
Pesticides for agricultural and horticultural use are useful, for example, as insecticides, acaricides, nematicides or soil insecticides. Plant parasitic mites such as rustic mites, mites, aphids such as peach aphids and cotton aphids; diamondback moths, weevil, scallops, codling moths, ball worms, tobacco worms, mai moths, yellow moths, prickly winged clams, Colorado Agricultural pests such as leaf beetle, cucumber beetle, ball weevil, leafhoppers, leafhoppers, scale insects, stink bugs, whitefly, thrips, grasshoppers, fly flies, scarab beetles, tamanayaga, kaburagaga, ants, etc .; Plant parasitic nematodes such as cucumbers, cyst nematodes, nesting nematodes, rice scented nematodes, strawberry nematodes, pine wood nematodes; gastropods such as slugs, maimai, etc .; Soil pests such as isopods; hygiene pests such as house dust mites, cockroaches, house flies, mosquitoes; storage pests such as bark moths, azuki beetles, bark beetles, bark beetles, bark beetles, etc .; It is effective for controlling clothes such as termites, house pests; indoor dust mites such as white mites, white leopard mites, and white ticks. The agricultural and horticultural pest control agent containing the compound of the present invention is particularly effective for controlling plant parasitic mites, agricultural pests, plant parasitic nematodes and the like. Among them, it is most useful as an insecticidal or acaricidal agent because it exhibits a further excellent effect in controlling plant parasitic mites and agricultural pests. Moreover, the agricultural and horticultural pesticide containing the compound of the present invention is also effective for controlling various resistant pests against drugs such as organic phosphorus agents, carbamate agents, and synthetic pyrethroid agents. Furthermore, since the compound of the present invention has excellent osmotic transfer properties, soil harmful insects, mites, nematodes by treating agricultural and horticultural pesticides containing the compound of the present invention on the soil It is possible to control pests on the foliage at the same time as the control of gastropods and isopods.
本発明化合物を含有する有害生物防除剤の別の望ましい態様としては、前記した植物寄生性ダニ類、農業害虫類、植物寄生性線虫類、腹足類、土壌害虫類などを総合的に防除する農園芸用有害生物防除剤が挙げられる。
Another desirable embodiment of the pest control agent containing the compound of the present invention is a farm that comprehensively controls the aforementioned plant parasitic mites, agricultural pests, plant parasitic nematodes, gastropods, soil pests, etc. Examples include horticultural pest control agents.
本発明化合物を含有する農園芸用有害生物防除剤は、通常、該化合物と各種農業上の補助剤とを混合して粉剤、粒剤、顆粒水和剤、水和剤、水性懸濁剤、油性懸濁剤、水溶剤、乳剤、液剤、ペースト剤、エアゾール剤、微量散布剤などの種々の形態に製剤して使用されるが、本発明の目的に適合するかぎり、通常の当該分野で用いられているあらゆる製剤形態にすることができる。製剤に使用する補助剤としては、珪藻土、消石灰、炭酸カルシウム、タルク、ホワイトカーボン、カオリン、ベントナイト、カオリナイト、セリサイト、クレー、炭酸ナトリウム、重曹、芒硝、ゼオライト、澱粉などの固型担体;水、トルエン、キシレン、ソルベントナフサ、ジオキサン、アセトン、イソホロン、メチルイソブチルケトン、クロロベンゼン、シクロヘキサン、ジメチルスルホキシド、N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド、N-メチル-2-ピロリドン、アルコールなどの溶剤;脂肪酸塩、安息香酸塩、アルキルスルホコハク酸塩、ジアルキルスルホコハク酸塩、ポリカルボン酸塩、アルキル硫酸エステル塩、アルキル硫酸塩、アルキルアリール硫酸塩、アルキルジグリコールエーテル硫酸塩、アルコール硫酸エステル塩、アルキルスルホン酸塩、アルキルアリールスルホン酸塩、アリールスルホン酸塩、リグニンスルホン酸塩、アルキルジフェニルエーテルジスルホン酸塩、ポリスチレンスルホン酸塩、アルキルリン酸エステル塩、アルキルアリールリン酸塩、スチリルアリールリン酸塩、ポリオキシエチレンアルキルエーテル硫酸エステル塩、ポリオキシエチレンアルキルアリールエーテル硫酸塩、ポリオキシエチレンアルキルアリールエーテル硫酸エステル塩、ポリオキシエチレンアルキルエーテルリン酸塩、ポリオキシエチレンアルキルアリールリン酸エステル塩、ナフタレンスルホン酸ホルマリン縮合物の塩のような陰イオン系の界面活性剤;ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、脂肪酸ポリグリセライド、脂肪酸アルコールポリグリコールエーテル、アセチレングリコール、アセチレンアルコール、オキシアルキレンブロックポリマー、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリールエーテル、ポリオキシエチレンスチリルアリールエーテル、ポリオキシエチレングリコールアルキルエーテル、ポリエチレングリコール、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシプロピレン脂肪酸エステルのような非イオン系の界面活性剤;オリーブ油、カポック油、ひまし油、シュロ油、椿油、ヤシ油、ごま油、トウモロコシ油、米ぬか油、落花生油、綿実油、大豆油、菜種油、亜麻仁油、きり油、液状パラフィンなどの植物油や鉱物油;などが挙げられる。これら補助剤の各成分は、本発明の目的から逸脱しないかぎり、1種又は2種以上を適宜選択して使用することができる。また、前記した補助剤以外にも当該分野で知られたものの中から適宜選んで使用することもできる。例えば、増量剤、増粘剤、沈降防止剤、凍結防止剤、分散安定剤、薬害軽減剤、防黴剤、など通常使用される各種補助剤も使用することができる。本発明化合物と各種補助剤との配合割合は0.001:99.999~95:5、望ましくは0.005:99.995~90:10である。これら製剤の実際の使用に際しては、そのまま使用するか、又は水等の希釈剤で所定濃度に希釈し、必要に応じて各種展着剤(界面活性剤、植物油、鉱物油など)を添加して使用することができる。
The agricultural and horticultural pest control agent containing the compound of the present invention is usually a powder, granule, granule wettable powder, wettable powder, aqueous suspension, by mixing the compound with various agricultural adjuvants, Used in various forms such as oil suspensions, aqueous solvents, emulsions, solutions, pastes, aerosols, microdispersions, etc. It can be in any formulation form. Adjuvants used in the formulation include solid carriers such as diatomaceous earth, slaked lime, calcium carbonate, talc, white carbon, kaolin, bentonite, kaolinite, sericite, clay, sodium carbonate, sodium bicarbonate, sodium sulfate, zeolite, starch; water , Toluene, xylene, solvent naphtha, dioxane, acetone, isophorone, methyl isobutyl ketone, chlorobenzene, cyclohexane, dimethyl sulfoxide, N, N-dimethylformamide, N, N-dimethylacetamide, N-methyl-2-pyrrolidone, alcohol, etc. Solvent; fatty acid salt, benzoate, alkylsulfosuccinate, dialkylsulfosuccinate, polycarboxylate, alkylsulfate, alkylsulfate, alkylarylsulfate, alkyldiglycolethersulfate, al Cole sulfate ester salt, alkyl sulfonate salt, alkyl aryl sulfonate salt, aryl sulfonate salt, lignin sulfonate salt, alkyl diphenyl ether disulfonate salt, polystyrene sulfonate salt, alkyl phosphate ester salt, alkyl aryl phosphate salt, styryl Aryl phosphate, polyoxyethylene alkyl ether sulfate, polyoxyethylene alkyl aryl ether sulfate, polyoxyethylene alkyl aryl ether sulfate, polyoxyethylene alkyl ether phosphate, polyoxyethylene alkyl aryl phosphate Salts, anionic surfactants such as salt of naphthalenesulfonic acid formalin condensate; sorbitan fatty acid ester, glycerin fatty acid ester, fatty acid polyglyceride, Fatty acid alcohol polyglycol ether, acetylene glycol, acetylene alcohol, oxyalkylene block polymer, polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, polyoxyethylene styryl aryl ether, polyoxyethylene glycol alkyl ether, polyethylene glycol, polyoxy Nonionic surfactants such as ethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxypropylene fatty acid ester; olive oil, kapok oil, castor oil, palm oil , Coconut oil, palm oil, sesame oil, corn oil, rice bran oil, peanut oil, cottonseed oil, soybean oil, rapeseed oil, linseed oil Tung oil, vegetable oil or mineral oil such as liquid paraffin; and the like. Each component of these adjuvants can be used by appropriately selecting one or two or more types without departing from the object of the present invention. In addition to the above-mentioned auxiliary agents, they can be appropriately selected from those known in the art. For example, various commonly used adjuvants such as extenders, thickeners, anti-settling agents, antifreeze agents, dispersion stabilizers, safeners, and antifungal agents can be used. The compounding ratio of the compound of the present invention and various adjuvants is 0.001: 99.999 to 95: 5, preferably 0.005: 99.995 to 90:10. In actual use of these preparations, use them as they are, or dilute them to a predetermined concentration with a diluent such as water, and add various spreading agents (surfactants, vegetable oils, mineral oils, etc.) as necessary. Can be used.
本発明化合物を含有する農園芸用有害生物防除剤の施用は、気象条件、製剤形態、施用時期、施用場所、病害虫の種類や発生状況などの相違により一概に規定できないが、一般に0.05~800,000ppm、望ましくは0.5~500,000ppmの有効成分濃度で行ない、その単位面積あたりの施用量は、1ヘクタール当り本発明化合物が0.05~50,000g、望ましくは1~30,000gである。また、本発明化合物を含有する有害生物防除剤の別の望ましい態様である農園芸用の有害生物防除剤の施用は、前記有害生物防除剤の施用に準じて行われる。本発明には、このような施用方法による有害生物の防除方法、特に植物寄生性ダニ類、農業害虫類、植物寄生性線虫類の防除方法も含まれる。
Application of the agricultural and horticultural pest control agent containing the compound of the present invention cannot be defined unconditionally due to differences in weather conditions, formulation form, application time, application location, type of pests and occurrence, etc., but generally 0.05 to 800,000 ppm The active ingredient concentration is preferably 0.5 to 500,000 ppm, and the application amount per unit area is 0.05 to 50,000 g, preferably 1 to 30,000 g of the compound of the present invention per hectare. In addition, application of the agricultural and horticultural pest control agent, which is another desirable embodiment of the pest control agent containing the compound of the present invention, is performed according to the application of the pest control agent. The present invention also includes a method for controlling pests by such an application method, particularly a method for controlling plant parasitic mites, agricultural pests, and plant parasitic nematodes.
本発明化合物を含有する農園芸用有害生物防除剤の種々の製剤、又はその希釈物の施用は、通常、一般に行なわれている施用方法すなわち、散布(例えば散布、噴霧、ミスティング、アトマイジング、散粒、水面施用等)、土壌施用(混入、灌注等)、表面施用(塗布、粉衣、被覆等)、浸漬毒餌等により行うことができる。また、家畜に対して前記有効成分を飼料に混合して与え、その排泄物での有害虫、特に有害昆虫の発生及び生育を阻害することも可能である。また、いわゆる超高濃度少量散布法(ultra low volume)により施用することもできる。この方法においては、活性成分を100%含有することが可能である。
Application of various preparations or dilutions of agricultural and horticultural pesticides containing the compound of the present invention is usually performed by a commonly used application method, that is, spraying (for example, spraying, spraying, misting, atomizing, It can be carried out by powder application, water surface application, etc.), soil application (mixing, irrigation, etc.), surface application (application, powder coating, coating, etc.), immersion poison bait, etc. It is also possible to feed livestock with the above-mentioned active ingredient mixed with feed to inhibit the occurrence and growth of harmful insects, particularly harmful insects, in the excreta. It can also be applied by the so-called ultra-low concentration low volume method. In this method, it is possible to contain 100% of the active ingredient.
また、本発明化合物を含有する農園芸用有害生物防除剤は、他の農薬、肥料、薬害軽減剤などと混用或は併用することができ、この場合に一層優れた効果、作用性を示すことがある。他の農薬としては、除草剤、殺虫剤、殺ダニ剤、殺線虫剤、殺土壌害虫剤、殺菌剤、抗ウィルス剤、誘引剤、抗生物質、植物ホルモン、植物成長調整剤、などが挙げられる。特に、本発明化合物と他の農薬の有効成分化合物の1種又は2種以上とを混用或は併用した混合有害生物防除用組成物は、適用範囲、薬剤処理の時期、防除活性等を好ましい方向へ改良することが可能である。尚、本発明化合物と他の農薬の有効成分化合物は各々別々に製剤したものを散布時に混合して使用しても、両者を一緒に製剤して使用してもよい。本発明には、このような混合有害生物防除用組成物も含まれる。
In addition, the agricultural and horticultural pest control agent containing the compound of the present invention can be mixed or used in combination with other agricultural chemicals, fertilizers, safeners, etc. There is. Other agrochemicals include herbicides, insecticides, acaricides, nematicides, soil insecticides, fungicides, antiviral agents, attractants, antibiotics, plant hormones, plant growth regulators, etc. It is done. In particular, a mixed pest control composition in which the compound of the present invention and one or more active compound compounds of other agricultural chemicals are used in combination or in combination is preferred in terms of application range, timing of chemical treatment, control activity, etc. It is possible to improve. The compound of the present invention and the other active ingredient compounds of other agricultural chemicals may be prepared separately and mixed at the time of spraying, or both may be used together. The present invention includes such a composition for controlling mixed pests.
本発明化合物と他の農薬の有効成分化合物との混合比は、気象条件、製剤形態、施用時期、施用場所、病害虫の種類や発生状況などの相違により一概に規定できないが、一般に1:300~300:1、望ましくは1:100~100:1である。また、施用適量は1ヘクタール当りの総有効成分化合物量として0.1~50,000g、望ましくは1~30,000gである。本発明には、このような混合有害生物防除用組成物の施用方法による有害生物の防除方法も含まれる。
The mixing ratio between the compound of the present invention and the active ingredient compound of other agricultural chemicals cannot be defined unconditionally due to differences in weather conditions, formulation form, application time, application location, type of pests and occurrence, etc., but generally from 1: 300 to 300: 1, preferably 1: 100 to 100: 1. The appropriate amount to be applied is 0.1 to 50,000 g, preferably 1 to 30,000 g as the total amount of active ingredient compounds per hectare. The present invention also includes a method for controlling pests by a method for applying such a composition for controlling mixed pests.
上記他の農薬中の、殺虫剤、殺ダニ剤、殺線虫剤或いは殺土壌害虫剤の有効成分化合物(一般名;一部申請中を含む、又は日本植物防疫協会試験コード)としては、例えばプロフェノホス(profenofos)、ジクロルボス(dichlorvos)、フェナミホス(fenamiphos)、フェニトロチオン(fenitrothion)、EPN、ダイアジノン(diazinon)、クロルピリホス(chlorpyrifos)、クロルピリホスメチル(chlorpyrifos-methyl)、アセフェート(acephate)、プロチオホス(prothiofos)、ホスチアゼート(fosthiazate)、カズサホス(cadusafos)、ジスルホトン(dislufoton)、イソキサチオン(isoxathion)、イソフェンホス(isofenphos)、エチオン(ethion)、エトリムホス(etrimfos)、キナルホス(quinalphos)、ジメチルビンホス(dimethylvinphos)、ジメトエート(dimethoate)、スルプロホス(sulprofos)、チオメトン(thiometon)、バミドチオン(vamidothion)、ピラクロホス(pyraclofos)、ピリダフェンチオン(pyridaphenthion)、ピリミホスメチル(pirimiphos-methyl)、プロパホス(propaphos)、ホサロン(phosalone)、ホルモチオン(formothion)、マラチオン(malathion)、テトラクロルビンホス(tetrachlovinphos)、クロルフェンビンホス(chlorfenvinphos)、シアノホス(cyanophos)、トリクロルホン(trichlorfon)、メチダチオン(methidathion)、フェントエート(phenthoate)、ESP、アジンホスメチル(azinphos-methyl)、フェンチオン(fenthion)、ヘプテノホス(heptenophos)、メトキシクロル(methoxychlor)、パラチオン(parathion)、ホスホカルブ(phosphocarb)、デメトン-S-メチル(demeton-S-methyl)、モノクロトホス(monocrotophos)、メタミドホス(methamidophos)、イミシアホス(imicyafos)、パラチオン-メチル(parathion-methyl)、テルブホス(terbufos)、ホスファミドン(phosphamidon)、ホスメット(phosmet)、ホレート(phorate)のような有機リン酸エステル系化合物;
カルバリル(carbaryl)、プロポキスル(propoxur)、アルジカルブ(aldicarb)、カルボフラン(carbofuran)、チオジカルブ(thiodicarb)、メソミル(methomyl)、オキサミル(oxamyl)、エチオフェンカルブ(ethiofencarb)、ピリミカルブ(pirimicarb)、フェノブカルブ(fenobucarb)、カルボスルファン(carbosulfan)、ベンフラカルブ(benfuracarb)、ベンダイオカルブ(bendiocarb)、フラチオカルブ(furathiocab)、イソプロカルブ(isoprocarb)、メトルカルブ(metolcarb)、キシリルカルブ(xylylcarb)、XMC、フェノチオカルブ(fenothiocarb)のようなカーバメート系化合物;
カルタップ(cartap)、チオシクラム(thiocyclam)、ベンスルタップ(bensultap)、チオスルタップナトリウム(thiosultap-sodium)のようなネライストキシン誘導体;
ジコホル(dicofol)、テトラジホン(tetradifon)、エンドスルファン(endosulfan)、ジエノクロル(dienochlor)、ディルドリン(dieldrin)のような有機塩素系化合物; In the above-mentioned other agricultural chemicals, as an active ingredient compound of an insecticide, acaricide, nematicide or soil pesticide (generic name; including some pending applications or Japan Plant Protection Association test code), for example Profenofos, dichlorvos, fenamiphos, fenitrothion, EPN, diazinon, chlorpyrifos, chlorpyrifos-methyl, acephate, prothiophos, prothiophos Fosthiazate, cadusafos, dislufoton, isoxathion, isofenphos, ethion, etrimfos, quinalphos, dimethylvinphos, dimethoate ), Sulprofos, thiometon, Vmidothion, pyraclofos, pyridaphenthion, pirimiphos-methyl, propaphos, phosalone, formothion, malathion, tetrachlovinphos, tetrachlovinphos Chlorfenvinphos, cyanophos, trichlorfon, methidathion, phenthoate, ESP, azinphos-methyl, fenthion, heptenophos, methoxychlor ), Parathion, phosphocarb, demeton-S-methyl, monocrotophos, metamidophos, imicyafos, parathion-methyl, Terbufos, ho Famidon (phosphamidon), phosmet (phosmet), organic phosphoric acid ester compounds such as folate (phorate);
Carbaryl, propoxur, aldicarb, carbofuran, thiodicarb, methomyl, oxamyl, ethiofencarb, pirimicarb, fenobucarb, fenobucarb Carbamates such as carbosulfan, benfuracarb, bendiocarb, furathiocab, isoprocarb, metolcarb, xylylcarb, XMC, fenothiocarb Compound;
Nereistoxin derivatives such as cartap, thiocyclam, bensultap, sodium thiosultap-sodium;
Organochlorine compounds such as dicofol, tetradifon, endosulfan, dienochlor, dieldrin;
カルバリル(carbaryl)、プロポキスル(propoxur)、アルジカルブ(aldicarb)、カルボフラン(carbofuran)、チオジカルブ(thiodicarb)、メソミル(methomyl)、オキサミル(oxamyl)、エチオフェンカルブ(ethiofencarb)、ピリミカルブ(pirimicarb)、フェノブカルブ(fenobucarb)、カルボスルファン(carbosulfan)、ベンフラカルブ(benfuracarb)、ベンダイオカルブ(bendiocarb)、フラチオカルブ(furathiocab)、イソプロカルブ(isoprocarb)、メトルカルブ(metolcarb)、キシリルカルブ(xylylcarb)、XMC、フェノチオカルブ(fenothiocarb)のようなカーバメート系化合物;
カルタップ(cartap)、チオシクラム(thiocyclam)、ベンスルタップ(bensultap)、チオスルタップナトリウム(thiosultap-sodium)のようなネライストキシン誘導体;
ジコホル(dicofol)、テトラジホン(tetradifon)、エンドスルファン(endosulfan)、ジエノクロル(dienochlor)、ディルドリン(dieldrin)のような有機塩素系化合物; In the above-mentioned other agricultural chemicals, as an active ingredient compound of an insecticide, acaricide, nematicide or soil pesticide (generic name; including some pending applications or Japan Plant Protection Association test code), for example Profenofos, dichlorvos, fenamiphos, fenitrothion, EPN, diazinon, chlorpyrifos, chlorpyrifos-methyl, acephate, prothiophos, prothiophos Fosthiazate, cadusafos, dislufoton, isoxathion, isofenphos, ethion, etrimfos, quinalphos, dimethylvinphos, dimethoate ), Sulprofos, thiometon, Vmidothion, pyraclofos, pyridaphenthion, pirimiphos-methyl, propaphos, phosalone, formothion, malathion, tetrachlovinphos, tetrachlovinphos Chlorfenvinphos, cyanophos, trichlorfon, methidathion, phenthoate, ESP, azinphos-methyl, fenthion, heptenophos, methoxychlor ), Parathion, phosphocarb, demeton-S-methyl, monocrotophos, metamidophos, imicyafos, parathion-methyl, Terbufos, ho Famidon (phosphamidon), phosmet (phosmet), organic phosphoric acid ester compounds such as folate (phorate);
Carbaryl, propoxur, aldicarb, carbofuran, thiodicarb, methomyl, oxamyl, ethiofencarb, pirimicarb, fenobucarb, fenobucarb Carbamates such as carbosulfan, benfuracarb, bendiocarb, furathiocab, isoprocarb, metolcarb, xylylcarb, XMC, fenothiocarb Compound;
Nereistoxin derivatives such as cartap, thiocyclam, bensultap, sodium thiosultap-sodium;
Organochlorine compounds such as dicofol, tetradifon, endosulfan, dienochlor, dieldrin;
酸化フェンブタスズ(fenbutatin Oxide)、シヘキサチン(cyhexatin)のような有機金属系化合物;
フェンバレレート(fenvalerate)、ペルメトリン(permethrin)、シペルメトリン(cypermethrin)、デルタメトリン(deltamethrin)、シハロトリン(cyhalothrin)、テフルトリン(tefluthrin)、エトフェンプロックス(ethofenprox)、フルフェンプロックス(flufenprox)、シフルトリン(cyfluthrin)、フェンプロパトリン(fenpropathrin)、フルシトリネート(flucythrinate)、フルバリネート(fluvalinate)、シクロプロトリン(cycloprothrin)、ラムダシハロトリン(lambda-cyhalothrin)、ピレスリン(pyrethrins)、エスフェンバレレート(esfenvalerate)、テトラメスリン(tetramethrin)、レスメスリン(resmethrin)、プロトリフェンブト(protrifenbute)、ビフェンスリン(bifenthrin)、ゼータシペルメトリン(zeta-cypermethrin)、アクリナトリン(acrinathrin)、アルファシペルメトリン(alpha-cypermethrin)、アレスリン(allethrin)、ガンマシハロトリン(gamma-cyhalothrin)、シータシペルメトリン(theta-cypermethrin)、タウフルバリネート(tau-fluvalinate)、トラロメスリン(tralomethrin)、プロフルスリン(profluthrin)、ベータシペルメトリン(beta-cypermethrin)、ベータシフルトリン(beta-cyfluthrin)、メトフルトリン(metofluthrin)、フェノトリン(phenothrin)のようなピレスロイド系化合物;
ジフルベンズロン(diflubenzuron)、クロルフルアズロン(chlorfluazuron)、テフルベンズロン(teflubenzuron)、フルフェノクスロン(flufenoxuron)、トリフルムロン(triflumuron)、ヘキサフルムロン(hexaflumuron)、ルフェヌロン(lufenuron)、ノバルロン(novaluron)、ノビフルムロン(noviflumuron)、ビストリフルロン(bistrifluron)、フルアズロン(fluazuron)のようなベンゾイルウレア系化合物;
メトプレン(methoprene)、ピリプロキシフェン(pyriproxyfen)、フェノキシカルブ(fenoxycarb)、ジオフェノラン(diofenolan)のような幼若ホルモン様化合物;
フェンピロキシメート(fenpyroximate)、フィプロニル(fipronil)、テブフェンピラド(tebufenpyrad)、エチプロール(ethiprole)、トルフェンピラド(tolfenpyrad)、アセトプロール(acetoprole)、ピラフルプロール(pyrafluprole)、ピリプロール(pyriprole)のようなピラゾール系化合物;
イミダクロプリド(imidacloprid)、ニテンピラム(nitenpyram)、アセタミプリド(acetamiprid)、チアクロプリド(thiacloprid)、チアメトキサム(thiamethoxam)、クロチアニジン(clothianidin)、ジノテフラン(dinotefuran)、ニチアジン(nithiazine)などのネオニコチノイド;
テブフェノジド(tebufenozide)、メトキシフェノジド(methoxyfenozide)、クロマフェノジド(chromafenozide)、ハロフェノジド(halofenozide)などのヒドラジン系化合物; Organometallic compounds such as fenbutatin oxide and cyhexatin;
Fenvalerate, permethrin, cypermethrin, deltamethrin, cyhalothrin, tefluthrin, etofenprox, flufenprox, cyfluthrin , Fenpropathrin, flucytrinate, fluvalinate, cycloprothrin, lambda-cyhalothrin, pyrethrin, esfenvalerate, Tetramethrin, resmethrin, protrifenbute, bifenthrin, zeta-cypermethrin, acrinathrin, alpha-cypermethri n), allethrin, gamma-cyhalothrin, theta-cypermethrin, tau-fluvalinate, tralomethrin, profluthrin, beta cypermethrin ( pyrethroid compounds such as beta-cypermethrin, beta-cyfluthrin, metofurthrin, phenothrin;
Diflubenzuron, chlorfluazuron, teflubenzuron, flufenoxuron, triflumuron, hexaflumuron, lufenuron, novaluron, novaluron, ), Bistrifluron, benzoylurea compounds such as fluazuron;
Juvenile hormone-like compounds such as metoprene, pyriproxyfen, phenoxycarb, diofenolan;
Pyrazole compounds such as fenpyroximate, fipronil, tebufenpyrad, etiprole, tolfenpyrad, acetoprole, pyrafluprole, pyriprole;
Neonicochioids such as imidacloprid, nitenpyram, acetamiprid, thiacloprid, thiamethoxam, clothianidin, dinotefuran, nithiazine;
Hydrazine compounds such as tebufenozide, methoxyfenozide, chromafenozide, halofenozide;
フェンバレレート(fenvalerate)、ペルメトリン(permethrin)、シペルメトリン(cypermethrin)、デルタメトリン(deltamethrin)、シハロトリン(cyhalothrin)、テフルトリン(tefluthrin)、エトフェンプロックス(ethofenprox)、フルフェンプロックス(flufenprox)、シフルトリン(cyfluthrin)、フェンプロパトリン(fenpropathrin)、フルシトリネート(flucythrinate)、フルバリネート(fluvalinate)、シクロプロトリン(cycloprothrin)、ラムダシハロトリン(lambda-cyhalothrin)、ピレスリン(pyrethrins)、エスフェンバレレート(esfenvalerate)、テトラメスリン(tetramethrin)、レスメスリン(resmethrin)、プロトリフェンブト(protrifenbute)、ビフェンスリン(bifenthrin)、ゼータシペルメトリン(zeta-cypermethrin)、アクリナトリン(acrinathrin)、アルファシペルメトリン(alpha-cypermethrin)、アレスリン(allethrin)、ガンマシハロトリン(gamma-cyhalothrin)、シータシペルメトリン(theta-cypermethrin)、タウフルバリネート(tau-fluvalinate)、トラロメスリン(tralomethrin)、プロフルスリン(profluthrin)、ベータシペルメトリン(beta-cypermethrin)、ベータシフルトリン(beta-cyfluthrin)、メトフルトリン(metofluthrin)、フェノトリン(phenothrin)のようなピレスロイド系化合物;
ジフルベンズロン(diflubenzuron)、クロルフルアズロン(chlorfluazuron)、テフルベンズロン(teflubenzuron)、フルフェノクスロン(flufenoxuron)、トリフルムロン(triflumuron)、ヘキサフルムロン(hexaflumuron)、ルフェヌロン(lufenuron)、ノバルロン(novaluron)、ノビフルムロン(noviflumuron)、ビストリフルロン(bistrifluron)、フルアズロン(fluazuron)のようなベンゾイルウレア系化合物;
メトプレン(methoprene)、ピリプロキシフェン(pyriproxyfen)、フェノキシカルブ(fenoxycarb)、ジオフェノラン(diofenolan)のような幼若ホルモン様化合物;
フェンピロキシメート(fenpyroximate)、フィプロニル(fipronil)、テブフェンピラド(tebufenpyrad)、エチプロール(ethiprole)、トルフェンピラド(tolfenpyrad)、アセトプロール(acetoprole)、ピラフルプロール(pyrafluprole)、ピリプロール(pyriprole)のようなピラゾール系化合物;
イミダクロプリド(imidacloprid)、ニテンピラム(nitenpyram)、アセタミプリド(acetamiprid)、チアクロプリド(thiacloprid)、チアメトキサム(thiamethoxam)、クロチアニジン(clothianidin)、ジノテフラン(dinotefuran)、ニチアジン(nithiazine)などのネオニコチノイド;
テブフェノジド(tebufenozide)、メトキシフェノジド(methoxyfenozide)、クロマフェノジド(chromafenozide)、ハロフェノジド(halofenozide)などのヒドラジン系化合物; Organometallic compounds such as fenbutatin oxide and cyhexatin;
Fenvalerate, permethrin, cypermethrin, deltamethrin, cyhalothrin, tefluthrin, etofenprox, flufenprox, cyfluthrin , Fenpropathrin, flucytrinate, fluvalinate, cycloprothrin, lambda-cyhalothrin, pyrethrin, esfenvalerate, Tetramethrin, resmethrin, protrifenbute, bifenthrin, zeta-cypermethrin, acrinathrin, alpha-cypermethri n), allethrin, gamma-cyhalothrin, theta-cypermethrin, tau-fluvalinate, tralomethrin, profluthrin, beta cypermethrin ( pyrethroid compounds such as beta-cypermethrin, beta-cyfluthrin, metofurthrin, phenothrin;
Diflubenzuron, chlorfluazuron, teflubenzuron, flufenoxuron, triflumuron, hexaflumuron, lufenuron, novaluron, novaluron, ), Bistrifluron, benzoylurea compounds such as fluazuron;
Juvenile hormone-like compounds such as metoprene, pyriproxyfen, phenoxycarb, diofenolan;
Pyrazole compounds such as fenpyroximate, fipronil, tebufenpyrad, etiprole, tolfenpyrad, acetoprole, pyrafluprole, pyriprole;
Neonicochioids such as imidacloprid, nitenpyram, acetamiprid, thiacloprid, thiamethoxam, clothianidin, dinotefuran, nithiazine;
Hydrazine compounds such as tebufenozide, methoxyfenozide, chromafenozide, halofenozide;
ピリダリル(pyridalyl)、フロニカミド(flonicamid)などのようなピリジン系化合物;
スピロジクロフェン(spirodiclofen)などのようなテトロニック酸系化合物;
フルアクリピリム(fluacrypyrim)などのようなストロビルリン系化合物;
フルフェネリム(flufenerim)などのようなピリジナミン系化合物;
ジニトロ系化合物;有機硫黄化合物;尿素系化合物;トリアジン系化合物;ヒドラゾン系化合物;また、その他の化合物として、ブプロフェジン(buprofezin)、ヘキシチアゾクス(hexythiazox)、アミトラズ(amitraz)、クロルジメホルム(chlordimeform)、シラフルオフェン(silafluofen)、トリアザメート(triazamate)、ピメトロジン(pymetrozine)、ピリミジフェン(pyrimidifen)、クロルフェナピル(chlorfenapyr)、インドキサカルブ(indoxacarb)、アセキノシル(acequinocyl)、エトキサゾール(etoxazole)、シロマジン(cyromazine)、1,3-ジクロロプロペン(1,3-dichloropropene)、ジアフェンチウロン(diafenthiuron)、ベンクロチアズ(benclothiaz)、ビフェナゼート(bifenazate)、スピロメシフェン(spiromesifen)、スピロテトラマット(spirotetramat)、プロパルギット(propargite)、クロフェンテジン(clofentezine)、メタフルミゾン(metaflumizone)、フルベンジアミド(flubendiamide)、シフルメトフェン(cyflumetofen)、クロラントラニリプロール(chlorantraniliprole)、シエノピラフェン(cyenopyrafen)、ピリフルキナゾン(pyrifluquinazon)、フェナザキン(fenazaquin)、ピリダベン(pyridaben)、アミドフルメト(amidoflumet)、クロロベンゾエート(chlorobenzoate)、スルフルアミド(sulfluramid)、ヒドラメチルノン(hydramethylnon)、メタアルデヒド(metaldehyde)、HGW 86、リアノジン(ryanodine)のような化合物;などが挙げられる。更に、Bacillus thuringienses aizawai、Bacillus thuringienses kurstaki、Bacillus thuringienses israelensis、Bacillus thuringienses japonensis、Bacillus thuringienses tenebrionis、Bacillus thuringiensesが生成する結晶タンパク毒素、昆虫病原ウイルス剤、昆虫病原糸状菌剤、線虫病原糸状菌剤などのような微生物農薬;アベルメクチン(avermectin)、エマメクチンベンゾエート(emamectin-benzoate)、ミルベメクチン(milbemectin)、ミルベマイシン(milbemycin)、スピノサド(spinosad)、イベルメクチン(ivermectin)、レピメクチン(lepimectin)、DE-175、アバメクチン(abamectin)、エマメクチン(emamectin)のような抗生物質及び半合成抗生物質;アザディラクチン(azadirachtin)、ロテノン(rotenone)のような天然物;ディート(deet)のような忌避剤;などが挙げられる。 Pyridine compounds such as pyridalyl, flonicamid and the like;
Tetronic acid compounds such as spirodiclofen;
Strobilurin-based compounds such as fluacrypyrim;
Pyridinamine compounds such as flufenerim;
Dinitro compounds; organic sulfur compounds; urea compounds; triazine compounds; hydrazone compounds; and other compounds such as buprofezin, hexythiazox, amitraz, chlordimeform, silafluofen ), Triazamate, pymetrozine, pyrimidifen, chlorfenapyr, indoxacarb, acequinocyl, etoxazole, cyromazine, 1,3-dichloropropene (1,3-dichloropropene), diafenthiuron, benclothiaz, bifenazate, spiromesifen, spirotetramat, propargi Propargite, clofentezine, metaflumizone, flubendiamide, cyflumetofen, chlorantraniliprole, cyenopyrafen, pyrifluquinazon, pirafluquinazon ), Pyridaben, amidoflumet, chlorobenzoate, sulfluramid, hydramethylnon, metaldehyde, HGW 86, ryanodine, and the like; Can be mentioned. Furthermore, Bacillus thuringienses aizawai, Bacillus thuringienses kurstaki, Bacillus thuringienses israelensis, Bacillus thuringienses japonensis, Bacillus thuringienses tenebrionis, crystalline protein toxins produced by Bacillus thuringienses, entomopathogenic fungi, nematode pathogenic fungi, etc. Microbial pesticides such as: avermectin, emamectin-benzoate, milbemectin, milbemycin, spinosad, ivermectin, lepimectin, DE-175, abamectin and antibiotics such as abamectin and emamectin; semi-synthetic antibiotics; natural products such as azadirachtin and rotenone; repellents such as deet;
スピロジクロフェン(spirodiclofen)などのようなテトロニック酸系化合物;
フルアクリピリム(fluacrypyrim)などのようなストロビルリン系化合物;
フルフェネリム(flufenerim)などのようなピリジナミン系化合物;
ジニトロ系化合物;有機硫黄化合物;尿素系化合物;トリアジン系化合物;ヒドラゾン系化合物;また、その他の化合物として、ブプロフェジン(buprofezin)、ヘキシチアゾクス(hexythiazox)、アミトラズ(amitraz)、クロルジメホルム(chlordimeform)、シラフルオフェン(silafluofen)、トリアザメート(triazamate)、ピメトロジン(pymetrozine)、ピリミジフェン(pyrimidifen)、クロルフェナピル(chlorfenapyr)、インドキサカルブ(indoxacarb)、アセキノシル(acequinocyl)、エトキサゾール(etoxazole)、シロマジン(cyromazine)、1,3-ジクロロプロペン(1,3-dichloropropene)、ジアフェンチウロン(diafenthiuron)、ベンクロチアズ(benclothiaz)、ビフェナゼート(bifenazate)、スピロメシフェン(spiromesifen)、スピロテトラマット(spirotetramat)、プロパルギット(propargite)、クロフェンテジン(clofentezine)、メタフルミゾン(metaflumizone)、フルベンジアミド(flubendiamide)、シフルメトフェン(cyflumetofen)、クロラントラニリプロール(chlorantraniliprole)、シエノピラフェン(cyenopyrafen)、ピリフルキナゾン(pyrifluquinazon)、フェナザキン(fenazaquin)、ピリダベン(pyridaben)、アミドフルメト(amidoflumet)、クロロベンゾエート(chlorobenzoate)、スルフルアミド(sulfluramid)、ヒドラメチルノン(hydramethylnon)、メタアルデヒド(metaldehyde)、HGW 86、リアノジン(ryanodine)のような化合物;などが挙げられる。更に、Bacillus thuringienses aizawai、Bacillus thuringienses kurstaki、Bacillus thuringienses israelensis、Bacillus thuringienses japonensis、Bacillus thuringienses tenebrionis、Bacillus thuringiensesが生成する結晶タンパク毒素、昆虫病原ウイルス剤、昆虫病原糸状菌剤、線虫病原糸状菌剤などのような微生物農薬;アベルメクチン(avermectin)、エマメクチンベンゾエート(emamectin-benzoate)、ミルベメクチン(milbemectin)、ミルベマイシン(milbemycin)、スピノサド(spinosad)、イベルメクチン(ivermectin)、レピメクチン(lepimectin)、DE-175、アバメクチン(abamectin)、エマメクチン(emamectin)のような抗生物質及び半合成抗生物質;アザディラクチン(azadirachtin)、ロテノン(rotenone)のような天然物;ディート(deet)のような忌避剤;などが挙げられる。 Pyridine compounds such as pyridalyl, flonicamid and the like;
Tetronic acid compounds such as spirodiclofen;
Strobilurin-based compounds such as fluacrypyrim;
Pyridinamine compounds such as flufenerim;
Dinitro compounds; organic sulfur compounds; urea compounds; triazine compounds; hydrazone compounds; and other compounds such as buprofezin, hexythiazox, amitraz, chlordimeform, silafluofen ), Triazamate, pymetrozine, pyrimidifen, chlorfenapyr, indoxacarb, acequinocyl, etoxazole, cyromazine, 1,3-dichloropropene (1,3-dichloropropene), diafenthiuron, benclothiaz, bifenazate, spiromesifen, spirotetramat, propargi Propargite, clofentezine, metaflumizone, flubendiamide, cyflumetofen, chlorantraniliprole, cyenopyrafen, pyrifluquinazon, pirafluquinazon ), Pyridaben, amidoflumet, chlorobenzoate, sulfluramid, hydramethylnon, metaldehyde, HGW 86, ryanodine, and the like; Can be mentioned. Furthermore, Bacillus thuringienses aizawai, Bacillus thuringienses kurstaki, Bacillus thuringienses israelensis, Bacillus thuringienses japonensis, Bacillus thuringienses tenebrionis, crystalline protein toxins produced by Bacillus thuringienses, entomopathogenic fungi, nematode pathogenic fungi, etc. Microbial pesticides such as: avermectin, emamectin-benzoate, milbemectin, milbemycin, spinosad, ivermectin, lepimectin, DE-175, abamectin and antibiotics such as abamectin and emamectin; semi-synthetic antibiotics; natural products such as azadirachtin and rotenone; repellents such as deet;
上記他の農薬中の、殺菌性有効成分化合物(一般名;一部申請中を含む、又は日本植物防疫協会試験コード)としては、例えば、メパニピリム(mepanipyrim)、ピリメサニル(pyrimethanil)、シプロジニル(cyprodinil)、フェリムゾン(ferimzone)のようなアニリノピリミジン系化合物;
5-クロロ-6-(2,4,6-トリフルオロフェニル)-7-(4-メチルピペリジン-1-イル)[1,2,4]トリアゾロ[1,5-a]ピリミジンのようなトリアゾロピリミジン系化合物;
フルアジナム(fluazinam)のようなピリジナミン系化合物;
トリアジメホン(triadimefon)、ビテルタノール(bitertanol)、トリフルミゾール(triflumizole)、エタコナゾール(etaconazole)、プロピコナゾール(propiconazole)、ペンコナゾール(penconazole)、フルシラゾール(flusilazole)、マイクロブタニル(myclobutanil)、シプロコナゾール(cyproconazole)、テブコナゾール(tebuconazole)、ヘキサコナゾール(hexaconazole)、ファーコナゾールシス(furconazole‐cis)、プロクロラズ(prochloraz)、メトコナゾール(metconazole)、エポキシコナゾール(epoxiconazole)、テトラコナゾール(tetraconazole)、オキスポコナゾールフマル酸塩(oxpoconazole fumarate)、シプコナゾール(sipconazole)、プロチオコナゾール(prothioconazole)、トリアジメノール(triadimenol)、フルトリアホール(flutriafol)、ジフェノコナゾール(difenoconazole)、フルキンコナゾール(fluquinconazole)、フェンブコナゾール(fenbuconazole)、ブロムコナゾール(bromuconazole)、ジニコナゾール(diniconazole)、トリシクラゾール(tricyclazole)、プロベナゾール(probenazole)、シメコナゾール(simeconazole)、ペフラゾエート(pefurazoate)、イプコナゾール(ipconazole)、イミベンコナゾール(imibenconazole)のようなアゾール系化合物; Examples of the bactericidal active ingredient compounds (generic name; including partial application or Japanese Plant Protection Association test code) in the above-mentioned other agricultural chemicals include, for example, mepanipyrim, pyrimethanil, cyprodinil Anilinopyrimidine compounds such as ferimzone;
Tria such as 5-chloro-6- (2,4,6-trifluorophenyl) -7- (4-methylpiperidin-1-yl) [1,2,4] triazolo [1,5-a] pyrimidine Zolopyrimidine compounds;
Pyridinamine compounds such as fluazinam;
Triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, microbutanil, cyproconazole cyproconazole), tebuconazole, hexaconazole, furconazole-cis, prochloraz, metconazole, epoxiconazole, tetraconazole, o Oxpoconazole fumarate, sipconazole, prothioconazole, triadimenol, flutriafol, difenoconazole , Fluquinconazole, fenbuconazole, bromuconazole, diniconazole, tricyclazole, probenazole, cimeconazole, pefurazoate, ipconazole, ipconazole ), Azole compounds such as imibenconazole;
5-クロロ-6-(2,4,6-トリフルオロフェニル)-7-(4-メチルピペリジン-1-イル)[1,2,4]トリアゾロ[1,5-a]ピリミジンのようなトリアゾロピリミジン系化合物;
フルアジナム(fluazinam)のようなピリジナミン系化合物;
トリアジメホン(triadimefon)、ビテルタノール(bitertanol)、トリフルミゾール(triflumizole)、エタコナゾール(etaconazole)、プロピコナゾール(propiconazole)、ペンコナゾール(penconazole)、フルシラゾール(flusilazole)、マイクロブタニル(myclobutanil)、シプロコナゾール(cyproconazole)、テブコナゾール(tebuconazole)、ヘキサコナゾール(hexaconazole)、ファーコナゾールシス(furconazole‐cis)、プロクロラズ(prochloraz)、メトコナゾール(metconazole)、エポキシコナゾール(epoxiconazole)、テトラコナゾール(tetraconazole)、オキスポコナゾールフマル酸塩(oxpoconazole fumarate)、シプコナゾール(sipconazole)、プロチオコナゾール(prothioconazole)、トリアジメノール(triadimenol)、フルトリアホール(flutriafol)、ジフェノコナゾール(difenoconazole)、フルキンコナゾール(fluquinconazole)、フェンブコナゾール(fenbuconazole)、ブロムコナゾール(bromuconazole)、ジニコナゾール(diniconazole)、トリシクラゾール(tricyclazole)、プロベナゾール(probenazole)、シメコナゾール(simeconazole)、ペフラゾエート(pefurazoate)、イプコナゾール(ipconazole)、イミベンコナゾール(imibenconazole)のようなアゾール系化合物; Examples of the bactericidal active ingredient compounds (generic name; including partial application or Japanese Plant Protection Association test code) in the above-mentioned other agricultural chemicals include, for example, mepanipyrim, pyrimethanil, cyprodinil Anilinopyrimidine compounds such as ferimzone;
Tria such as 5-chloro-6- (2,4,6-trifluorophenyl) -7- (4-methylpiperidin-1-yl) [1,2,4] triazolo [1,5-a] pyrimidine Zolopyrimidine compounds;
Pyridinamine compounds such as fluazinam;
Triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, microbutanil, cyproconazole cyproconazole), tebuconazole, hexaconazole, furconazole-cis, prochloraz, metconazole, epoxiconazole, tetraconazole, o Oxpoconazole fumarate, sipconazole, prothioconazole, triadimenol, flutriafol, difenoconazole , Fluquinconazole, fenbuconazole, bromuconazole, diniconazole, tricyclazole, probenazole, cimeconazole, pefurazoate, ipconazole, ipconazole ), Azole compounds such as imibenconazole;
キノメチオネート(quinomethionate)のようなキノキサリン系化合物;
マンネブ(maneb)、ジネブ(zineb)、マンゼブ(mancozeb)、ポリカーバメート(polycarbamate)、メチラム(metiram)、プロピネブ(propineb)、チラム(thiram)のようなジチオカーバメート系化合物;
フサライド(fthalide)、クロロタロニル(chlorothalonil)、キントゼン(quintozene)のような有機塩素系化合物;
ベノミル(benomyl)、チオファネートメチル(thiophanate‐methyl)、カーベンダジム(carbendazim)、チアベンダゾール(thiabendazole)、フベリアゾール(fuberiazole)、シアゾファミド(cyazofamid)のようなイミダゾール系化合物;
シモキサニル(cymoxanil)のようなシアノアセトアミド系化合物;
メタラキシル(metalaxyl)、メタラキシル-M(metalaxyl-M)、メフェノキサム(mefenoxam)、オキサジキシル(oxadixyl)、オフレース(ofurace)、ベナラキシル(benalaxyl)、ベナラキシル-M(benalaxyl-M、別名キララキシル(kiralaxyl、chiralaxyl))、フララキシル(furalaxyl)、シプロフラム(cyprofuram)のようなフェニルアミド系化合物; Quinoxaline compounds such as quinomethionate;
Dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, metiram, propineb, thiram;
Organochlorine compounds such as fthalide, chlorothalonil, quintozene;
Imidazole compounds such as benomyl, thiophanate-methyl, carbendazim, thiabendazole, fuberiazole, cyazofamid;
Cyanoacetamide compounds such as cymoxanil;
Metalaxyl, metalaxyl-M, mefenoxam, oxadixyl, offurace, benalaxyl, benalaxyl-M, also known as kiralaxyl, chiax ), Phenylamide compounds such as furalaxyl, cyprofuram;
マンネブ(maneb)、ジネブ(zineb)、マンゼブ(mancozeb)、ポリカーバメート(polycarbamate)、メチラム(metiram)、プロピネブ(propineb)、チラム(thiram)のようなジチオカーバメート系化合物;
フサライド(fthalide)、クロロタロニル(chlorothalonil)、キントゼン(quintozene)のような有機塩素系化合物;
ベノミル(benomyl)、チオファネートメチル(thiophanate‐methyl)、カーベンダジム(carbendazim)、チアベンダゾール(thiabendazole)、フベリアゾール(fuberiazole)、シアゾファミド(cyazofamid)のようなイミダゾール系化合物;
シモキサニル(cymoxanil)のようなシアノアセトアミド系化合物;
メタラキシル(metalaxyl)、メタラキシル-M(metalaxyl-M)、メフェノキサム(mefenoxam)、オキサジキシル(oxadixyl)、オフレース(ofurace)、ベナラキシル(benalaxyl)、ベナラキシル-M(benalaxyl-M、別名キララキシル(kiralaxyl、chiralaxyl))、フララキシル(furalaxyl)、シプロフラム(cyprofuram)のようなフェニルアミド系化合物; Quinoxaline compounds such as quinomethionate;
Dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, metiram, propineb, thiram;
Organochlorine compounds such as fthalide, chlorothalonil, quintozene;
Imidazole compounds such as benomyl, thiophanate-methyl, carbendazim, thiabendazole, fuberiazole, cyazofamid;
Cyanoacetamide compounds such as cymoxanil;
Metalaxyl, metalaxyl-M, mefenoxam, oxadixyl, offurace, benalaxyl, benalaxyl-M, also known as kiralaxyl, chiax ), Phenylamide compounds such as furalaxyl, cyprofuram;
ジクロフルアニド(dichlofluanid)のようなスルフェン酸系化合物;
水酸化第二銅(cupric hydroxide)、有機銅(oxine copper)のような銅系化合物;
ヒメキサゾール(hymexazol)のようなイソキサゾール系化合物;
ホセチルアルミニウム(fosetyl‐Al)、トルクロホスメチル(tolclofos‐methyl)、エジフェンホス(edifenphos)、イプロベンホス(iprobenfos)、S-ベンジル O,O-ジイソプロピルホスホロチオエート、O-エチル S,S-ジフェニルホスホロジチオエート、アルミニウムエチルハイドロゲンホスホネートのような有機リン系化合物;
キャプタン(captan)、キャプタホル(captafol)、フォルペット(folpet)のようなN-ハロゲノチオアルキル系化合物;
プロシミドン(procymidone)、イプロジオン(iprodione)、ビンクロゾリン(vinclozolin)のようなジカルボキシイミド系化合物; Sulfenic acid compounds such as dichlofluanid;
Copper-based compounds such as cupric hydroxide and oxine copper;
Isoxazole compounds such as hymexazol;
Fosetyl aluminum (fosetyl-Al), tolclofos-methyl, edifenphos, iprobenfos, S-benzyl O, O-diisopropyl phosphorothioate, O-ethyl S, S-diphenyl phosphorodithioate, aluminum Organophosphorus compounds such as ethyl hydrogen phosphonate;
N-halogenothioalkyl compounds such as captan, captafol, folpet;
Dicarboximide compounds such as procymidone, iprodione, vinclozolin;
水酸化第二銅(cupric hydroxide)、有機銅(oxine copper)のような銅系化合物;
ヒメキサゾール(hymexazol)のようなイソキサゾール系化合物;
ホセチルアルミニウム(fosetyl‐Al)、トルクロホスメチル(tolclofos‐methyl)、エジフェンホス(edifenphos)、イプロベンホス(iprobenfos)、S-ベンジル O,O-ジイソプロピルホスホロチオエート、O-エチル S,S-ジフェニルホスホロジチオエート、アルミニウムエチルハイドロゲンホスホネートのような有機リン系化合物;
キャプタン(captan)、キャプタホル(captafol)、フォルペット(folpet)のようなN-ハロゲノチオアルキル系化合物;
プロシミドン(procymidone)、イプロジオン(iprodione)、ビンクロゾリン(vinclozolin)のようなジカルボキシイミド系化合物; Sulfenic acid compounds such as dichlofluanid;
Copper-based compounds such as cupric hydroxide and oxine copper;
Isoxazole compounds such as hymexazol;
Fosetyl aluminum (fosetyl-Al), tolclofos-methyl, edifenphos, iprobenfos, S-benzyl O, O-diisopropyl phosphorothioate, O-ethyl S, S-diphenyl phosphorodithioate, aluminum Organophosphorus compounds such as ethyl hydrogen phosphonate;
N-halogenothioalkyl compounds such as captan, captafol, folpet;
Dicarboximide compounds such as procymidone, iprodione, vinclozolin;
フルトラニル(flutolanil)、メプロニル(mepronil)、ゾキサミド(zoxamid)、チアジニル(tiadinil)のようなベンズアニリド系化合物;
カルボキシン(carboxin)、オキシカルボキシン(oxycarboxin)、チフルザミド(thifluzamide)、ペンチオピラド(penthiopyrad)、ボスカリド(boscalid) 、イソチアニル(isothianil)、ビキサフェン(bixafen)、3-(ジフロロメチル)-1-メチル-N-[(1RS,4SR,9RS)-1,2,3,4-テトラヒドロ-9-イソプロピル-1,4-メタノナフタレン-5-イル]ピラゾール-4-カルボキサミドと3-(ジフロロメチル)-1-メチル-N-[(1RS,4SR,9SR)-1,2,3,4-テトラヒドロ-9-イソプロピル-1,4-メタノナフタレン-5-イル]ピラゾール-4-カルボキサミドの混合物(イソピラザム(isopyrazam))のようなアニリド系化合物;
トリホリン(triforine)のようなピペラジン系化合物;
ピリフェノックス(pyrifenox)のようなピリジン系化合物;
フェナリモル(fenarimol)、フルトリアフォル(flutriafol)のようなカルビノール系化合物;
フェンプロピディン(fenpropidine)のようなピペリジン系化合物;
フェンプロピモルフ(fenpropimorph)、スピロキサミン(spiroxamine)、トリデモルフ(tridemorph)のようなモルフォリン系化合物; Benzanilide compounds such as flutolanil, mepronil, zoxamid, tiadinil;
Carboxin (carboxin), oxycarboxin, thifluzamide, penthiopyrad, boscalid, isothianil, bixafen, 3- (difluoromethyl) -1-methyl-N- [(1RS, 4SR, 9RS) -1,2,3,4-Tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] pyrazole-4-carboxamide and 3- (difluoromethyl) -1-methyl- Of a mixture of N-[(1RS, 4SR, 9SR) -1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] pyrazole-4-carboxamide (isopyrazam) Such anilide compounds;
Piperazine compounds such as triforine;
Pyridine compounds such as pyrifenox;
Carbinol compounds such as fenarimol, flutriafol;
Piperidine-based compounds such as fenpropidine;
Morpholine compounds such as fenpropimorph, spiroxamine, tridemorph;
カルボキシン(carboxin)、オキシカルボキシン(oxycarboxin)、チフルザミド(thifluzamide)、ペンチオピラド(penthiopyrad)、ボスカリド(boscalid) 、イソチアニル(isothianil)、ビキサフェン(bixafen)、3-(ジフロロメチル)-1-メチル-N-[(1RS,4SR,9RS)-1,2,3,4-テトラヒドロ-9-イソプロピル-1,4-メタノナフタレン-5-イル]ピラゾール-4-カルボキサミドと3-(ジフロロメチル)-1-メチル-N-[(1RS,4SR,9SR)-1,2,3,4-テトラヒドロ-9-イソプロピル-1,4-メタノナフタレン-5-イル]ピラゾール-4-カルボキサミドの混合物(イソピラザム(isopyrazam))のようなアニリド系化合物;
トリホリン(triforine)のようなピペラジン系化合物;
ピリフェノックス(pyrifenox)のようなピリジン系化合物;
フェナリモル(fenarimol)、フルトリアフォル(flutriafol)のようなカルビノール系化合物;
フェンプロピディン(fenpropidine)のようなピペリジン系化合物;
フェンプロピモルフ(fenpropimorph)、スピロキサミン(spiroxamine)、トリデモルフ(tridemorph)のようなモルフォリン系化合物; Benzanilide compounds such as flutolanil, mepronil, zoxamid, tiadinil;
Carboxin (carboxin), oxycarboxin, thifluzamide, penthiopyrad, boscalid, isothianil, bixafen, 3- (difluoromethyl) -1-methyl-N- [(1RS, 4SR, 9RS) -1,2,3,4-Tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] pyrazole-4-carboxamide and 3- (difluoromethyl) -1-methyl- Of a mixture of N-[(1RS, 4SR, 9SR) -1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl] pyrazole-4-carboxamide (isopyrazam) Such anilide compounds;
Piperazine compounds such as triforine;
Pyridine compounds such as pyrifenox;
Carbinol compounds such as fenarimol, flutriafol;
Piperidine-based compounds such as fenpropidine;
Morpholine compounds such as fenpropimorph, spiroxamine, tridemorph;
フェンチンヒドロキシド(fentin hydroxide)、フェンチンアセテート(fentin acetate)のような有機スズ系化合物;
ペンシキュロン(pencycuron)のような尿素系化合物;
ジメトモルフ(dimethomorph)、フルモルフ(flumorph)のようなシンナミック酸系化合物;
ジエトフェンカルブ(diethofencarb)のようなフェニルカーバメート系化合物;
フルジオキソニル(fludioxonil)、フェンピクロニル(fenpiclonil)のようなシアノピロール系化合物;
アゾキシストロビン(azoxystrobin)、クレソキシムメチル(kresoxim‐methyl)、メトミノフェン(metominofen)、トリフロキシストロビン(trifloxystrobin)、ピコキシストロビン(picoxystrobin)、オリザストロビン(oryzastrobin)、ジモキシストロビン(dimoxystrobin)、ピラクロストロビン(pyraclostrobin)、フルオキサストロビン(fluoxastrobin)、フルアクリピリム(fluacrypyrin)のようなストロビルリン系化合物; Organotin compounds such as fentin hydroxide and fentin acetate;
Urea-based compounds such as pencycuron;
Synamic acid compounds such as dimethomorph and flumorph;
Phenyl carbamate compounds such as dietofencarb;
Cyanopyrrole compounds such as fludioxonil and fenpiclonil;
Azoxystrobin, kresoxim-methyl, metominofen, trifloxystrobin, picoxystrobin, oryzastrobin, dimoxystrobin Strobilurin-based compounds such as pyraclostrobin, fluoxastrobin, fluacrypyrin;
ペンシキュロン(pencycuron)のような尿素系化合物;
ジメトモルフ(dimethomorph)、フルモルフ(flumorph)のようなシンナミック酸系化合物;
ジエトフェンカルブ(diethofencarb)のようなフェニルカーバメート系化合物;
フルジオキソニル(fludioxonil)、フェンピクロニル(fenpiclonil)のようなシアノピロール系化合物;
アゾキシストロビン(azoxystrobin)、クレソキシムメチル(kresoxim‐methyl)、メトミノフェン(metominofen)、トリフロキシストロビン(trifloxystrobin)、ピコキシストロビン(picoxystrobin)、オリザストロビン(oryzastrobin)、ジモキシストロビン(dimoxystrobin)、ピラクロストロビン(pyraclostrobin)、フルオキサストロビン(fluoxastrobin)、フルアクリピリム(fluacrypyrin)のようなストロビルリン系化合物; Organotin compounds such as fentin hydroxide and fentin acetate;
Urea-based compounds such as pencycuron;
Synamic acid compounds such as dimethomorph and flumorph;
Phenyl carbamate compounds such as dietofencarb;
Cyanopyrrole compounds such as fludioxonil and fenpiclonil;
Azoxystrobin, kresoxim-methyl, metominofen, trifloxystrobin, picoxystrobin, oryzastrobin, dimoxystrobin Strobilurin-based compounds such as pyraclostrobin, fluoxastrobin, fluacrypyrin;
ファモキサドン(famoxadone)のようなオキサゾリジノン系化合物;
エタボキサム(ethaboxam)のようなチアゾールカルボキサミド系化合物;
シルチオファム(silthiopham)のようなシリルアミド系化合物;
イプロバリカルブ(iprovalicarb)、ベンチアバリカルブ-イソプロピル(benthiavalicarb-isopropyl)、メチル[S-(R,S)]-[3-(N-イソプロポキシカルボニルバリニル)-アミノ]-3-(4-クロロ-フェニル)プロパオネート(バリフェナール (valiphenal))のようなアミノアシッドアミドカーバメート系化合物;
フェナミドン(fenamidone)のようなイミダゾリジン系化合物;
フェンヘキサミド(fenhexamid)のようなハイドロキシアニリド系化合物;
フルスルファミド(flusulfamide)のようなベンゼンスルホンアミド系化合物;
シフルフェナミド(cyflufenamid)のようなオキシムエーテル系化合物;
フェノキサニル(fenoxanil)のようなフェノキシアミド系化合物;
バリダマイシン(validamycin)、カスガマイシン(kasugamycin)、ポリオキシン(polyoxins)のような抗生物質;
イミノクタジン(iminoctadine)、ドディン(dodine)のようなグアニジン系化合物;
6-ターシャリーブチル-8-フルオロ-2,3-ジメチルキノリン-4-イル アセテートのような4-キノリノール誘導体化合物;
2-(2-フルオロ-5-(トリフルオロメチル)フェニルチオ)-2-(3-(2-メトキシフェニル)チアゾリジン-2-イリデン)アセトニトリルのようなシアノメチレン系化合物; Oxazolidinone compounds such as famoxadone;
Thiazole carboxamide compounds such as ethaboxam;
Silylamide compounds such as silthiopham;
Iprovalicarb, Benthiavalicarb-isopropyl, methyl [S- (R, S)]-[3- (N-isopropoxycarbonylvalinyl) -amino] -3- (4-chloro Aminoacid amide carbamate compounds such as -phenyl) propionate (valiphenal);
Imidazolidine compounds such as fenamidone;
Hydroxyanilide compounds such as fenhexamid;
Benzenesulfonamide compounds such as flusulfamide;
Oxime ether compounds such as cyflufenamid;
Phenoxyamide compounds such as fenoxanil;
Antibiotics such as validamycin, kasugamycin, polyoxins;
Guanidine compounds such as iminoctadine and dodine;
4-quinolinol derivative compounds such as 6-tertiarybutyl-8-fluoro-2,3-dimethylquinolin-4-yl acetate;
Cyanomethylene compounds such as 2- (2-fluoro-5- (trifluoromethyl) phenylthio) -2- (3- (2-methoxyphenyl) thiazolidine-2-ylidene) acetonitrile;
エタボキサム(ethaboxam)のようなチアゾールカルボキサミド系化合物;
シルチオファム(silthiopham)のようなシリルアミド系化合物;
イプロバリカルブ(iprovalicarb)、ベンチアバリカルブ-イソプロピル(benthiavalicarb-isopropyl)、メチル[S-(R,S)]-[3-(N-イソプロポキシカルボニルバリニル)-アミノ]-3-(4-クロロ-フェニル)プロパオネート(バリフェナール (valiphenal))のようなアミノアシッドアミドカーバメート系化合物;
フェナミドン(fenamidone)のようなイミダゾリジン系化合物;
フェンヘキサミド(fenhexamid)のようなハイドロキシアニリド系化合物;
フルスルファミド(flusulfamide)のようなベンゼンスルホンアミド系化合物;
シフルフェナミド(cyflufenamid)のようなオキシムエーテル系化合物;
フェノキサニル(fenoxanil)のようなフェノキシアミド系化合物;
バリダマイシン(validamycin)、カスガマイシン(kasugamycin)、ポリオキシン(polyoxins)のような抗生物質;
イミノクタジン(iminoctadine)、ドディン(dodine)のようなグアニジン系化合物;
6-ターシャリーブチル-8-フルオロ-2,3-ジメチルキノリン-4-イル アセテートのような4-キノリノール誘導体化合物;
2-(2-フルオロ-5-(トリフルオロメチル)フェニルチオ)-2-(3-(2-メトキシフェニル)チアゾリジン-2-イリデン)アセトニトリルのようなシアノメチレン系化合物; Oxazolidinone compounds such as famoxadone;
Thiazole carboxamide compounds such as ethaboxam;
Silylamide compounds such as silthiopham;
Iprovalicarb, Benthiavalicarb-isopropyl, methyl [S- (R, S)]-[3- (N-isopropoxycarbonylvalinyl) -amino] -3- (4-chloro Aminoacid amide carbamate compounds such as -phenyl) propionate (valiphenal);
Imidazolidine compounds such as fenamidone;
Hydroxyanilide compounds such as fenhexamid;
Benzenesulfonamide compounds such as flusulfamide;
Oxime ether compounds such as cyflufenamid;
Phenoxyamide compounds such as fenoxanil;
Antibiotics such as validamycin, kasugamycin, polyoxins;
Guanidine compounds such as iminoctadine and dodine;
4-quinolinol derivative compounds such as 6-tertiarybutyl-8-fluoro-2,3-dimethylquinolin-4-yl acetate;
Cyanomethylene compounds such as 2- (2-fluoro-5- (trifluoromethyl) phenylthio) -2- (3- (2-methoxyphenyl) thiazolidine-2-ylidene) acetonitrile;
また、その他の化合物として、イソプロチオラン(isoprothiolane)、ピロキロン(Pyroquilon)、ジクロメジン(diclomezine)、キノキシフェン(quinoxyfen)、プロパモカルブ塩酸塩(propamocarb hydrochloride)、クロルピクリン(chloropicrin)、ダゾメット(dazomet)、メタムナトリウム塩(metam‐sodium)、ニコビフェン(nicobifen)、メトラフェノン(metrafenone)、MTF-753、UBF-307、ジクロシメット(diclocymet)、プロキンアジド(proquinazid)、アミスルブロム(amisulbrom)、ピリベンカルブ(pyribencarb)、マンジプロパミド(mandipropamid)、フルオピコリド(fluopicolide) 、カルプロパミド(carpropamid)、メプチルジノカップ(meptyldinocap)、フルオピラム(fluopyram)、BCF051、BCM061、BCM062;などが挙げられる。
As other compounds, isoprothiolane, pyroquilon, diclomezine, quinoxyfen, propamocarb hydrochloride, chloropicrin, dazomet, metam sodium salt ( metam-sodium, nicobifen, metrafenone, MTF-753, UBF-307, diclocymet, proquinazid, amisulbrom, pyribencarb, mandipropamid, flupropamide fluopicolide spp., carpropamid, meptyldinocap, fluopyram, BCF051, BCM061, BCM062; and the like.
その他、本発明化合物と混用或いは併用することが可能な農薬としては、例えば、The Pesticide Manual(第14版)に記載されているような除草剤の有効成分化合物、特に土壌処理型のものなどがある。
Other pesticides that can be used in combination with or combined with the compounds of the present invention include, for example, active ingredient compounds of herbicides such as those described in The な ど Pesticide Manual (14th edition), especially those of soil treatment type. is there.
動物寄生生物防除剤としては、例えば、宿主動物の体表(背、腋下、下腹部、内股部など)に寄生する外部寄生生物や、宿主動物の体内(胃、腸管、肺、心臓、肝臓、血管、皮下、リンパ組織など)に寄生する内部寄生生物の防除に有効であるが、中でも、外部寄生生物の防除に有効である。
Examples of animal parasite control agents include ectoparasites that parasitize on the body surface of the host animal (back, armpit, lower abdomen, inner thigh, etc.) and the host animal body (stomach, intestinal tract, lung, heart, liver). , Vascular, subcutaneous, lymphoid tissue, etc.) are effective in controlling endoparasites, and in particular, are effective in controlling ectoparasites.
外部寄生生物としては、例えば、動物寄生性のダニやノミなどが挙げられる。これらの種類は非常に多く、全てを列記することが困難であるので、その一例を挙げる。
Examples of ectoparasites include animal parasitic mites and fleas. There are so many of these types that it is difficult to list them all.
動物寄生性のダニとしては、例えばオウシマダニ(Boophilus microplus)、クリイロコイタマダニ(Rhipicephalus sanguineus)、フタトゲチマダニ(Haemaphysalis longicornis)、キチマダニ(Haemaphysalis flava)、ツリガネチマダニ(Haemaphysalis campanulata)、イスカチマダニ(Haemaphysalis concinna)、ヤマトチマダニ(Haemaphysalis japonica)、ヒゲナガチマダニ(Haemaphysalis kitaokai)、イヤスチマダニ(Haemaphysalis ias)、ヤマトマダニ(Ixodes ovatus)、タネガタマダニ(Ixodes nipponensis)、シュルツェマダニ(Ixodes persulcatus)、タカサゴキララマダニ(Amblyomma testudinarium)、オオトゲチマダニ(Haemaphysalis megaspinosa)、アミノカクマダニ(Dermacentor reticulatus)、タイワンカクマダニ(Dermacentor taiwanesis)のようなマダニ類;ワクモ(Dermanyssus gallinae);トリサシダニ(Ornithonyssus sylviarum)、ミナミトリサシダニ(Ornithonyssus bursa)のようなトリサシダニ類;ナンヨウツツガムシ(Eutrombicula wichmanni)、アカツツガムシ(Leptotrombidium akamushi)、フトゲツツガムシ(Leptotrombidium pallidum)、フジツツガムシ(Leptotrombidium fuji)、トサツツガムシ(Leptotrombidium tosa)、ヨーロッパアキダニ(Neotrombicula autumnalis)、アメリカツツガムシ(Eutrombicula alfreddugesi)、ミヤガワタマツツガムシ(Helenicula miyagawai)のようなツツガムシ類;イヌツメダニ(Cheyletiella yasguri)、ウサギツメダニ(Cheyletiella parasitivorax)、ネコツメダニ(Cheyletiella blakei)のようなツメダニ類;ウサギキュウセンダニ(Psoroptes cuniculi)、ウシショクヒダニ(Chorioptes bovis)、イヌミミヒゼンダニ(Otodectes cynotis)、ヒゼンダニ(Sarcoptes scabiei)、ネコショウセンコウヒゼンダニ(Notoedres cati)のようなヒゼンダニ類;イヌニキビダニ(Demodex canis)のようなニキビダニ類などが挙げられる。中でも、本発明化合物を含有する動物寄生生物防除剤は、マダニ類などの防除に特に有効である。
The animal parasitic mites, for example Boophilus microplus (Boophilus microplus), Rhipicephalus sanguineus (Rhipicephalus sanguineus), Haemaphysalis longicornis (Haemaphysalis longicornis), Haemaphysalis flava (Haemaphysalis flava), Adenophora chima tick (Haemaphysalis campanulata), Isukachimadani (Haemaphysalis concinna), Yamatochimadani (Haemaphysalis japonica), H. kitaokai (Haemaphysalis kitaokai), Iyasuchimadani (Haemaphysalis ias), Ixodes ovatus (Ixodes ovatus), I. nipponensis (Ixodes nipponensis), Schulze ticks (Ixodes persulcatus), Takasago testudinarium (Amblyomma testudinarium), Ootogechimadani (Haemaphysalis megaspinosa ), tick such as Dermacentor reticulatus , Dermacentor taiwanesis ; duck ( Dermanyssus gallinae ); Shidani (Ornithonyssus sylviarum), Torisashidani, such as Southern tri sand mite (Ornithonyssus bursa); Nan iodine tsutsugamushi (Eutrombicula wichmanni), red mites (Leptotrombidium akamushi), L. pallidum (Leptotrombidium pallidum), Fuji chiggers (Leptotrombidium fuji), Tosa mites ( Leptotrombidium tosa), Europe Aki mites (Neotrombicula autumnalis), the United States chiggers (Eutrombicula alfreddugesi), chiggers, such as Miyagawa Tama chiggers (Helenicula miyagawai); Inutsumedani (Cheyletiella yasguri), rabbit Tsumedani (Cheyletiella parasitivorax), Nekotsumedani (Cheyletiella blakei) Tsumedani, such as; rabbits 9,000 mite (Psoroptes cuniculi), Ushishokuhidani (Chorioptes bovis), dog ear mites (Otodectes cynotis), mange mites (Sar coptes scabiei ), mite mites like Notoedres cati ; mite mites like Demodex canis , and the like. Among them, the animal parasite control agent containing the compound of the present invention is particularly effective for controlling ticks and the like.
ノミとしては、例えば、ノミ目(Siphonaptera)に属する外部寄生性無翅昆虫、より具体的には、ヒトノミ科(Pulicidae)、ナガノミ科(Ceratephyllus)などに属するノミ類が挙げられる。ヒトノミ科に属するノミ類としては、例えば、イヌノミ(Ctenocephalides canis)、ネコノミ(Ctenocephalides felis)、ヒトノミ(Pulex irritans)、ニワトリフトノミ(Echidnophaga gallinacea)、ケオプスネズミノミ(Xenopsylla cheopis)、メクラネズミノミ(Leptopsylla segnis)、ヨーロッパネズミノミ(Nosopsyllus fasciatus)、ヤマトネズミノミ(Monopsyllus anisus)などが挙げられる。中でも、本発明化合物を含有する動物寄生生物防除剤は、ヒトノミ科に属するノミ類、特にイヌノミ、ネコノミなどの防除に有効である。
Examples of fleas include ectoparasite worms belonging to the order Flea ( Siphonaptera ), and more specifically fleas belonging to the family Flea family ( Pulicidae ), Nagano family ( Ceratephyllus ) and the like. Examples of fleas belonging to the family flea family include, for example, dog fleas ( Ctenocephalides canis ), cat fleas ( Ctenocephalides felis ), human fleas ( Purex irritans ), elephant fleas ( Echidnophaga gallinacea ), keops mouse fleas ( Xenopsylla cheopis ) Leptopsylla segnis ), European mud minnow ( Nosopsyllus fasciatus ), and Yamato mud mink ( Monopsyllus anisus ). Among them, the animal parasite control agent containing the compound of the present invention is effective for controlling fleas belonging to the family Flea, particularly dog fleas, cat fleas and the like.
その他の外部寄生生物としては、例えば、ウシジラミ、ウマジラミ、ヒツジジラミ、ウシホソジラミ、アタマジラミのようなシラミ類;イヌハジラミのようなハジラミ類;ウシアブ、ウアイヌカカ、ツメトゲブユのような吸血性双翅目害虫などが挙げられる。また、内部寄生生物としては、例えば、肺虫、ベンチュウ、結節状ウオーム、胃内寄生虫、回虫、糸状虫類のような線虫類;マンソン裂頭条虫、広節裂頭条虫、瓜実条虫、多頭条虫、単包条虫、多包条虫のような条虫類;日本住血吸虫、肝蛭のような吸虫類;コクシジウム、マラリア原虫、腸内肉胞子虫、トキソプラズマ、クリプトスポリジウムのような原生動物など;が挙げられる。
Other ectoparasites include, for example, lice such as bovine lice, foal lice, sheep lice, bovine white lice, head lice; lice such as dog lice; blood-sucking dipterous pests such as bovine abs, quail sharks, . In addition, examples of endoparasites include nematodes such as lungworms, benthic worms, tuberous worms, gastric parasites, roundworms, and filamentous worms; Tapeworms such as real tapeworms, multi-headed tapeworms, single-banded tapeworms, multi-banded tapeworms; Japanese schistosomiasis, fluke like liver fluke; coccidium, malaria parasite, intestinal granulocyst, toxoplasma, chestnut Protozoa such as Ptosporidium, and the like.
宿主動物としては、種々の愛玩動物、家畜、家禽などが挙げられ、より具体的には、イヌ、ネコ、マウス、ラット、ハムスター、モルモット、リス、ウサギ、フェレット、鳥(例えば、ハト、オウム、九官鳥、文鳥、インコ、ジュウシマツ、カナリアなど)、ウシ、ウマ、ブタ、ヒツジ、アヒル、ニワトリ、などが挙げられる。中でも、本発明化合物を含有する動物寄生生物防除剤は、愛玩動物又は家畜に寄生する有害生物、特に外部寄生生物の防除に有効である。愛玩動物又は家畜の中ではイヌ、ネコ、ウシ又はウマに特に有効である。
Examples of host animals include various pet animals, livestock, poultry, etc., and more specifically dogs, cats, mice, rats, hamsters, guinea pigs, squirrels, rabbits, ferrets, birds (eg, pigeons, parrots, (E.g., nine-bird, bird, parakeet, juvenile pine, canary, etc.), cattle, horses, pigs, sheep, ducks, chickens, etc. Among them, the animal parasite control agent containing the compound of the present invention is effective for controlling pests parasitic on pet animals or livestock, particularly ectoparasites. Among pet animals or domestic animals, it is particularly effective for dogs, cats, cows or horses.
本発明化合物を動物寄生生物防除剤として使用する際、そのまま使用してもよい。また、適当な補助剤と共に粉剤、粒剤、錠剤、散剤、カプセル剤、液状剤、乳剤、水性懸濁剤、油性懸濁剤などの種々の形態に製剤して使用することもできる。尚、前記製剤形態以外にも、本発明の目的に適合するかぎり、通常の当該分野で用いられているあらゆる製剤形態にすることができる。製剤に使用する補助剤としては、前記した農園芸用有害生物防除剤の製剤用補助剤として例示した陰イオン系の界面活性剤や非イオン系の界面活性剤;セチルトリメチルアンモニウムブロミドのような陽イオン系の界面活性剤;水、アセトン、アセトニトリル、N-メチルアセトアミド、N,N-ジメチルアセトアミド、N,N-ジメチルホルムアミド、2-ピロリドン、N-メチル-2-ピロリドン、ケロシン、トリアセチン、メタノール、エタノール、イソプロパノール、ベンジルアルコール、エチレングリコール、プロピレングリコール、ポリエチレングリコール、液体ポリオキシエチレングリコール、ブチルジグリコール、エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル、ジエチレングリコールモノエチルエーテル、ジエチレングリコールノルマルブチルエーテル、ジプロピレングリコールモノメチルエーテル、ジプロピレングリコールノルマルブチルエーテルのような溶剤;ブチルヒドロキシアニソール、ブチルヒドロキシトルエン、アスコルビン酸、メタ亜硫酸水素ナトリウム、プロピル没食子酸塩、チオ硫酸ナトリウムのような酸化防止剤;ポリビニルピロリドン、ポリビニルアルコール、酢酸ビニルとビニルピロリドンのコポリマーのような被膜形成剤;前記した農園芸用有害生物防除剤の製剤用補助剤として例示した植物油や鉱物油;乳糖、蔗糖、ブドウ糖、澱粉、麦粉、コーン粉、大豆油粕、脱脂米糠、炭酸カルシウム、その他市販の飼料原料のような担体;などが挙げられる。これら補助剤の各成分は、本発明の目的から逸脱しないかぎり、1種又は2種以上を適宜選択して使用することができる。また、前記した補助剤以外にも当該分野で知られたものの中から適宜選択して使用することもでき、更には、前記した農園芸分野で使用される各種補助剤などから適宜選択して使用することもできる。
When the compound of the present invention is used as an animal parasite control agent, it may be used as it is. In addition, it can be used in the form of various forms such as powders, granules, tablets, powders, capsules, liquids, emulsions, aqueous suspensions, oily suspensions and the like together with appropriate auxiliary agents. In addition to the above-mentioned preparation forms, any preparation forms used in the normal field can be used as long as the object of the present invention is met. Examples of the adjuvant used in the preparation include anionic surfactants and nonionic surfactants exemplified as the above-mentioned preparation adjuvants for agricultural and horticultural pest control agents; positive agents such as cetyltrimethylammonium bromide. Ionic surfactants: water, acetone, acetonitrile, N-methylacetamide, N, N-dimethylacetamide, N, N-dimethylformamide, 2-pyrrolidone, N-methyl-2-pyrrolidone, kerosene, triacetin, methanol, Ethanol, isopropanol, benzyl alcohol, ethylene glycol, propylene glycol, polyethylene glycol, liquid polyoxyethylene glycol, butyl diglycol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, diethylene glycol monoethyl Solvents such as ether, diethylene glycol normal butyl ether, dipropylene glycol monomethyl ether, dipropylene glycol normal butyl ether; oxidations such as butylhydroxyanisole, butylhydroxytoluene, ascorbic acid, sodium metabisulfite, propyl gallate, sodium thiosulfate Inhibitors; Film forming agents such as polyvinylpyrrolidone, polyvinyl alcohol, vinyl acetate and vinylpyrrolidone copolymers; vegetable oils and mineral oils exemplified as preparations for the aforementioned agricultural and horticultural pest control agents; lactose, sucrose, glucose , Starch, wheat flour, corn flour, soybean oil cake, defatted rice bran, calcium carbonate, and other carriers such as commercially available feed materials. Each component of these adjuvants can be used by appropriately selecting one or two or more types without departing from the object of the present invention. In addition to the above-mentioned adjuvants, it can be used by appropriately selecting from those known in the field, and further, selected from various adjuvants used in the above-mentioned agricultural and horticultural fields. You can also
本発明化合物と各種補助剤との配合割合は、通常、0.1:99.9~90:10程度である。これら製剤の実際の使用に際しては、そのまま使用するか、又は水等の希釈剤で所定濃度に希釈し、必要に応じて各種展着剤(界面活性剤、植物油、鉱物油など)を添加して使用することができる。
The compounding ratio of the compound of the present invention and various adjuvants is usually about 0.1: 99.9 to 90:10. In actual use of these preparations, use them as they are, or dilute them to a predetermined concentration with a diluent such as water, and add various spreading agents (surfactants, vegetable oils, mineral oils, etc.) as necessary. Can be used.
宿主動物への本発明化合物の投与は、経口又は非経口によって行われる。経口投与法としては、例えば本発明化合物を含有する錠剤、液状剤、カプセル剤、ウエハース、ビスケット、ミンチ肉、その他の飼料等を投与する方法などが挙げられる。非経口投与方法としては、例えば本発明化合物を適当な製剤に調製した上で、静注投与、筋肉内投与、皮内投与、皮下投与等により体内に取り込ませる方法;スポットオン(spot-on)処理、ポワオン(pour-on)処理、スプレー処理等により体表面に投与する方法;宿主動物の皮下に本発明化合物を含有する樹脂片等を埋め込む方法などが挙げられる。
Administration of the compound of the present invention to the host animal is performed orally or parenterally. Examples of the oral administration method include a method of administering tablets, liquid agents, capsules, wafers, biscuits, minced meat, and other feeds containing the compound of the present invention. As a parenteral administration method, for example, the compound of the present invention is prepared into an appropriate preparation and then taken into the body by intravenous administration, intramuscular administration, intradermal administration, subcutaneous administration, etc .; spot-on For example, a method of administering to the body surface by treatment, pour-on treatment, spray treatment, etc .; a method of embedding a resin piece containing the compound of the present invention under the skin of a host animal, and the like.
宿主動物への本発明化合物の投与量は、投与方法、投与目的、疾病症状等によって異なるが、通常、宿主動物の体重1Kgに対して0.01mg~100g、望ましくは0.1mg~10gの割合で投与するのが適当である。
The dose of the compound of the present invention to the host animal varies depending on the administration method, administration purpose, disease symptoms, etc., but is usually a ratio of 0.01 mg to 100 g, preferably 0.1 mg to 10 g, per 1 kg body weight of the host animal. Is suitable for administration.
本発明には、前記したような投与方法又は投与量による有害生物の防除方法、特に外部寄生生物又は内部寄生生物の防除方法も含まれる。
The present invention includes a method for controlling pests according to the administration method or dosage as described above, particularly a method for controlling ectoparasites or endoparasites.
また、本発明においては、前述のようにして動物寄生性の有害生物を防除することにより、それらに起因する宿主動物の各種疾患を予防又は治療できる場合がある。このように、本発明には、本発明化合物を有効成分として含有する寄生生物起因動物疾患の予防又は治療剤並びに、寄生生物起因動物疾患を予防又は治療する方法も含まれる。
Further, in the present invention, there are cases where various diseases of host animals caused by them can be prevented or treated by controlling animal parasitic pests as described above. As described above, the present invention includes a prophylactic or therapeutic agent for parasitic animal diseases containing the compound of the present invention as an active ingredient, and a method for preventing or treating parasitic animal diseases.
本発明化合物を動物寄生生物防除剤として使用する際、補助剤と共に、各種ビタミン類、ミネラル類、アミノ酸類、栄養剤、酵素製剤、解熱剤、鎮静剤、消炎剤、殺菌剤、着色剤、芳香剤、保存剤等と混用又は併用することができる。また、必要に応じて他の各種動物薬や農薬、例えば駆虫剤、抗コクシジウム剤、殺虫剤、殺ダニ剤、殺ノミ剤、殺線虫剤、殺菌剤、抗菌剤などと混用又は併用することができ、この場合に一層優れた効果を示すこともある。本発明には、前記したような各種成分を混用又は併用した混合有害生物防除用組成物が含まれ、また、それを使用した有害生物の防除方法、特に外部寄生生物又は内部寄生生物の防除方法も含まれる。
When the compound of the present invention is used as an animal parasite control agent, various vitamins, minerals, amino acids, nutrients, enzyme preparations, antipyretics, sedatives, anti-inflammatory agents, bactericides, coloring agents, fragrances, together with adjuvants These can be used in combination with or in combination with preservatives. Also, if necessary, mix or use with other animal drugs and pesticides such as anthelmintics, anticoccidials, insecticides, acaricides, fleas, nematicides, fungicides, antibacterials, etc. In this case, a more excellent effect may be exhibited. The present invention includes a composition for controlling mixed pests in which various components as described above are mixed or used together, and a method for controlling pests using the composition, particularly a method for controlling ectoparasites or endoparasites. Is also included.
次に本発明の望ましい態様の一例を記載するが、本発明はこれらに限定して解釈されるものではない。
(1)式(I)中、R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、Aで置換されてもよいアルキニル、ハロゲン原子、シアノ、アリール、アルキルで置換されてもよい複素環基、CH=NOR2、CH=NNR4R5、COR2、COOR2、OR2、S(O)nR3、NR4R5又はCONR4R5であり;Xがアルキル、アルケニル、アルキニル、アリール、ハロゲン原子、ハロアルキル、シアノ、ニトロ、NR4R5、S(O)nR3、OR2、COR2又はCOOR2であり;Aがハロゲン原子、OR2、S(O)nR3、OS(O)nR3、NR4R5、シアノ、アルキル、シクロアルキル、アリール、複素環基、SCH2COOR2、NHNR4R5、COOR2、ニトロ又は-CH(CN)2であり;R2が水素原子、アルキル、アルケニル、アルキニル、ハロアルキル、シアノアルキル、アルコキシアルキル、アセチル又はアリールであり;R3がアルキル又はアセチルであり;R4が水素原子又はアルキルであり;R5が水素原子、アルキル、ハロアルキル、COR2、COOR2、CH2CH2OR2又はCH2CNであり;mが1~4の整数であり;nが0~2の整数であるピリジル-トリアゾロピリミジン誘導体又はその塩。
(2) R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、Aで置換されてもよいアルキニル、ハロゲン原子、アルキルで置換されてもよい複素環基、CH=NOR2、CH=NNR4R5、COR2、COOR2、OR2、S(O)nR3、NR4R5又はCONR4R5であり;Xがアルキル、アリール、ハロゲン原子、ハロアルキル又はOR2であり;Aがハロゲン原子、OR2、S(O)nR3、OS(O)nR3、NR4R5、アルキル、シクロアルキル、複素環基、NHNR4R5、COOR2又はニトロであり;R2が水素原子、アルキル、ハロアルキル又はシアノアルキルであり;R3がアルキルであり;R5が水素原子、アルキル、ハロアルキル、COR2又はCOOR2である(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(3) R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、CH=NOR2、CH=NNR4R5、COR2、COOR2、NR4R5又はCONR4R5であり;AがOR2、S(O)nR3、OS(O)nR3、NR4R5又はニトロである(2)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(4) R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、CH=NOR2、CH=NNR4R5、COR2、COOR2、NR4R5又はCONR4R5であり;AがOR2、S(O)nR3、OS(O)nR3、NR4R5又はニトロであり;R5がハロアルキル、COR2又はCOOR2である(2)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(5) XがOR2である(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(6) R1がNR4R5であり;R5が水素原子、アルキル、ハロアルキル、COR2又はCOOR2である(2)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。 Next, although an example of the desirable mode of the present invention is described, the present invention is not limited to these.
(1) In formula (I), R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atoms, cyano, aryl which may be substituted by an alkyl heterocyclic group, CH = NOR 2, CH = NNR 4 R 5, COR 2, COOR 2, OR 2, S (O) n R 3, NR 4 R 5 Or CONR 4 R 5 ; X is alkyl, alkenyl, alkynyl, aryl, halogen atom, haloalkyl, cyano, nitro, NR 4 R 5 , S (O) n R 3 , OR 2 , COR 2 or COOR 2 A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , cyano, alkyl, cycloalkyl, aryl, heterocyclic group, SCH 2 COOR 2 , NHNR 4 R 5 , COOR 2 , nitro Or —CH (CN) 2 ; R 2 is a hydrogen atom, alkyl, alkenyl, alkynyl, haloalkyl, cyanoalkyl, alkoxyalkyl, acetyl or aryl; R 3 is alkyl or acetyl; R 4 is a hydrogen atom Or R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 , COOR 2 , CH 2 CH 2 OR 2 or CH 2 CN; m is an integer of 1 to 4; n is 0 to 2 An integer pyridyl-triazolopyrimidine derivative or a salt thereof.
(2) R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, substituted with alkyl An optionally heterocyclic group, CH═NOR 2 , CH═NNR 4 R 5 , COR 2 , COOR 2 , OR 2 , S (O) n R 3 , NR 4 R 5 or CONR 4 R 5 ; Alkyl, aryl, halogen atom, haloalkyl or OR 2 ; A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , alkyl, cycloalkyl, heterocycle A group, NHNR 4 R 5 , COOR 2 or nitro; R 2 is a hydrogen atom, alkyl, haloalkyl or cyanoalkyl; R 3 is alkyl; R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 or COOR 2 Triazolopyrimidine derivative or a salt thereof - pyridyl according to (1).
(3) R 1 is may be substituted by A alkyl, cycloalkyl which may be substituted by A, it may be substituted by A alkenyl, CH = NOR 2, CH = NNR 4 R 5, COR 2, COOR 2 , NR 4 R 5 or CONR 4 R 5 ; pyridyl according to (2), wherein A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro. A triazolopyrimidine derivative or a salt thereof.
(4) R 1 is may be substituted by A alkyl, cycloalkyl which may be substituted by A, it may be substituted by A alkenyl, CH = NOR 2, CH = NNR 4 R 5, COR 2, COOR 2 , NR 4 R 5 or CONR 4 R 5 ; A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro; R 5 is haloalkyl, COR The pyridyl-triazolopyrimidine derivative or a salt thereof according to (2), which is 2 or COOR 2 .
(5) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (1), wherein X is OR 2 .
(6) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (2), wherein R 1 is NR 4 R 5 ; R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 or COOR 2 .
(1)式(I)中、R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、Aで置換されてもよいアルキニル、ハロゲン原子、シアノ、アリール、アルキルで置換されてもよい複素環基、CH=NOR2、CH=NNR4R5、COR2、COOR2、OR2、S(O)nR3、NR4R5又はCONR4R5であり;Xがアルキル、アルケニル、アルキニル、アリール、ハロゲン原子、ハロアルキル、シアノ、ニトロ、NR4R5、S(O)nR3、OR2、COR2又はCOOR2であり;Aがハロゲン原子、OR2、S(O)nR3、OS(O)nR3、NR4R5、シアノ、アルキル、シクロアルキル、アリール、複素環基、SCH2COOR2、NHNR4R5、COOR2、ニトロ又は-CH(CN)2であり;R2が水素原子、アルキル、アルケニル、アルキニル、ハロアルキル、シアノアルキル、アルコキシアルキル、アセチル又はアリールであり;R3がアルキル又はアセチルであり;R4が水素原子又はアルキルであり;R5が水素原子、アルキル、ハロアルキル、COR2、COOR2、CH2CH2OR2又はCH2CNであり;mが1~4の整数であり;nが0~2の整数であるピリジル-トリアゾロピリミジン誘導体又はその塩。
(2) R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、Aで置換されてもよいアルキニル、ハロゲン原子、アルキルで置換されてもよい複素環基、CH=NOR2、CH=NNR4R5、COR2、COOR2、OR2、S(O)nR3、NR4R5又はCONR4R5であり;Xがアルキル、アリール、ハロゲン原子、ハロアルキル又はOR2であり;Aがハロゲン原子、OR2、S(O)nR3、OS(O)nR3、NR4R5、アルキル、シクロアルキル、複素環基、NHNR4R5、COOR2又はニトロであり;R2が水素原子、アルキル、ハロアルキル又はシアノアルキルであり;R3がアルキルであり;R5が水素原子、アルキル、ハロアルキル、COR2又はCOOR2である(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(3) R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、CH=NOR2、CH=NNR4R5、COR2、COOR2、NR4R5又はCONR4R5であり;AがOR2、S(O)nR3、OS(O)nR3、NR4R5又はニトロである(2)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(4) R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、CH=NOR2、CH=NNR4R5、COR2、COOR2、NR4R5又はCONR4R5であり;AがOR2、S(O)nR3、OS(O)nR3、NR4R5又はニトロであり;R5がハロアルキル、COR2又はCOOR2である(2)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(5) XがOR2である(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(6) R1がNR4R5であり;R5が水素原子、アルキル、ハロアルキル、COR2又はCOOR2である(2)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。 Next, although an example of the desirable mode of the present invention is described, the present invention is not limited to these.
(1) In formula (I), R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atoms, cyano, aryl which may be substituted by an alkyl heterocyclic group, CH = NOR 2, CH = NNR 4 R 5, COR 2, COOR 2, OR 2, S (O) n R 3, NR 4 R 5 Or CONR 4 R 5 ; X is alkyl, alkenyl, alkynyl, aryl, halogen atom, haloalkyl, cyano, nitro, NR 4 R 5 , S (O) n R 3 , OR 2 , COR 2 or COOR 2 A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , cyano, alkyl, cycloalkyl, aryl, heterocyclic group, SCH 2 COOR 2 , NHNR 4 R 5 , COOR 2 , nitro Or —CH (CN) 2 ; R 2 is a hydrogen atom, alkyl, alkenyl, alkynyl, haloalkyl, cyanoalkyl, alkoxyalkyl, acetyl or aryl; R 3 is alkyl or acetyl; R 4 is a hydrogen atom Or R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 , COOR 2 , CH 2 CH 2 OR 2 or CH 2 CN; m is an integer of 1 to 4; n is 0 to 2 An integer pyridyl-triazolopyrimidine derivative or a salt thereof.
(2) R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, substituted with alkyl An optionally heterocyclic group, CH═NOR 2 , CH═NNR 4 R 5 , COR 2 , COOR 2 , OR 2 , S (O) n R 3 , NR 4 R 5 or CONR 4 R 5 ; Alkyl, aryl, halogen atom, haloalkyl or OR 2 ; A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , alkyl, cycloalkyl, heterocycle A group, NHNR 4 R 5 , COOR 2 or nitro; R 2 is a hydrogen atom, alkyl, haloalkyl or cyanoalkyl; R 3 is alkyl; R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 or COOR 2 Triazolopyrimidine derivative or a salt thereof - pyridyl according to (1).
(3) R 1 is may be substituted by A alkyl, cycloalkyl which may be substituted by A, it may be substituted by A alkenyl, CH = NOR 2, CH = NNR 4 R 5, COR 2, COOR 2 , NR 4 R 5 or CONR 4 R 5 ; pyridyl according to (2), wherein A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro. A triazolopyrimidine derivative or a salt thereof.
(4) R 1 is may be substituted by A alkyl, cycloalkyl which may be substituted by A, it may be substituted by A alkenyl, CH = NOR 2, CH = NNR 4 R 5, COR 2, COOR 2 , NR 4 R 5 or CONR 4 R 5 ; A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro; R 5 is haloalkyl, COR The pyridyl-triazolopyrimidine derivative or a salt thereof according to (2), which is 2 or COOR 2 .
(5) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (1), wherein X is OR 2 .
(6) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (2), wherein R 1 is NR 4 R 5 ; R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 or COOR 2 .
(7) R5がハロアルキル、COR2又はCOOR2である(6)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(8) R5が水素原子又はCOR2である(6)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(9)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する有害生物防除剤。
(10)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する農園芸用有害生物防除剤。
(11)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する殺虫、殺ダニ、殺線虫又は殺土壌害虫剤。
(12)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する殺虫又は殺ダニ剤。
(13)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩の有効量を施用して有害生物を防除する方法。 (7) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (6), wherein R 5 is haloalkyl, COR 2 or COOR 2 .
(8) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (6), wherein R 5 is a hydrogen atom or COR 2 .
(9) A pest control agent comprising the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(10) An agricultural and horticultural pest control agent comprising the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(11) An insecticide, acaricide, nematicide or soil insecticide containing the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(12) An insecticide or acaricide containing the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(13) A method for controlling pests by applying an effective amount of the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1).
(8) R5が水素原子又はCOR2である(6)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。
(9)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する有害生物防除剤。
(10)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する農園芸用有害生物防除剤。
(11)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する殺虫、殺ダニ、殺線虫又は殺土壌害虫剤。
(12)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する殺虫又は殺ダニ剤。
(13)(1)に記載のピリジル-トリアゾロピリミジン誘導体又はその塩の有効量を施用して有害生物を防除する方法。 (7) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (6), wherein R 5 is haloalkyl, COR 2 or COOR 2 .
(8) The pyridyl-triazolopyrimidine derivative or a salt thereof according to (6), wherein R 5 is a hydrogen atom or COR 2 .
(9) A pest control agent comprising the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(10) An agricultural and horticultural pest control agent comprising the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(11) An insecticide, acaricide, nematicide or soil insecticide containing the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(12) An insecticide or acaricide containing the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1) as an active ingredient.
(13) A method for controlling pests by applying an effective amount of the pyridyl-triazolopyrimidine derivative or a salt thereof according to (1).
次に本発明の実施例を記載するが、本発明はこれらに限定して解釈されるものではない。まず、本発明化合物の合成例を記載する。
Next, examples of the present invention will be described, but the present invention should not be construed as being limited thereto. First, the synthesis example of this invention compound is described.
合成例1
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.18)の合成
(1)2-アセチル-3-クロロ-5-(トリフルオロメチル)ピリジン1.0gとN,N-ジメチルアセトアミドジメチルアセタール715mgとを、トルエン6ml中100℃にて14時間反応させた。反応液を減圧下濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(溶離液:酢酸エチル)で精製し、融点83-86℃の1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-3-(ジメチルアミノ)-2-ブテン-1-オン869mgを得た。
(2)1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-3-(ジメチルアミノ)-2-ブテン-1-オン850mgを酢酸3mlに溶解し、3-アミノ-1H-1,2,4-トリアゾール244mgを加え17時間加熱還流した。反応終了後、反応液に水を加え酢酸エチルで抽出し、飽和炭酸水素ナトリウム水溶液で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、融点105-107℃の7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン609mgを得た。
(3)7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン8.0gとN,N-ジメチルホルムアミドジメチルアセタール25mlの混合溶液を12時間加熱還流した。反応終了後、反応溶液を減圧下に濃縮した。得られた残渣と30mlのN,N-ジメチルホルムアミドの混合溶液に過ヨウ素酸ナトリウム17.1gと水60mlの混合溶液をゆっくりと滴下し、室温で5時間攪拌した。セライトのパッドで不溶の固形物を除去した後、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物5.9gを淡黄色結晶として得た。 Synthesis example 1
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 18)
(1) 2-acetyl-3-chloro-5- (trifluoromethyl) pyridine (1.0 g) and N, N-dimethylacetamide dimethylacetal (715 mg) were reacted in toluene (6 ml) at 100 ° C. for 14 hours. The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (eluent: ethyl acetate) to give 1- [3-chloro-5- (trifluoromethyl) pyridine- 869 mg of 2-yl] -3- (dimethylamino) -2-buten-1-one was obtained.
(2) 1- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -3- (dimethylamino) -2-buten-1-one 850 mg was dissolved in 3 ml of acetic acid, and 3-amino- 244 mg of 1H-1,2,4-triazole was added and heated to reflux for 17 hours. After completion of the reaction, water was added to the reaction mixture, and the mixture was extracted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 1/1), and 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl having a melting point of 105-107 ° C. 609 mg of] -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine was obtained.
(3) 8.0 g of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine and N, N -A mixed solution of 25 ml of dimethylformamide dimethylacetal was heated to reflux for 12 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure. To a mixed solution of the obtained residue and 30 ml of N, N-dimethylformamide, a mixed solution of 17.1 g of sodium periodate and 60 ml of water was slowly added dropwise and stirred at room temperature for 5 hours. Insoluble solids were removed with a pad of celite, followed by extraction twice with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 5.9 g of the desired product as pale yellow crystals.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.18)の合成
(1)2-アセチル-3-クロロ-5-(トリフルオロメチル)ピリジン1.0gとN,N-ジメチルアセトアミドジメチルアセタール715mgとを、トルエン6ml中100℃にて14時間反応させた。反応液を減圧下濃縮し、得られた残渣をシリカゲルカラムクロマトグラフィー(溶離液:酢酸エチル)で精製し、融点83-86℃の1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-3-(ジメチルアミノ)-2-ブテン-1-オン869mgを得た。
(2)1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-3-(ジメチルアミノ)-2-ブテン-1-オン850mgを酢酸3mlに溶解し、3-アミノ-1H-1,2,4-トリアゾール244mgを加え17時間加熱還流した。反応終了後、反応液に水を加え酢酸エチルで抽出し、飽和炭酸水素ナトリウム水溶液で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、融点105-107℃の7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン609mgを得た。
(3)7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン8.0gとN,N-ジメチルホルムアミドジメチルアセタール25mlの混合溶液を12時間加熱還流した。反応終了後、反応溶液を減圧下に濃縮した。得られた残渣と30mlのN,N-ジメチルホルムアミドの混合溶液に過ヨウ素酸ナトリウム17.1gと水60mlの混合溶液をゆっくりと滴下し、室温で5時間攪拌した。セライトのパッドで不溶の固形物を除去した後、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物5.9gを淡黄色結晶として得た。 Synthesis example 1
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 18)
(1) 2-acetyl-3-chloro-5- (trifluoromethyl) pyridine (1.0 g) and N, N-dimethylacetamide dimethylacetal (715 mg) were reacted in toluene (6 ml) at 100 ° C. for 14 hours. The reaction mixture was concentrated under reduced pressure, and the obtained residue was purified by silica gel column chromatography (eluent: ethyl acetate) to give 1- [3-chloro-5- (trifluoromethyl) pyridine- 869 mg of 2-yl] -3- (dimethylamino) -2-buten-1-one was obtained.
(2) 1- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -3- (dimethylamino) -2-buten-1-one 850 mg was dissolved in 3 ml of acetic acid, and 3-amino- 244 mg of 1H-1,2,4-triazole was added and heated to reflux for 17 hours. After completion of the reaction, water was added to the reaction mixture, and the mixture was extracted with ethyl acetate, washed with saturated aqueous sodium hydrogen carbonate solution and dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 1/1), and 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl having a melting point of 105-107 ° C. 609 mg of] -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine was obtained.
(3) 8.0 g of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine and N, N -A mixed solution of 25 ml of dimethylformamide dimethylacetal was heated to reflux for 12 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure. To a mixed solution of the obtained residue and 30 ml of N, N-dimethylformamide, a mixed solution of 17.1 g of sodium periodate and 60 ml of water was slowly added dropwise and stirred at room temperature for 5 hours. Insoluble solids were removed with a pad of celite, followed by extraction twice with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 5.9 g of the desired product as pale yellow crystals.
合成例2
(E)-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルバルデヒド O-メチルオキシム(化合物No.1)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン33mgとメタノール3mlの混合溶液にO-メチルヒドロキシルアミン塩酸塩17mg及び酢酸ナトリウム17mgを加え室温で2時間攪拌した。反応終了後、水5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物27mgを白色の結晶として得た。 Synthesis example 2
(E) -7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carbaldehyde O-methyloxime ( Synthesis of Compound No. 1) 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine 33 mg and methanol To 3 ml of the mixed solution, 17 mg of O-methylhydroxylamine hydrochloride and 17 mg of sodium acetate were added and stirred at room temperature for 2 hours. After completion of the reaction, 5 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 27 mg of the desired product as white crystals.
(E)-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルバルデヒド O-メチルオキシム(化合物No.1)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン33mgとメタノール3mlの混合溶液にO-メチルヒドロキシルアミン塩酸塩17mg及び酢酸ナトリウム17mgを加え室温で2時間攪拌した。反応終了後、水5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物27mgを白色の結晶として得た。 Synthesis example 2
(E) -7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carbaldehyde O-methyloxime ( Synthesis of Compound No. 1) 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine 33 mg and methanol To 3 ml of the mixed solution, 17 mg of O-methylhydroxylamine hydrochloride and 17 mg of sodium acetate were added and stirred at room temperature for 2 hours. After completion of the reaction, 5 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 27 mg of the desired product as white crystals.
合成例3
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ジメトキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.7)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン220mgとメタノール10mlの混合溶液に触媒量のパラトルエンスルホン酸を加え、7時間加熱還流した。反応終了後、飽和炭酸水素ナトリウム水溶液を加えて中和し、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物89mgを無色の油状物として得た。 Synthesis example 3
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-dimethoxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 7) 7 -[3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine in a mixed solution of 220 mg and methanol Paratoluenesulfonic acid was added and heated to reflux for 7 hours. After completion of the reaction, the mixture was neutralized by adding a saturated aqueous sodium hydrogen carbonate solution, extracted twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 89 mg of the desired product as a colorless oil.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ジメトキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.7)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン220mgとメタノール10mlの混合溶液に触媒量のパラトルエンスルホン酸を加え、7時間加熱還流した。反応終了後、飽和炭酸水素ナトリウム水溶液を加えて中和し、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物89mgを無色の油状物として得た。 Synthesis example 3
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-dimethoxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 7) 7 -[3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine in a mixed solution of 220 mg and methanol Paratoluenesulfonic acid was added and heated to reflux for 7 hours. After completion of the reaction, the mixture was neutralized by adding a saturated aqueous sodium hydrogen carbonate solution, extracted twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 89 mg of the desired product as a colorless oil.
合成例4
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヒドロキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.36)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン710mgとメタノール10mlの混合溶液を氷冷し、水素化ホウ素ナトリウム164mgを加え、30分間攪拌した。反応終了後、飽和塩化アンモニウム水溶液5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/3)で精製し、目的物336mgを白色の結晶として得た。 Synthesis example 4
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 36) 7 A mixed solution of 710 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 10 ml of methanol was ice-cooled. 164 mg of sodium borohydride was added and stirred for 30 minutes. After completion of the reaction, 5 ml of a saturated aqueous ammonium chloride solution was added, and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/3) to obtain 336 mg of the desired product as white crystals.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヒドロキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.36)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン710mgとメタノール10mlの混合溶液を氷冷し、水素化ホウ素ナトリウム164mgを加え、30分間攪拌した。反応終了後、飽和塩化アンモニウム水溶液5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/3)で精製し、目的物336mgを白色の結晶として得た。 Synthesis example 4
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 36) 7 A mixed solution of 710 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 10 ml of methanol was ice-cooled. 164 mg of sodium borohydride was added and stirred for 30 minutes. After completion of the reaction, 5 ml of a saturated aqueous ammonium chloride solution was added, and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/3) to obtain 336 mg of the desired product as white crystals.
合成例5
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メタンスルホニルオキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.51)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヒドロキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン136mg、トリエチルアミン0.23ml及びクロロホルム5mlの混合溶液を氷冷し、塩化メタンスルホニル0.05mlを加え、氷冷下に1時間攪拌した。反応終了後、水5mlを加え、クロロホルムで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物80mgを白色のアモルファスとして得た。 Synthesis example 5
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methanesulfonyloxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 51) Synthesis 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxymethyl [1,2,4] triazolo [1,5-a] pyrimidine 136 mg, triethylamine 0.23 ml and chloroform 5 ml of the mixed solution was ice-cooled, 0.05 ml of methanesulfonyl chloride was added, and the mixture was stirred for 1 hour under ice-cooling. After completion of the reaction, 5 ml of water was added and the mixture was extracted twice with chloroform. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 80 mg of the desired product as white amorphous.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メタンスルホニルオキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.51)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヒドロキシメチル[1,2,4]トリアゾロ[1,5-a]ピリミジン136mg、トリエチルアミン0.23ml及びクロロホルム5mlの混合溶液を氷冷し、塩化メタンスルホニル0.05mlを加え、氷冷下に1時間攪拌した。反応終了後、水5mlを加え、クロロホルムで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物80mgを白色のアモルファスとして得た。 Synthesis example 5
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methanesulfonyloxymethyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 51) Synthesis 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxymethyl [1,2,4] triazolo [1,5-a] pyrimidine 136 mg, triethylamine 0.23 ml and chloroform 5 ml of the mixed solution was ice-cooled, 0.05 ml of methanesulfonyl chloride was added, and the mixture was stirred for 1 hour under ice-cooling. After completion of the reaction, 5 ml of water was added and the mixture was extracted twice with chloroform. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 80 mg of the desired product as white amorphous.
合成例6
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(2-メトキシビニル)[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.28)の合成
(メトキシメチル)トリフェニルホスホニウムクロリド293mgとテトラヒドロフラン8mlの懸濁液を氷冷し、n-ブチルリチウムのヘキサン溶液(1.6M)0.48mlを滴下し、30分間攪拌した。この混合溶液に7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン140mgとテトラヒドロフラン1mlの混合溶液を滴下し、室温で一晩攪拌した。反応終了後、飽和塩化アンモニウム水溶液5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物14mgを白色の結晶として得た。 Synthesis Example 6
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (2-methoxyvinyl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 28 ) A suspension of 293 mg of (methoxymethyl) triphenylphosphonium chloride and 8 ml of tetrahydrofuran was ice-cooled, 0.48 ml of a hexane solution (1.6 M) of n-butyllithium was added dropwise, and the mixture was stirred for 30 minutes. To this mixed solution was mixed 140 mg of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 1 ml of tetrahydrofuran. The solution was added dropwise and stirred at room temperature overnight. After completion of the reaction, 5 ml of a saturated aqueous ammonium chloride solution was added, and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 14 mg of the desired product as white crystals.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(2-メトキシビニル)[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.28)の合成
(メトキシメチル)トリフェニルホスホニウムクロリド293mgとテトラヒドロフラン8mlの懸濁液を氷冷し、n-ブチルリチウムのヘキサン溶液(1.6M)0.48mlを滴下し、30分間攪拌した。この混合溶液に7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン140mgとテトラヒドロフラン1mlの混合溶液を滴下し、室温で一晩攪拌した。反応終了後、飽和塩化アンモニウム水溶液5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物14mgを白色の結晶として得た。 Synthesis Example 6
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (2-methoxyvinyl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 28 ) A suspension of 293 mg of (methoxymethyl) triphenylphosphonium chloride and 8 ml of tetrahydrofuran was ice-cooled, 0.48 ml of a hexane solution (1.6 M) of n-butyllithium was added dropwise, and the mixture was stirred for 30 minutes. To this mixed solution was mixed 140 mg of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 1 ml of tetrahydrofuran. The solution was added dropwise and stirred at room temperature overnight. After completion of the reaction, 5 ml of a saturated aqueous ammonium chloride solution was added, and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 14 mg of the desired product as white crystals.
合成例7
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(オキシラン-2-イル)[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.21)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン200mg、ヨウ化トリメチルスルホキソニウム215mg及びジメチルスルホキシド5mlの混合溶液にカリウムtert-ブトキシド110mgを加え、室温で20時間攪拌した。反応終了後、水10mlを加えた後、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物34mgを白色の結晶として得た。 Synthesis example 7
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (oxiran-2-yl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 1) 21) Synthesis 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine 200 mg, trimethyl sulfoiodide 110 mg of potassium tert-butoxide was added to a mixed solution of 215 mg of xsonium and 5 ml of dimethyl sulfoxide, and stirred at room temperature for 20 hours. After completion of the reaction, 10 ml of water was added, followed by extraction twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 34 mg of the desired product as white crystals.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(オキシラン-2-イル)[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.21)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン200mg、ヨウ化トリメチルスルホキソニウム215mg及びジメチルスルホキシド5mlの混合溶液にカリウムtert-ブトキシド110mgを加え、室温で20時間攪拌した。反応終了後、水10mlを加えた後、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物34mgを白色の結晶として得た。 Synthesis example 7
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (oxiran-2-yl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 1) 21) Synthesis 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine 200 mg, trimethyl sulfoiodide 110 mg of potassium tert-butoxide was added to a mixed solution of 215 mg of xsonium and 5 ml of dimethyl sulfoxide, and stirred at room temperature for 20 hours. After completion of the reaction, 10 ml of water was added, followed by extraction twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 34 mg of the desired product as white crystals.
合成例8
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルボン酸(化合物No.48)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン1.0gとアセトン10mlの混合溶液を氷冷し、ジョーンズ試薬3mlをゆっくりと滴下した後、氷冷下に1時間攪拌した。反応終了後、イソプロパノール3mlを加えて室温で30分間攪拌した。セライトのパッドで不溶の固形物を除去した後、水10mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去する事で、目的物394mgを薄褐色の固体として得た。 Synthesis example 8
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid (Compound No. 48) 7 A mixed solution of 1.0 g of 10- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 10 ml of acetone was added to ice. After cooling, 3 ml of Jones reagent was slowly added dropwise, and the mixture was stirred for 1 hour under ice cooling. After completion of the reaction, 3 ml of isopropanol was added and stirred at room temperature for 30 minutes. After removing insoluble solids with a pad of celite, 10 ml of water was added and extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure to obtain 394 mg of the desired product as a light brown solid.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルボン酸(化合物No.48)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ホルミル[1,2,4]トリアゾロ[1,5-a]ピリミジン1.0gとアセトン10mlの混合溶液を氷冷し、ジョーンズ試薬3mlをゆっくりと滴下した後、氷冷下に1時間攪拌した。反応終了後、イソプロパノール3mlを加えて室温で30分間攪拌した。セライトのパッドで不溶の固形物を除去した後、水10mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去する事で、目的物394mgを薄褐色の固体として得た。 Synthesis example 8
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid (Compound No. 48) 7 A mixed solution of 1.0 g of 10- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-formyl [1,2,4] triazolo [1,5-a] pyrimidine and 10 ml of acetone was added to ice. After cooling, 3 ml of Jones reagent was slowly added dropwise, and the mixture was stirred for 1 hour under ice cooling. After completion of the reaction, 3 ml of isopropanol was added and stirred at room temperature for 30 minutes. After removing insoluble solids with a pad of celite, 10 ml of water was added and extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure to obtain 394 mg of the desired product as a light brown solid.
合成例9
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メトキシカルボニル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.8)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルボン酸50mgとジエチルエーテル5mlの混合溶液にトリメチルシリルジアゾメタンのジエチルエーテル溶液(2M)1mlを加え、室温で1時間攪拌した。反応終了後、過剰のトリメチルシリルジアゾメタンを酢酸1mlで分解させた。次いで飽和炭酸水素ナトリウム水溶液を加えて中和した後、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物33mgを白色の結晶として得た。 Synthesis Example 9
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methoxycarbonyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 8) 7 Trimethylsilyl in a mixed solution of 50 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid and 5 ml of diethyl ether 1 ml of a diethyl ether solution of diazomethane (2M) was added and stirred at room temperature for 1 hour. After completion of the reaction, excess trimethylsilyldiazomethane was decomposed with 1 ml of acetic acid. Next, the mixture was neutralized by adding a saturated aqueous sodium hydrogen carbonate solution, and extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 33 mg of the desired product as white crystals.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メトキシカルボニル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.8)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルボン酸50mgとジエチルエーテル5mlの混合溶液にトリメチルシリルジアゾメタンのジエチルエーテル溶液(2M)1mlを加え、室温で1時間攪拌した。反応終了後、過剰のトリメチルシリルジアゾメタンを酢酸1mlで分解させた。次いで飽和炭酸水素ナトリウム水溶液を加えて中和した後、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物33mgを白色の結晶として得た。 Synthesis Example 9
Synthesis of 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methoxycarbonyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 8) 7 Trimethylsilyl in a mixed solution of 50 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid and 5 ml of diethyl ether 1 ml of a diethyl ether solution of diazomethane (2M) was added and stirred at room temperature for 1 hour. After completion of the reaction, excess trimethylsilyldiazomethane was decomposed with 1 ml of acetic acid. Next, the mixture was neutralized by adding a saturated aqueous sodium hydrogen carbonate solution, and extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 33 mg of the desired product as white crystals.
合成例10
tert-ブチル 7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-イルカーバメート(化合物No.23)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルボン酸394mg、tert-ブタノール0.34ml及びトルエン10mlの混合溶液にジフェニルリン酸アジド0.28ml、次いでトリエチルアミン0.18mlを加え3時間加熱還流した。反応終了後、水10mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物178mgを白色の結晶として得た。 Synthesis Example 10
tert-Butyl 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidin-5-ylcarbamate (Compound No. 23) Synthesis of 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid 394 mg, tert-butanol To a mixed solution of 34 ml and 10 ml of toluene, 0.28 ml of diphenylphosphoric acid azide and then 0.18 ml of triethylamine were added and heated to reflux for 3 hours. After completion of the reaction, 10 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 178 mg of the desired product as white crystals.
tert-ブチル 7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-イルカーバメート(化合物No.23)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-カルボン酸394mg、tert-ブタノール0.34ml及びトルエン10mlの混合溶液にジフェニルリン酸アジド0.28ml、次いでトリエチルアミン0.18mlを加え3時間加熱還流した。反応終了後、水10mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物178mgを白色の結晶として得た。 Synthesis Example 10
tert-Butyl 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidin-5-ylcarbamate (Compound No. 23) Synthesis of 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine-5-carboxylic acid 394 mg, tert-butanol To a mixed solution of 34 ml and 10 ml of toluene, 0.28 ml of diphenylphosphoric acid azide and then 0.18 ml of triethylamine were added and heated to reflux for 3 hours. After completion of the reaction, 10 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 178 mg of the desired product as white crystals.
合成例11
5-アミノ-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.15)の合成
tert-ブチル 7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-イルカーバメート178mgとクロロホルム10mlの混合溶液にトリフルオロ酢酸1mlを加え、12時間加熱還流した。反応終了後、溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:酢酸エチル/メタノール=15/1)で精製し、目的物147mgを白色の結晶として得た。 Synthesis Example 11
Synthesis of 5-amino-7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 15) tert- In a mixed solution of 178 mg of butyl 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidin-5-ylcarbamate and 10 ml of chloroform 1 ml of trifluoroacetic acid was added and heated to reflux for 12 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel chromatography (eluent: ethyl acetate / methanol = 15/1) to obtain 147 mg of the desired product as white crystals.
5-アミノ-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.15)の合成
tert-ブチル 7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-イルカーバメート178mgとクロロホルム10mlの混合溶液にトリフルオロ酢酸1mlを加え、12時間加熱還流した。反応終了後、溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:酢酸エチル/メタノール=15/1)で精製し、目的物147mgを白色の結晶として得た。 Synthesis Example 11
Synthesis of 5-amino-7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 15) tert- In a mixed solution of 178 mg of butyl 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidin-5-ylcarbamate and 10 ml of chloroform 1 ml of trifluoroacetic acid was added and heated to reflux for 12 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel chromatography (eluent: ethyl acetate / methanol = 15/1) to obtain 147 mg of the desired product as white crystals.
合成例12
N-{7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-イル}-2,2,2-トリフルオロアセトアミド(化合物No.26)の合成
5-アミノ-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン56mg、触媒量の4-ジメチルアミノピリジン及びピリジン1mlの混合溶液に無水トリフルオロ酢酸0.5mlを滴下し、室温で12時間攪拌した。反応終了後、反応溶液を減圧下に濃縮し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物15mgを白色の結晶として得た。 Synthesis Example 12
N- {7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidin-5-yl} -2,2,2 Of 2-trifluoroacetamide (Compound No. 26) 5-Amino-7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a ] To a mixed solution of 56 mg of pyrimidine, a catalytic amount of 4-dimethylaminopyridine and 1 ml of pyridine, 0.5 ml of trifluoroacetic anhydride was added dropwise and stirred at room temperature for 12 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 15 mg of the desired product as white crystals. .
N-{7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン-5-イル}-2,2,2-トリフルオロアセトアミド(化合物No.26)の合成
5-アミノ-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン56mg、触媒量の4-ジメチルアミノピリジン及びピリジン1mlの混合溶液に無水トリフルオロ酢酸0.5mlを滴下し、室温で12時間攪拌した。反応終了後、反応溶液を減圧下に濃縮し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物15mgを白色の結晶として得た。 Synthesis Example 12
N- {7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidin-5-yl} -2,2,2 Of 2-trifluoroacetamide (Compound No. 26) 5-Amino-7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a ] To a mixed solution of 56 mg of pyrimidine, a catalytic amount of 4-dimethylaminopyridine and 1 ml of pyridine, 0.5 ml of trifluoroacetic anhydride was added dropwise and stirred at room temperature for 12 hours. After completion of the reaction, the reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 15 mg of the desired product as white crystals. .
合成例13
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヨード[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.40)及び7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヒドロキシ[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.41)の合成
5-アミノ-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン61mg、ヨウ素148mg及びアセトニトリル5mlの混合溶液を氷冷し、亜硝酸tert-ブチル0.05mlを加えた。反応混合物を氷冷下に30分間、次いで室温で一晩攪拌した。反応終了後、水5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物(化合物No.40)12mg及び目的物(化合物No.41)16mgをいづれも白色の結晶として得た。 Synthesis Example 13
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-iodo [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 40) and 7- [ Synthesis of 3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxy [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 41) 5-amino-7 A mixed solution of 61 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine, 148 mg of iodine and 5 ml of acetonitrile was ice-cooled, 0.05 ml of tert-butyl nitrite was added. The reaction mixture was stirred for 30 minutes under ice cooling and then overnight at room temperature. After completion of the reaction, 5 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 12 mg of the desired product (Compound No. 40) and the desired product (Compound). No. 41) 16 mg was obtained as white crystals.
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヨード[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.40)及び7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-ヒドロキシ[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.41)の合成
5-アミノ-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン61mg、ヨウ素148mg及びアセトニトリル5mlの混合溶液を氷冷し、亜硝酸tert-ブチル0.05mlを加えた。反応混合物を氷冷下に30分間、次いで室温で一晩攪拌した。反応終了後、水5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物(化合物No.40)12mg及び目的物(化合物No.41)16mgをいづれも白色の結晶として得た。 Synthesis Example 13
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-iodo [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 40) and 7- [ Synthesis of 3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-hydroxy [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 41) 5-amino-7 A mixed solution of 61 mg of [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine, 148 mg of iodine and 5 ml of acetonitrile was ice-cooled, 0.05 ml of tert-butyl nitrite was added. The reaction mixture was stirred for 30 minutes under ice cooling and then overnight at room temperature. After completion of the reaction, 5 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 12 mg of the desired product (Compound No. 40) and the desired product (Compound). No. 41) 16 mg was obtained as white crystals.
合成例14
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(1-エトキシエチル)[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.12)の合成
(1)3-クロロ‐5-(トリフルオロメチル)ピリジン-2-カルボン酸エチル6.0g、メチルエチルケトン2.6g及びテトラヒドロフラン(脱水)80mlの混合溶液にナトリウムエトキシド3.2gを加え室温で15分間攪拌した。反応終了後、反応液に1N塩酸を加え酸性とした後、酢酸エチルで抽出し、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去して得た液状物に、1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-ペンタン-1,3-ジオンが含まれることを1H-NMRにて確認した。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、1.22(3H, t, J = 7.2Hz), 2.48(2H, q, J = 7.2Hz), 6.28(1H, s),8.02(1H, s), 8.77(1H, s)であった。
(2)(1)で得られた1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-ペンタン-1,3-ジオンを含む液状物全量に、酢酸65ml及び 3-アミノ-1H-1,2,4-トリアゾール2.2gを加え、100℃で一晩攪拌した。反応終了後、減圧下で溶媒を留去し、得られた残渣に水を加え、酢酸エチルで抽出した。有機層を飽和炭酸水素ナトリウム水溶液で洗浄した後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=3/1)で精製し、7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-エチル[1,2,4]トリアゾロ[1,5-a]ピリミジン3.1gを得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、1.47(3H, t, J = 8.0Hz), 3.09(2H, q, J = 8.0Hz), 7.17(1H, s), 8.21(1H, d, J = 1.6Hz), 8.47(1H, s), 8.98(1H, m)であった。 Synthesis Example 14
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (1-ethoxyethyl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 12 ) Synthesis
(1) To a mixed solution of 6.0 g of ethyl 3-chloro-5- (trifluoromethyl) pyridine-2-carboxylate, 2.6 g of methyl ethyl ketone and 80 ml of tetrahydrofuran (dehydrated) was added 3.2 g of sodium ethoxide at room temperature. Stir for minutes. After completion of the reaction, the reaction mixture was acidified with 1N hydrochloric acid, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to give 1- [3-chloro- The presence of 5- (trifluoromethyl) pyridin-2-yl] -pentane-1,3-dione was confirmed by 1 H-NMR. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is 1.22 (3H, t, J = 7.2Hz), 2.48 (2H, q, J = 7.2Hz), 6.28 (1H, s), 8.02 (1H , s), 8.77 (1H, s).
(2) To the total amount of liquid containing 1- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -pentane-1,3-dione obtained in (1), 65 ml of acetic acid and 3- Amino-1H-1,2,4-triazole (2.2 g) was added, and the mixture was stirred at 100 ° C. overnight. After completion of the reaction, the solvent was distilled off under reduced pressure, water was added to the resulting residue, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and then dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 3/1), and 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-ethyl [ 3.1 g of 1,2,4] triazolo [1,5-a] pyrimidine was obtained. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is 1.47 (3H, t, J = 8.0Hz), 3.09 (2H, q, J = 8.0Hz), 7.17 (1H, s), 8.21 (1H , d, J = 1.6Hz), 8.47 (1H, s), 8.98 (1H, m).
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(1-エトキシエチル)[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.12)の合成
(1)3-クロロ‐5-(トリフルオロメチル)ピリジン-2-カルボン酸エチル6.0g、メチルエチルケトン2.6g及びテトラヒドロフラン(脱水)80mlの混合溶液にナトリウムエトキシド3.2gを加え室温で15分間攪拌した。反応終了後、反応液に1N塩酸を加え酸性とした後、酢酸エチルで抽出し、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去して得た液状物に、1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-ペンタン-1,3-ジオンが含まれることを1H-NMRにて確認した。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、1.22(3H, t, J = 7.2Hz), 2.48(2H, q, J = 7.2Hz), 6.28(1H, s),8.02(1H, s), 8.77(1H, s)であった。
(2)(1)で得られた1-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-ペンタン-1,3-ジオンを含む液状物全量に、酢酸65ml及び 3-アミノ-1H-1,2,4-トリアゾール2.2gを加え、100℃で一晩攪拌した。反応終了後、減圧下で溶媒を留去し、得られた残渣に水を加え、酢酸エチルで抽出した。有機層を飽和炭酸水素ナトリウム水溶液で洗浄した後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=3/1)で精製し、7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-エチル[1,2,4]トリアゾロ[1,5-a]ピリミジン3.1gを得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、1.47(3H, t, J = 8.0Hz), 3.09(2H, q, J = 8.0Hz), 7.17(1H, s), 8.21(1H, d, J = 1.6Hz), 8.47(1H, s), 8.98(1H, m)であった。 Synthesis Example 14
7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (1-ethoxyethyl) [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 12 ) Synthesis
(1) To a mixed solution of 6.0 g of ethyl 3-chloro-5- (trifluoromethyl) pyridine-2-carboxylate, 2.6 g of methyl ethyl ketone and 80 ml of tetrahydrofuran (dehydrated) was added 3.2 g of sodium ethoxide at room temperature. Stir for minutes. After completion of the reaction, the reaction mixture was acidified with 1N hydrochloric acid, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to give 1- [3-chloro- The presence of 5- (trifluoromethyl) pyridin-2-yl] -pentane-1,3-dione was confirmed by 1 H-NMR. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is 1.22 (3H, t, J = 7.2Hz), 2.48 (2H, q, J = 7.2Hz), 6.28 (1H, s), 8.02 (1H , s), 8.77 (1H, s).
(2) To the total amount of liquid containing 1- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -pentane-1,3-dione obtained in (1), 65 ml of acetic acid and 3- Amino-1H-1,2,4-triazole (2.2 g) was added, and the mixture was stirred at 100 ° C. overnight. After completion of the reaction, the solvent was distilled off under reduced pressure, water was added to the resulting residue, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and then dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 3/1), and 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-ethyl [ 3.1 g of 1,2,4] triazolo [1,5-a] pyrimidine was obtained. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is 1.47 (3H, t, J = 8.0Hz), 3.09 (2H, q, J = 8.0Hz), 7.17 (1H, s), 8.21 (1H , d, J = 1.6Hz), 8.47 (1H, s), 8.98 (1H, m).
(3)7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-エチル[1,2,4]トリアゾロ[1,5-a]ピリミジン5.76gをクロロホルム30mlに溶解した溶液に、N-ブロモスクシンイミド4.47g及びアゾビスイソブチロニトリル(AIBN)50mgを加え、加熱還流下一晩攪拌した。反応終了後、反応液に水を加え酢酸エチルで抽出し、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=5/2)で精製し、5-(1-ブロモエチル)-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン4.47gを融点118℃の固体として得た。
(3) 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5-ethyl [1,2,4] triazolo [1,5-a] pyrimidine (5.76 g) in 30 ml of chloroform To the dissolved solution, 4.47 g of N-bromosuccinimide and 50 mg of azobisisobutyronitrile (AIBN) were added, and the mixture was stirred overnight with heating under reflux. After completion of the reaction, water was added to the reaction solution, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 5/2) to give 5- (1-bromoethyl) -7- [3-chloro-5- (trifluoromethyl) pyridine-2. There was obtained 4.47 g of -yl] [1,2,4] triazolo [1,5-a] pyrimidine as a solid with a melting point of 118 ° C.
(4)5-(1-ブロモエチル)-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン840mgとジメチルスルホキシド10mlの混合溶液にテトラフルオロほう酸銀30mgを加え、室温で一晩攪拌した。反応終了後、水10mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去する事で、7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(1-ヒドロキシエチル)[1,2,4]トリアゾロ[1,5-a]ピリミジンを融点178℃の白色の結晶として得た。
(4) 840 mg of 5- (1-bromoethyl) -7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine and dimethyl 30 mg of silver tetrafluoroborate was added to a mixed solution of 10 ml of sulfoxide and stirred overnight at room temperature. After completion of the reaction, 10 ml of water was added and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine and dried over anhydrous sodium sulfate. By distilling off the solvent under reduced pressure, 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (1-hydroxyethyl) [1,2,4] triazolo [1 , 5-a] pyrimidine was obtained as white crystals with a melting point of 178 ° C.
(5)7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(1-ヒドロキシエチル)[1,2,4]トリアゾロ[1,5-a]ピリミジン100mg、10規定水酸化ナトリウム水溶液0.2ml及びN,N-ジメチルホルムアミド5mlの混合溶液を氷冷し、ヨウ化エチル0.2mlを加えた。反応溶液を氷冷下に30分間、次いで室温で4時間攪拌した。反応終了後、飽和塩化アンモニウム水溶液5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物63mgを無色の結晶として得た。
(5) 7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (1-hydroxyethyl) [1,2,4] triazolo [1,5-a] pyrimidine 100 mg, A mixed solution of 0.2 ml of 10N aqueous sodium hydroxide and 5 ml of N, N-dimethylformamide was ice-cooled, and 0.2 ml of ethyl iodide was added. The reaction solution was stirred under ice-cooling for 30 minutes and then at room temperature for 4 hours. After completion of the reaction, 5 ml of a saturated aqueous ammonium chloride solution was added, and the mixture was extracted twice with ethyl acetate. The organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 63 mg of the desired product as colorless crystals.
合成例15
5-アセチル-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.3)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(1-ヒドロキシエチル)[1,2,4]トリアゾロ[1,5-a]ピリミジン240mgとアセトン5mlの混合溶液を氷冷し、ジョーンズ試薬1mlをゆっくりと滴下した後、氷冷下に30分間、次いで室温で1時間攪拌した。反応終了後、イソプロパノール1mlを加えて室温で30分間攪拌した。セライトのパッドで不溶の固形物を除去した後、水5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物152mgを白色の結晶として得た。 Synthesis Example 15
Synthesis of 5-acetyl-7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 3) 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (1-hydroxyethyl) [1,2,4] triazolo [1,5-a] pyrimidine 240 mg and acetone 5 ml mixed solution The mixture was ice-cooled, and 1 ml of Jones reagent was slowly added dropwise, followed by stirring under ice-cooling for 30 minutes and then at room temperature for 1 hour. After completion of the reaction, 1 ml of isopropanol was added and stirred at room temperature for 30 minutes. After removing insoluble solids with a pad of celite, 5 ml of water was added and extracted twice with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 152 mg of the desired product as white crystals.
5-アセチル-7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.3)の合成
7-[3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-(1-ヒドロキシエチル)[1,2,4]トリアゾロ[1,5-a]ピリミジン240mgとアセトン5mlの混合溶液を氷冷し、ジョーンズ試薬1mlをゆっくりと滴下した後、氷冷下に30分間、次いで室温で1時間攪拌した。反応終了後、イソプロパノール1mlを加えて室温で30分間攪拌した。セライトのパッドで不溶の固形物を除去した後、水5mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=2/1)で精製し、目的物152mgを白色の結晶として得た。 Synthesis Example 15
Synthesis of 5-acetyl-7- [3-chloro-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 3) 7- [3-Chloro-5- (trifluoromethyl) pyridin-2-yl] -5- (1-hydroxyethyl) [1,2,4] triazolo [1,5-a] pyrimidine 240 mg and acetone 5 ml mixed solution The mixture was ice-cooled, and 1 ml of Jones reagent was slowly added dropwise, followed by stirring under ice-cooling for 30 minutes and then at room temperature for 1 hour. After completion of the reaction, 1 ml of isopropanol was added and stirred at room temperature for 30 minutes. After removing insoluble solids with a pad of celite, 5 ml of water was added and extracted twice with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 2/1) to obtain 152 mg of the desired product as white crystals.
合成例16
5-シクロプロピル-7-[3-ヨード-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.74)の合成
(1)ジメチルスルホキシド400ml中にフッ化カリウム72gを加え、120℃で10分間攪拌した後、2-クロロ-3-ヨード-5-(トリフルオロメチル)ピリジン127gを加え120℃で2時間攪拌した。反応終了後、反応液を室温に戻し、析出固体をろ過し、2-フルオロ-3-ヨード-5-(トリフルオロメチル)ピリジンを含むろ液を得た。得られたろ液全量にシアン化ナトリウム22.3g、テトラブチルアンモニウムブロミド6.7gを加え50℃で6時間攪拌した。反応終了後、反応液を水4,000ml中に投入し、析出固体をろ過した。得られた個体をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=95/5)で精製し、3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボニトリル87gを白色の結晶として得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、8.44(1H,s), 8.90(1H, s) であった。
(2)水60ml中に96%硫酸520mlを0℃でゆっくり加えた後、室温で3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボニトリル87gを加え、120℃で3時間攪拌した。反応終了後、反応液を氷水5,000ml中に投入し、得られた結晶をろ過し、水洗した後、乾燥することで、3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボン酸80gを白色の結晶として得た。 Synthesis Example 16
Synthesis of 5-cyclopropyl-7- [3-iodo-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 74)
(1) After adding 72 g of potassium fluoride in 400 ml of dimethyl sulfoxide and stirring at 120 ° C. for 10 minutes, 127 g of 2-chloro-3-iodo-5- (trifluoromethyl) pyridine was added and stirred at 120 ° C. for 2 hours. . After completion of the reaction, the reaction solution was returned to room temperature, and the precipitated solid was filtered to obtain a filtrate containing 2-fluoro-3-iodo-5- (trifluoromethyl) pyridine. To the total amount of the filtrate obtained, 22.3 g of sodium cyanide and 6.7 g of tetrabutylammonium bromide were added and stirred at 50 ° C. for 6 hours. After completion of the reaction, the reaction solution was poured into 4,000 ml of water, and the precipitated solid was filtered. The obtained solid was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 95/5) to obtain 87 g of 3-iodo-5- (trifluoromethyl) pyridine-2-carbonitrile as white crystals. Got as. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is, 8.44 (1H, s), was 8.90 (1H, s).
(2) After slowly adding 520 ml of 96% sulfuric acid to 60 ml of water, 87 g of 3-iodo-5- (trifluoromethyl) pyridine-2-carbonitrile was added at room temperature, and the mixture was stirred at 120 ° C. for 3 hours. . After completion of the reaction, the reaction solution was poured into 5,000 ml of ice water, and the resulting crystals were filtered, washed with water, and dried to give 3-iodo-5- (trifluoromethyl) pyridine-2-carboxylic acid. 80 g was obtained as white crystals.
5-シクロプロピル-7-[3-ヨード-5-(トリフルオロメチル)ピリジン-2-イル][1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.74)の合成
(1)ジメチルスルホキシド400ml中にフッ化カリウム72gを加え、120℃で10分間攪拌した後、2-クロロ-3-ヨード-5-(トリフルオロメチル)ピリジン127gを加え120℃で2時間攪拌した。反応終了後、反応液を室温に戻し、析出固体をろ過し、2-フルオロ-3-ヨード-5-(トリフルオロメチル)ピリジンを含むろ液を得た。得られたろ液全量にシアン化ナトリウム22.3g、テトラブチルアンモニウムブロミド6.7gを加え50℃で6時間攪拌した。反応終了後、反応液を水4,000ml中に投入し、析出固体をろ過した。得られた個体をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=95/5)で精製し、3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボニトリル87gを白色の結晶として得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、8.44(1H,s), 8.90(1H, s) であった。
(2)水60ml中に96%硫酸520mlを0℃でゆっくり加えた後、室温で3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボニトリル87gを加え、120℃で3時間攪拌した。反応終了後、反応液を氷水5,000ml中に投入し、得られた結晶をろ過し、水洗した後、乾燥することで、3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボン酸80gを白色の結晶として得た。 Synthesis Example 16
Synthesis of 5-cyclopropyl-7- [3-iodo-5- (trifluoromethyl) pyridin-2-yl] [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 74)
(1) After adding 72 g of potassium fluoride in 400 ml of dimethyl sulfoxide and stirring at 120 ° C. for 10 minutes, 127 g of 2-chloro-3-iodo-5- (trifluoromethyl) pyridine was added and stirred at 120 ° C. for 2 hours. . After completion of the reaction, the reaction solution was returned to room temperature, and the precipitated solid was filtered to obtain a filtrate containing 2-fluoro-3-iodo-5- (trifluoromethyl) pyridine. To the total amount of the filtrate obtained, 22.3 g of sodium cyanide and 6.7 g of tetrabutylammonium bromide were added and stirred at 50 ° C. for 6 hours. After completion of the reaction, the reaction solution was poured into 4,000 ml of water, and the precipitated solid was filtered. The obtained solid was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 95/5) to obtain 87 g of 3-iodo-5- (trifluoromethyl) pyridine-2-carbonitrile as white crystals. Got as. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is, 8.44 (1H, s), was 8.90 (1H, s).
(2) After slowly adding 520 ml of 96% sulfuric acid to 60 ml of water, 87 g of 3-iodo-5- (trifluoromethyl) pyridine-2-carbonitrile was added at room temperature, and the mixture was stirred at 120 ° C. for 3 hours. . After completion of the reaction, the reaction solution was poured into 5,000 ml of ice water, and the resulting crystals were filtered, washed with water, and dried to give 3-iodo-5- (trifluoromethyl) pyridine-2-carboxylic acid. 80 g was obtained as white crystals.
(3)1,2-ジクロロエタン13ml中に3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボン酸4.0g、塩化チオニル2.3g及びN,N-ジメチルホルムアミド92mgを加え75℃で2時間攪拌した。反応液を室温に戻し、減圧下溶媒を留去して得た液状物をエタノール13ml中に0℃で加えた後、室温で1時間攪拌した。反応終了後、反応液の溶媒を減圧下留去し、水15mlを加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=9/1)で精製し、3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボン酸エチル4.05gを黄色の液体として得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、1.42(3H, t, J=7.2Hz), 4.49(2H, q, J = 7.2Hz), 8.44(1H, s), 8.84(1H, s)であった。
(3) To 13 ml of 1,2-dichloroethane, 4.0 g of 3-iodo-5- (trifluoromethyl) pyridine-2-carboxylic acid, 2.3 g of thionyl chloride and 92 mg of N, N-dimethylformamide were added at 75 ° C. Stir for 2 hours. The reaction solution was returned to room temperature, the liquid obtained by distilling off the solvent under reduced pressure was added to 13 ml of ethanol at 0 ° C., and the mixture was stirred at room temperature for 1 hour. After completion of the reaction, the solvent of the reaction solution was distilled off under reduced pressure, 15 ml of water was added, the mixture was extracted twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 9/1) to give 3-iodo-5- (trifluoromethyl) pyridine- 4.05 g of ethyl 2-carboxylate was obtained as a yellow liquid. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is, 1.42 (3H, t, J = 7.2Hz), 4.49 (2H, q, J = 7.2Hz), 8.44 (1H, s), 8.84 (1H , s).
(4)3-ヨード-5-(トリフルオロメチル)ピリジン-2-カルボン酸エチル4.0g、シクロプロピルメチルケトン1.46g及びテトラヒドロフラン(脱水)23mlの混合溶液にナトリウムエトキシド955mgを加え室温で15分間攪拌した。反応終了後、反応液に1規定塩酸を加え酸性とした後、酢酸エチルで抽出し、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去することで、粗製の1-シクロプロピル-3-[3-ヨード-5-(トリフルオロメチル)ピリジン-2-イル]プロパン-1,3-ジオンを液状物として得た。
(5)(4)で得られた粗製の1-シクロプロピル-3-[3-ヨード-5-(トリフルオロメチル)ピリジン-2-イル]プロパン-1,3-ジオンである液状物全量と酢酸23mlの混合溶液に3-アミノ-1H-1,2,4-トリアゾール1.02gを加え、100℃で一晩攪拌した。反応終了後、減圧下で溶媒を留去し、得られた残渣に水を加え酢酸エチルで抽出した。有機層を飽和炭酸水素ナトリウム水溶液で洗浄した後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物1.7gを白色の結晶として得た。 (4) 955 mg of sodium ethoxide was added to a mixed solution of 4.0 g of ethyl 3-iodo-5- (trifluoromethyl) pyridine-2-carboxylate, 1.46 g of cyclopropyl methyl ketone and 23 ml of tetrahydrofuran (dehydrated) at room temperature. Stir for 15 minutes. After completion of the reaction, the reaction mixture was acidified with 1N hydrochloric acid, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and evaporated under reduced pressure to remove crude 1-cyclopropyl-3- [ 3-Iodo-5- (trifluoromethyl) pyridin-2-yl] propane-1,3-dione was obtained as a liquid.
(5) The total amount of the crude liquid 1-cyclopropyl-3- [3-iodo-5- (trifluoromethyl) pyridin-2-yl] propane-1,3-dione obtained in (4) To a mixed solution of acetic acid (23 ml), 3-amino-1H-1,2,4-triazole (1.02 g) was added, and the mixture was stirred at 100 ° C. overnight. After completion of the reaction, the solvent was distilled off under reduced pressure, water was added to the obtained residue, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and then dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 1.7 g of the desired product as white crystals.
(5)(4)で得られた粗製の1-シクロプロピル-3-[3-ヨード-5-(トリフルオロメチル)ピリジン-2-イル]プロパン-1,3-ジオンである液状物全量と酢酸23mlの混合溶液に3-アミノ-1H-1,2,4-トリアゾール1.02gを加え、100℃で一晩攪拌した。反応終了後、減圧下で溶媒を留去し、得られた残渣に水を加え酢酸エチルで抽出した。有機層を飽和炭酸水素ナトリウム水溶液で洗浄した後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物1.7gを白色の結晶として得た。 (4) 955 mg of sodium ethoxide was added to a mixed solution of 4.0 g of ethyl 3-iodo-5- (trifluoromethyl) pyridine-2-carboxylate, 1.46 g of cyclopropyl methyl ketone and 23 ml of tetrahydrofuran (dehydrated) at room temperature. Stir for 15 minutes. After completion of the reaction, the reaction mixture was acidified with 1N hydrochloric acid, extracted with ethyl acetate, dried over anhydrous sodium sulfate, and evaporated under reduced pressure to remove crude 1-cyclopropyl-3- [ 3-Iodo-5- (trifluoromethyl) pyridin-2-yl] propane-1,3-dione was obtained as a liquid.
(5) The total amount of the crude liquid 1-cyclopropyl-3- [3-iodo-5- (trifluoromethyl) pyridin-2-yl] propane-1,3-dione obtained in (4) To a mixed solution of acetic acid (23 ml), 3-amino-1H-1,2,4-triazole (1.02 g) was added, and the mixture was stirred at 100 ° C. overnight. After completion of the reaction, the solvent was distilled off under reduced pressure, water was added to the obtained residue, and the mixture was extracted with ethyl acetate. The organic layer was washed with a saturated aqueous sodium hydrogen carbonate solution and then dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 1.7 g of the desired product as white crystals.
合成例17
3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸メチル(化合物No.98)の合成
(1)2,3-ジクロロ-5-(トリフルオロメチル)イソニコチン酸メチル500mg、トリブチル(1-エトキシビニル)スズ0.66ml、テトラキス(トリフェニルホスフィン)パラジウム216mg及びトルエン10mlの混合溶液を加熱還流下にて5時間反応させた。反応液を減圧下濃縮し、得られた残渣とテトラヒドロフラン5mlの混合溶液に6N塩酸1mlを加えて2時間加熱還流した。反応終了後、水3mlを加え酢酸エチルで抽出し、飽和炭酸水素ナトリウム水溶液、次いで飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=6/1)で精製し、2-アセチル-3-クロロ-5-(トリフルオロメチル)イソニコチン酸メチル307mgを無色の油状物として得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、2.72(3H, s), 4.02(3H, s), 8.84(1H, s)であった。
(2)2-アセチル-3-クロロ-5-(トリフルオロメチル)イソニコチン酸メチル307mgとN,N-ジメチルアセトアミドジメチルアセタール0.41mgとを、トルエン5ml中100℃にて4時間反応させた。反応液を減圧下濃縮し、得られた残渣を酢酸3mlに溶解し、3-アミノ-1H-1,2,4-トリアゾール100mgを加え17時間加熱還流した。反応終了後、減圧下溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/5)で精製し、目的物138mgを得た。 Synthesis Example 17
Of 3-chloro-2- (5-methyl [1,2,4] triazolo [1,5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinate (Compound No. 98) Composition
(1) Heating a mixed solution of 500 mg of methyl 2,3-dichloro-5- (trifluoromethyl) isonicotinate, 0.66 ml of tributyl (1-ethoxyvinyl) tin, 216 mg of tetrakis (triphenylphosphine) palladium and 10 ml of toluene The reaction was carried out for 5 hours under reflux. The reaction solution was concentrated under reduced pressure, 1 ml of 6N hydrochloric acid was added to a mixed solution of the obtained residue and 5 ml of tetrahydrofuran, and the mixture was heated to reflux for 2 hours. After completion of the reaction, 3 ml of water was added, and the mixture was extracted with ethyl acetate. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 6/1), and 307 mg of methyl 2-acetyl-3-chloro-5- (trifluoromethyl) isonicotinate was obtained as a colorless oil. Got as. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is, 2.72 (3H, s), 4.02 (3H, s), was 8.84 (1H, s).
(2) Methyl 2-acetyl-3-chloro-5- (trifluoromethyl) isonicotinate (307 mg) and N, N-dimethylacetamide dimethyl acetal (0.41 mg) were reacted in 5 ml of toluene at 100 ° C. for 4 hours. . The reaction mixture was concentrated under reduced pressure, and the resulting residue was dissolved in 3 ml of acetic acid, 100 mg of 3-amino-1H-1,2,4-triazole was added, and the mixture was heated to reflux for 17 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 1/5) to obtain 138 mg of the desired product.
3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸メチル(化合物No.98)の合成
(1)2,3-ジクロロ-5-(トリフルオロメチル)イソニコチン酸メチル500mg、トリブチル(1-エトキシビニル)スズ0.66ml、テトラキス(トリフェニルホスフィン)パラジウム216mg及びトルエン10mlの混合溶液を加熱還流下にて5時間反応させた。反応液を減圧下濃縮し、得られた残渣とテトラヒドロフラン5mlの混合溶液に6N塩酸1mlを加えて2時間加熱還流した。反応終了後、水3mlを加え酢酸エチルで抽出し、飽和炭酸水素ナトリウム水溶液、次いで飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去した。残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=6/1)で精製し、2-アセチル-3-クロロ-5-(トリフルオロメチル)イソニコチン酸メチル307mgを無色の油状物として得た。その1H-NMR δppm ( Solvent : CDCl3 /400MHz )は、2.72(3H, s), 4.02(3H, s), 8.84(1H, s)であった。
(2)2-アセチル-3-クロロ-5-(トリフルオロメチル)イソニコチン酸メチル307mgとN,N-ジメチルアセトアミドジメチルアセタール0.41mgとを、トルエン5ml中100℃にて4時間反応させた。反応液を減圧下濃縮し、得られた残渣を酢酸3mlに溶解し、3-アミノ-1H-1,2,4-トリアゾール100mgを加え17時間加熱還流した。反応終了後、減圧下溶媒を留去し、残渣をシリカゲルカラムクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/5)で精製し、目的物138mgを得た。 Synthesis Example 17
Of 3-chloro-2- (5-methyl [1,2,4] triazolo [1,5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinate (Compound No. 98) Composition
(1) Heating a mixed solution of 500 mg of methyl 2,3-dichloro-5- (trifluoromethyl) isonicotinate, 0.66 ml of tributyl (1-ethoxyvinyl) tin, 216 mg of tetrakis (triphenylphosphine) palladium and 10 ml of toluene The reaction was carried out for 5 hours under reflux. The reaction solution was concentrated under reduced pressure, 1 ml of 6N hydrochloric acid was added to a mixed solution of the obtained residue and 5 ml of tetrahydrofuran, and the mixture was heated to reflux for 2 hours. After completion of the reaction, 3 ml of water was added, and the mixture was extracted with ethyl acetate. The residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 6/1), and 307 mg of methyl 2-acetyl-3-chloro-5- (trifluoromethyl) isonicotinate was obtained as a colorless oil. Got as. Its 1 H-NMR δppm (Solvent: CDCl 3 / 400MHz) is, 2.72 (3H, s), 4.02 (3H, s), was 8.84 (1H, s).
(2) Methyl 2-acetyl-3-chloro-5- (trifluoromethyl) isonicotinate (307 mg) and N, N-dimethylacetamide dimethyl acetal (0.41 mg) were reacted in 5 ml of toluene at 100 ° C. for 4 hours. . The reaction mixture was concentrated under reduced pressure, and the resulting residue was dissolved in 3 ml of acetic acid, 100 mg of 3-amino-1H-1,2,4-triazole was added, and the mixture was heated to reflux for 17 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (eluent: n-hexane / ethyl acetate = 1/5) to obtain 138 mg of the desired product.
合成例18
7-[4-アミノ-3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.114)の合成
(1)3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸メチル502mgとメタノール3mlの混合溶液に10規定水酸化ナトリウム0.32mlを加え、55℃にて2時間反応させた。反応液を減圧下濃縮し、得られた残渣に6N塩酸を加えて酸性(pH=3~4)とした。酢酸エチルで抽出し、飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去することで、3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸407mgを固体として得た。その1H-NMR δppm ( Solvent : DMSO-d6 /400MHz )は、2.73(3H, s), 7.64(1H, s), 8.63(1H, s),9.28(1H, s)であった。
(2)3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸237mg、tert-ブタノール0.24ml及びトルエン5mlの混合溶液にジフェニルリン酸アジド0.18ml、次いでトリエチルアミン0.13mlを加え5時間加熱還流した。反応終了後、溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:メタノール/酢酸エチル=1/40)で精製し、目的物55mgを得た。 Synthesis Example 18
7- [4-Amino-3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 114) Synthesis of
(1) Methyl 3-chloro-2- (5-methyl [1,2,4] triazolo [1,5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinate 502 mg and methanol 3 ml To the mixed solution was added 0.32 ml of 10N sodium hydroxide and reacted at 55 ° C. for 2 hours. The reaction solution was concentrated under reduced pressure, and 6N hydrochloric acid was added to the resulting residue to make it acidic (pH = 3-4). Extracted with ethyl acetate, washed with saturated brine, dried over anhydrous sodium sulfate, and evaporated under reduced pressure to remove 3-chloro-2- (5-methyl [1,2,4] triazolo [1 , 5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinic acid 407 mg was obtained as a solid. Its 1 H-NMR δppm (Solvent: DMSO-d 6 / 400MHz) is, 2.73 (3H, s), 7.64 (1H, s), 8.63 (1H, s), was 9.28 (1H, s).
(2) 3-chloro-2- (5-methyl [1,2,4] triazolo [1,5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinic acid 237 mg, tert-butanol To a mixed solution of 0.24 ml and toluene 5 ml, 0.18 ml of diphenylphosphoric acid azide and then 0.13 ml of triethylamine were added and heated to reflux for 5 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel chromatography (eluent: methanol / ethyl acetate = 1/40) to obtain 55 mg of the desired product.
7-[4-アミノ-3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル]-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.114)の合成
(1)3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸メチル502mgとメタノール3mlの混合溶液に10規定水酸化ナトリウム0.32mlを加え、55℃にて2時間反応させた。反応液を減圧下濃縮し、得られた残渣に6N塩酸を加えて酸性(pH=3~4)とした。酢酸エチルで抽出し、飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下溶媒を留去することで、3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸407mgを固体として得た。その1H-NMR δppm ( Solvent : DMSO-d6 /400MHz )は、2.73(3H, s), 7.64(1H, s), 8.63(1H, s),9.28(1H, s)であった。
(2)3-クロロ-2-(5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン-7-イル)-5-(トリフルオロメチル)イソニコチン酸237mg、tert-ブタノール0.24ml及びトルエン5mlの混合溶液にジフェニルリン酸アジド0.18ml、次いでトリエチルアミン0.13mlを加え5時間加熱還流した。反応終了後、溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:メタノール/酢酸エチル=1/40)で精製し、目的物55mgを得た。 Synthesis Example 18
7- [4-Amino-3-chloro-5- (trifluoromethyl) pyridin-2-yl] -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 114) Synthesis of
(1) Methyl 3-chloro-2- (5-methyl [1,2,4] triazolo [1,5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinate 502 mg and methanol 3 ml To the mixed solution was added 0.32 ml of 10N sodium hydroxide and reacted at 55 ° C. for 2 hours. The reaction solution was concentrated under reduced pressure, and 6N hydrochloric acid was added to the resulting residue to make it acidic (pH = 3-4). Extracted with ethyl acetate, washed with saturated brine, dried over anhydrous sodium sulfate, and evaporated under reduced pressure to remove 3-chloro-2- (5-methyl [1,2,4] triazolo [1 , 5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinic acid 407 mg was obtained as a solid. Its 1 H-NMR δppm (Solvent: DMSO-d 6 / 400MHz) is, 2.73 (3H, s), 7.64 (1H, s), 8.63 (1H, s), was 9.28 (1H, s).
(2) 3-chloro-2- (5-methyl [1,2,4] triazolo [1,5-a] pyrimidin-7-yl) -5- (trifluoromethyl) isonicotinic acid 237 mg, tert-butanol To a mixed solution of 0.24 ml and toluene 5 ml, 0.18 ml of diphenylphosphoric acid azide and then 0.13 ml of triethylamine were added and heated to reflux for 5 hours. After completion of the reaction, the solvent was distilled off under reduced pressure, and the resulting residue was purified by silica gel chromatography (eluent: methanol / ethyl acetate = 1/40) to obtain 55 mg of the desired product.
合成例19
7-(3-クロロ-4-ヨード-5-(トリフルオロメチル)ピリジン-2-イル)-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.115)の合成
7-(4-アミノ-3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル)-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン55mg、ヨウ素82mg及びアセトニトリル5mlの混合溶液を0℃に冷却し、亜硝酸tert-ブチル0.02mlを滴下した。滴下終了後、反応液を室温まで昇温し、12時間攪拌した。反応終了後、チオ硫酸ナトリウム水溶液0.5mlを加えてさらに30分攪拌した。水を5ml加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物33mgを淡黄色結晶として得た。 Synthesis Example 19
7- (3-Chloro-4-iodo-5- (trifluoromethyl) pyridin-2-yl) -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 115) Synthesis of 7- (4-amino-3-chloro-5- (trifluoromethyl) pyridin-2-yl) -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine 55 mg, iodine 82 mg And the mixed solution of 5 ml of acetonitrile was cooled to 0 ° C., and 0.02 ml of tert-butyl nitrite was added dropwise. After completion of dropping, the reaction solution was warmed to room temperature and stirred for 12 hours. After completion of the reaction, 0.5 ml of an aqueous sodium thiosulfate solution was added and stirred for another 30 minutes. 5 ml of water was added, extracted twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 33 mg of the desired product as pale yellow crystals.
7-(3-クロロ-4-ヨード-5-(トリフルオロメチル)ピリジン-2-イル)-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン(化合物No.115)の合成
7-(4-アミノ-3-クロロ-5-(トリフルオロメチル)ピリジン-2-イル)-5-メチル[1,2,4]トリアゾロ[1,5-a]ピリミジン55mg、ヨウ素82mg及びアセトニトリル5mlの混合溶液を0℃に冷却し、亜硝酸tert-ブチル0.02mlを滴下した。滴下終了後、反応液を室温まで昇温し、12時間攪拌した。反応終了後、チオ硫酸ナトリウム水溶液0.5mlを加えてさらに30分攪拌した。水を5ml加え、酢酸エチルで2回抽出し、有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムを加えて乾燥した。溶媒を減圧下に留去し、得られた残渣をシリカゲルクロマトグラフィー(溶離液:n-ヘキサン/酢酸エチル=1/1)で精製し、目的物33mgを淡黄色結晶として得た。 Synthesis Example 19
7- (3-Chloro-4-iodo-5- (trifluoromethyl) pyridin-2-yl) -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine (Compound No. 115) Synthesis of 7- (4-amino-3-chloro-5- (trifluoromethyl) pyridin-2-yl) -5-methyl [1,2,4] triazolo [1,5-a] pyrimidine 55 mg, iodine 82 mg And the mixed solution of 5 ml of acetonitrile was cooled to 0 ° C., and 0.02 ml of tert-butyl nitrite was added dropwise. After completion of dropping, the reaction solution was warmed to room temperature and stirred for 12 hours. After completion of the reaction, 0.5 ml of an aqueous sodium thiosulfate solution was added and stirred for another 30 minutes. 5 ml of water was added, extracted twice with ethyl acetate, the organic layer was washed with saturated brine, and dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel chromatography (eluent: n-hexane / ethyl acetate = 1/1) to obtain 33 mg of the desired product as pale yellow crystals.
前記式(I)の化合物の代表例を第1表に挙げる。第1表中、No.は化合物No.を示し、Meはメチル、Etはエチルを、n-Prはノルマルプロピルを、i-Prはイソプロピルを、i-Buはイソブチルを、t-Buはターシャリーブチルを、sec-Buはセカンダリーブチルを、Phはフェニルを各々示し、物性として示した温度は融点である。但し、decは、その温度で分解したことを示す。また、前記式(I)の化合物のいくつかにつき、1H-NMRを第2表に示す。これら化合物は、前記合成例1~19或は前記した本発明化合物の種々の製造方法に基づいて合成することができる。
Representative examples of the compounds of formula (I) are listed in Table 1. In Table 1, No. indicates the compound No., Me is methyl, Et is ethyl, n-Pr is normal propyl, i-Pr is isopropyl, i-Bu is isobutyl, and t-Bu is tertiary. Ri-butyl, sec-Bu represents secondary butyl, Ph represents phenyl, and the temperature indicated as a physical property is the melting point. However, dec indicates that decomposition occurred at that temperature. Table 2 shows 1 H-NMR for some of the compounds of formula (I). These compounds can be synthesized based on the above-described Synthesis Examples 1 to 19 or various production methods of the compound of the present invention described above.
次に試験例を記載する。
試験例1 モモアカアブラムシに対する効果試験
ダイコン葉を水の入った試験管に挿し、その葉上にモモアカアブラムシ1齢幼虫を約20頭放飼した。翌日、ダイコン葉上に寄生している幼虫数を数えた後、寄生したダイコン葉を本発明化合物の濃度が200ppmとなるように調整した薬液に約10秒間浸漬処理した。薬液が風乾した後に、25℃の照明付恒温室内に放置した。処理5日後にモモアカアブラムシの生死を判定し、下記の計算式により死虫率を求めた。尚、離脱虫及び異常虫は死亡虫とみなした。前記化合物No.15、20、24、26、34、41、46、49、59、65、70、74、78、79、87、95、96、104、111及び116を供試したところ、全ての化合物が90%以上の死虫率を示した。
死虫率(%)=(1-(生存虫数/処理虫数))×100 Next, test examples are described.
Test Example 1 Effect test on peach aphid Japanese radish leaves were inserted into a test tube containing water, and about 20 first-instar larvae were released on the leaves. The next day, after counting the number of larvae parasitic on the radish leaves, the parasitic radish leaves were immersed in a chemical solution adjusted to a concentration of 200 ppm of the present compound for about 10 seconds. After the chemical solution was air-dried, it was left in a constant temperature room at 25 ° C. with illumination. Five days after the treatment, the viability of the peach aphid was determined, and the mortality rate was determined by the following formula. The detached insects and abnormal insects were regarded as dead insects. When the compound Nos. 15, 20, 24, 26, 34, 41, 46, 49, 59, 65, 70, 74, 78, 79, 87, 95, 96, 104, 111 and 116 were tested, all This compound showed a death rate of 90% or more.
Death rate (%) = (1− (number of surviving insects / number of treated insects)) × 100
試験例1 モモアカアブラムシに対する効果試験
ダイコン葉を水の入った試験管に挿し、その葉上にモモアカアブラムシ1齢幼虫を約20頭放飼した。翌日、ダイコン葉上に寄生している幼虫数を数えた後、寄生したダイコン葉を本発明化合物の濃度が200ppmとなるように調整した薬液に約10秒間浸漬処理した。薬液が風乾した後に、25℃の照明付恒温室内に放置した。処理5日後にモモアカアブラムシの生死を判定し、下記の計算式により死虫率を求めた。尚、離脱虫及び異常虫は死亡虫とみなした。前記化合物No.15、20、24、26、34、41、46、49、59、65、70、74、78、79、87、95、96、104、111及び116を供試したところ、全ての化合物が90%以上の死虫率を示した。
死虫率(%)=(1-(生存虫数/処理虫数))×100 Next, test examples are described.
Test Example 1 Effect test on peach aphid Japanese radish leaves were inserted into a test tube containing water, and about 20 first-instar larvae were released on the leaves. The next day, after counting the number of larvae parasitic on the radish leaves, the parasitic radish leaves were immersed in a chemical solution adjusted to a concentration of 200 ppm of the present compound for about 10 seconds. After the chemical solution was air-dried, it was left in a constant temperature room at 25 ° C. with illumination. Five days after the treatment, the viability of the peach aphid was determined, and the mortality rate was determined by the following formula. The detached insects and abnormal insects were regarded as dead insects. When the compound Nos. 15, 20, 24, 26, 34, 41, 46, 49, 59, 65, 70, 74, 78, 79, 87, 95, 96, 104, 111 and 116 were tested, all This compound showed a death rate of 90% or more.
Death rate (%) = (1− (number of surviving insects / number of treated insects)) × 100
試験例2 トビイロウンカに対する効果試験
本発明化合物の濃度が200ppmとなるよう調整した薬液に、イネ幼苗を約10秒間浸漬処理した。薬液が風乾した後に、湿った脱脂綿で根部を包んで試験管に入れた。この中へトビイロウンカ2~3齢幼虫を10頭放ち、管口をガーゼでふたをして25℃の照明付恒温室内に放置した。放虫5日後にトビイロウンカの生死を判定し、下記の計算式により死虫率を求めた。前記化合物No.7、12、15、17、20、21、23、24、25、26、28、34、39、41、42、47、49、50、59、62、65、66、70、71、72、74、75、77、78、79、82、83、84、86、87、88、89、90、91、92、95、96、97、99、101、103、104、106、107、111、112、114、115、116及び117を供試したところ、全ての化合物が90%以上の死虫率を示した。
死虫率(%)=(死虫数/放虫数)×100 Test Example 2 Effect test on green planthopper Rice seedlings were immersed in a chemical solution adjusted to have a concentration of the present compound of 200 ppm for about 10 seconds. After the chemical solution was air-dried, the root was wrapped with wet absorbent cotton and placed in a test tube. Ten 10-year-old larvae of the green planthopper were released into this, and the tube mouth was covered with gauze and left in a constant temperature room at 25 ° C. Five days after the insect release, the dead planthopper was judged to be alive or dead, and the mortality rate was determined by the following formula. Compound No. 7, 12, 15, 17, 20, 21, 23, 24, 25, 26, 28, 34, 39, 41, 42, 47, 49, 50, 59, 62, 65, 66, 70, 71, 72, 74, 75, 77, 78, 79, 82, 83, 84, 86, 87, 88, 89, 90, 91, 92, 95, 96, 97, 99, 101, 103, 104, 106, When 107, 111, 112, 114, 115, 116 and 117 were tested, all the compounds showed a mortality rate of 90% or more.
Death rate (%) = (Number of dead insects / Number of dead insects) × 100
本発明化合物の濃度が200ppmとなるよう調整した薬液に、イネ幼苗を約10秒間浸漬処理した。薬液が風乾した後に、湿った脱脂綿で根部を包んで試験管に入れた。この中へトビイロウンカ2~3齢幼虫を10頭放ち、管口をガーゼでふたをして25℃の照明付恒温室内に放置した。放虫5日後にトビイロウンカの生死を判定し、下記の計算式により死虫率を求めた。前記化合物No.7、12、15、17、20、21、23、24、25、26、28、34、39、41、42、47、49、50、59、62、65、66、70、71、72、74、75、77、78、79、82、83、84、86、87、88、89、90、91、92、95、96、97、99、101、103、104、106、107、111、112、114、115、116及び117を供試したところ、全ての化合物が90%以上の死虫率を示した。
死虫率(%)=(死虫数/放虫数)×100 Test Example 2 Effect test on green planthopper Rice seedlings were immersed in a chemical solution adjusted to have a concentration of the present compound of 200 ppm for about 10 seconds. After the chemical solution was air-dried, the root was wrapped with wet absorbent cotton and placed in a test tube. Ten 10-year-old larvae of the green planthopper were released into this, and the tube mouth was covered with gauze and left in a constant temperature room at 25 ° C. Five days after the insect release, the dead planthopper was judged to be alive or dead, and the mortality rate was determined by the following formula. Compound No. 7, 12, 15, 17, 20, 21, 23, 24, 25, 26, 28, 34, 39, 41, 42, 47, 49, 50, 59, 62, 65, 66, 70, 71, 72, 74, 75, 77, 78, 79, 82, 83, 84, 86, 87, 88, 89, 90, 91, 92, 95, 96, 97, 99, 101, 103, 104, 106, When 107, 111, 112, 114, 115, 116 and 117 were tested, all the compounds showed a mortality rate of 90% or more.
Death rate (%) = (Number of dead insects / Number of dead insects) × 100
試験例3 シルバーリーフコナジラミに対する効果試験
シルバーリーフコナジラミ1~2齢幼虫が寄生したポット植えのキュウリ苗に、本発明化合物の濃度が200ppmとなるよう調整した薬液を、ハンドスプレーを用い散布処理した。薬液が風乾した後に、25℃の照明付恒温室内に放置した。処理7日後に老齢幼虫数を調査し、下記計算式により防除効率(%)を求めた。前記化合物No.15、20、21、24、25、26、34、49、59、74、87、88、91、92、96、97、99、101、103、106、107、111、112、114、115、116及び117を供試したところ、全ての化合物が80%以上の防除効率を示した。 Test Example 3 Effect test on silver leaf whitefly A potted cucumber seedling infested with silver leaf whitefly 1-2 larvae was sprayed with a chemical solution adjusted to a concentration of 200 ppm of the compound of the present invention using a hand spray. After the chemical solution was air-dried, it was left in a constant temperature room at 25 ° C. with illumination. Seven days after the treatment, the number of old larvae was examined, and the control efficiency (%) was determined by the following formula. Compound No. 15, 20, 21, 24, 25, 26, 34, 49, 59, 74, 87, 88, 91, 92, 96, 97, 99, 101, 103, 106, 107, 111, 112, When 114, 115, 116 and 117 were tested, all compounds showed a control efficiency of 80% or more.
シルバーリーフコナジラミ1~2齢幼虫が寄生したポット植えのキュウリ苗に、本発明化合物の濃度が200ppmとなるよう調整した薬液を、ハンドスプレーを用い散布処理した。薬液が風乾した後に、25℃の照明付恒温室内に放置した。処理7日後に老齢幼虫数を調査し、下記計算式により防除効率(%)を求めた。前記化合物No.15、20、21、24、25、26、34、49、59、74、87、88、91、92、96、97、99、101、103、106、107、111、112、114、115、116及び117を供試したところ、全ての化合物が80%以上の防除効率を示した。 Test Example 3 Effect test on silver leaf whitefly A potted cucumber seedling infested with silver leaf whitefly 1-2 larvae was sprayed with a chemical solution adjusted to a concentration of 200 ppm of the compound of the present invention using a hand spray. After the chemical solution was air-dried, it was left in a constant temperature room at 25 ° C. with illumination. Seven days after the treatment, the number of old larvae was examined, and the control efficiency (%) was determined by the following formula. Compound No. 15, 20, 21, 24, 25, 26, 34, 49, 59, 74, 87, 88, 91, 92, 96, 97, 99, 101, 103, 106, 107, 111, 112, When 114, 115, 116 and 117 were tested, all compounds showed a control efficiency of 80% or more.
防除効率(%)=(1-(Ta×Cb)/(Tb×Ca))×100
Ta: 処理キュウリ苗における処理後の老齢幼虫
Tb:処理キュウリ苗における処理前の1~2齢幼虫数
Ca: 無処理キュウリ苗における処理後の老齢幼虫数
Cb:無処理キュウリ苗における処理前の1~2齢幼虫数 Control efficiency (%) = (1− (Ta × Cb) / (Tb × Ca)) × 100
Ta: old larvae after treatment in treated cucumber seedlings
Tb: Number of 1-2 instar larvae before treatment in treated cucumber seedlings
Ca: number of old larvae after treatment in untreated cucumber seedlings
Cb: Number of 1-2 instar larvae before treatment in untreated cucumber seedlings
Ta: 処理キュウリ苗における処理後の老齢幼虫
Tb:処理キュウリ苗における処理前の1~2齢幼虫数
Ca: 無処理キュウリ苗における処理後の老齢幼虫数
Cb:無処理キュウリ苗における処理前の1~2齢幼虫数 Control efficiency (%) = (1− (Ta × Cb) / (Tb × Ca)) × 100
Ta: old larvae after treatment in treated cucumber seedlings
Tb: Number of 1-2 instar larvae before treatment in treated cucumber seedlings
Ca: number of old larvae after treatment in untreated cucumber seedlings
Cb: Number of 1-2 instar larvae before treatment in untreated cucumber seedlings
試験例4 フタトゲチマダニに対するイヌを用いた薬効試験
イヌ(ビーグル、8ヶ月齢)に10mg/kg体重の本発明化合物を含むゼラチンカプセルを投与し、その直後にフタトゲチマダニの若ダニ約50頭をイヌの耳介に放ち、人工寄生させる。処理後、寄生数、落下数及び落下したフタトゲチマダニの生死を観察する。その結果、本発明化合物は、寄生させたフタトゲチマダニを落下又は致死させる。 Test Example 4 Medicinal Efficacy Test Using Dogs Against Phytophyllum Tick A dog (beagle, 8 months old) was administered a gelatin capsule containing 10 mg / kg body weight of the compound of the present invention. Immediately thereafter, about 50 young mites were collected from the ear of the dog. Let go through and artificially infest. After the treatment, observe the number of infestations, the number of drops, and the life and death of the fallen spider mites. As a result, the compound of the present invention drops or kills the parasitic spider mite.
イヌ(ビーグル、8ヶ月齢)に10mg/kg体重の本発明化合物を含むゼラチンカプセルを投与し、その直後にフタトゲチマダニの若ダニ約50頭をイヌの耳介に放ち、人工寄生させる。処理後、寄生数、落下数及び落下したフタトゲチマダニの生死を観察する。その結果、本発明化合物は、寄生させたフタトゲチマダニを落下又は致死させる。 Test Example 4 Medicinal Efficacy Test Using Dogs Against Phytophyllum Tick A dog (beagle, 8 months old) was administered a gelatin capsule containing 10 mg / kg body weight of the compound of the present invention. Immediately thereafter, about 50 young mites were collected from the ear of the dog. Let go through and artificially infest. After the treatment, observe the number of infestations, the number of drops, and the life and death of the fallen spider mites. As a result, the compound of the present invention drops or kills the parasitic spider mite.
試験例5 ネコノミに対するイヌを用いた薬効試験
イヌ(ビーグル、8ヶ月齢)に10mg/kg体重の本発明化合物を含むゼラチンカプセルを投与し、その直後にネコノミ未吸血成虫約100頭を背部被毛上に放ち人工寄生させる。本発明化合物は、処理された成虫の産下卵に対し、孵化阻止効果を示す。
試験例5 ネコノミに対するイヌを用いた薬効試験 Test Example 5 Medicinal Efficacy Test Using a Dog against a Cat Flea A gelatin capsule containing 10 mg / kg body weight of the compound of the present invention was administered to a dog (beagle, 8 months old), and immediately after that about 100 cat flea non-blood-sucking adults were covered in the back Let go on and let it infest. The compound of the present invention exhibits a hatching-inhibiting effect on the treated eggs of treated adults.
Test Example 5 Drug efficacy test using dogs against cat fleas
イヌ(ビーグル、8ヶ月齢)に10mg/kg体重の本発明化合物を含むゼラチンカプセルを投与し、その直後にネコノミ未吸血成虫約100頭を背部被毛上に放ち人工寄生させる。本発明化合物は、処理された成虫の産下卵に対し、孵化阻止効果を示す。
試験例5 ネコノミに対するイヌを用いた薬効試験 Test Example 5 Medicinal Efficacy Test Using a Dog against a Cat Flea A gelatin capsule containing 10 mg / kg body weight of the compound of the present invention was administered to a dog (beagle, 8 months old), and immediately after that about 100 cat flea non-blood-sucking adults were covered in the back Let go on and let it infest. The compound of the present invention exhibits a hatching-inhibiting effect on the treated eggs of treated adults.
Test Example 5 Drug efficacy test using dogs against cat fleas
次に製剤例を記載する。
製剤例1
(1)本発明化合物 20重量部
(2)クレー 70重量部
(3)ホワイトカーボン 5重量部
(4)ポリカルボン酸ナトリウム 3重量部
(5)アルキルナフタレンスルホン酸ナトリウム 2重量部
以上のものを均一に混合して水和剤とする。 Next, formulation examples are described.
Formulation Example 1
(1) Compound of the present invention 20 parts by weight (2) Clay 70 parts by weight (3) White carbon 5 parts by weight (4) Sodium polycarboxylate 3 parts by weight (5) Sodium alkylnaphthalene sulfonate 2 parts by weight or more To make a wettable powder.
製剤例1
(1)本発明化合物 20重量部
(2)クレー 70重量部
(3)ホワイトカーボン 5重量部
(4)ポリカルボン酸ナトリウム 3重量部
(5)アルキルナフタレンスルホン酸ナトリウム 2重量部
以上のものを均一に混合して水和剤とする。 Next, formulation examples are described.
Formulation Example 1
(1) Compound of the present invention 20 parts by weight (2) Clay 70 parts by weight (3) White carbon 5 parts by weight (4) Sodium polycarboxylate 3 parts by weight (5) Sodium alkylnaphthalene sulfonate 2 parts by weight or more To make a wettable powder.
製剤例2
(1)本発明化合物 5重量部
(2)タルク 60重量部
(3)炭酸カルシウム 34.5重量部
(4)流動パラフィン 0.5重量部
以上のものを均一に混合して粉剤とする。 Formulation Example 2
(1) Compound of the present invention 5 parts by weight (2) Talc 60 parts by weight (3) Calcium carbonate 34.5 parts by weight (4) Liquid paraffin 0.5 parts by weight or more are uniformly mixed to obtain a powder.
(1)本発明化合物 5重量部
(2)タルク 60重量部
(3)炭酸カルシウム 34.5重量部
(4)流動パラフィン 0.5重量部
以上のものを均一に混合して粉剤とする。 Formulation Example 2
(1) Compound of the present invention 5 parts by weight (2) Talc 60 parts by weight (3) Calcium carbonate 34.5 parts by weight (4) Liquid paraffin 0.5 parts by weight or more are uniformly mixed to obtain a powder.
製剤例3
(1)本発明化合物 20重量部
(2)N,N-ジメチルアセトアミド 20重量部
(3)ポリオキシエチレントリスチリルフェニルエーテル 10重量部
(4)ドデシルベンゼンスルホン酸カルシウム 2重量部
(5)キシレン 48重量部
以上のものを均一に混合、溶解して乳剤とする。 Formulation Example 3
(1) Compound of the present invention 20 parts by weight (2) N, N-dimethylacetamide 20 parts by weight (3) Polyoxyethylene tristyryl phenyl ether 10 parts by weight (4) Calcium dodecylbenzenesulfonate 2 parts by weight (5) Xylene 48 A mixture of more than parts by weight is uniformly mixed and dissolved to obtain an emulsion.
(1)本発明化合物 20重量部
(2)N,N-ジメチルアセトアミド 20重量部
(3)ポリオキシエチレントリスチリルフェニルエーテル 10重量部
(4)ドデシルベンゼンスルホン酸カルシウム 2重量部
(5)キシレン 48重量部
以上のものを均一に混合、溶解して乳剤とする。 Formulation Example 3
(1) Compound of the present invention 20 parts by weight (2) N, N-dimethylacetamide 20 parts by weight (3) Polyoxyethylene tristyryl phenyl ether 10 parts by weight (4) Calcium dodecylbenzenesulfonate 2 parts by weight (5) Xylene 48 A mixture of more than parts by weight is uniformly mixed and dissolved to obtain an emulsion.
製剤例4
(1)クレー 68重量部
(2)リグニンスルホン酸ナトリウム 2重量部
(3)ポリオキシエチレンアルキルアリールサルフェート 5重量部
(4)ホワイトカーボン 25重量部
以上の各成分の混合物と、本発明化合物とを4:1の重量割合で混合し、水和剤とする。 Formulation Example 4
(1) Clay 68 parts by weight (2) Sodium lignin sulfonate 2 parts by weight (3) Polyoxyethylene alkylaryl sulfate 5 parts by weight (4) White carbon 25 parts by weight A mixture of each component and the present compound Mix at a weight ratio of 4: 1 to make a wettable powder.
(1)クレー 68重量部
(2)リグニンスルホン酸ナトリウム 2重量部
(3)ポリオキシエチレンアルキルアリールサルフェート 5重量部
(4)ホワイトカーボン 25重量部
以上の各成分の混合物と、本発明化合物とを4:1の重量割合で混合し、水和剤とする。 Formulation Example 4
(1) Clay 68 parts by weight (2) Sodium lignin sulfonate 2 parts by weight (3) Polyoxyethylene alkylaryl sulfate 5 parts by weight (4) White carbon 25 parts by weight A mixture of each component and the present compound Mix at a weight ratio of 4: 1 to make a wettable powder.
製剤例5
(1)本発明化合物 50重量部
(2)アルキルナフタレンスルホン酸ナトリウムホルムアルデヒド縮合物 2重量部
(3)シリコーンオイル 0.2重量部
(4)水 47.8重量部
以上のものを均一に混合、粉砕した原液に更に
(5)ポリカルボン酸ナトリウム 5重量部
(6)無水硫酸ナトリウム 42.8重量部
を加え均一に混合、造粒、乾燥して顆粒水和剤とする。 Formulation Example 5
(1) Compound of the present invention 50 parts by weight (2) Sodium alkylnaphthalene sulfonate formaldehyde condensate 2 parts by weight (3) Silicone oil 0.2 parts by weight (4) Water 47.8 parts by weight or more uniformly mixed (5) 5 parts by weight of sodium polycarboxylate (6) 42.8 parts by weight of anhydrous sodium sulfate are further added to the crushed stock solution, and the mixture is uniformly mixed, granulated and dried to obtain a granulated wettable powder.
(1)本発明化合物 50重量部
(2)アルキルナフタレンスルホン酸ナトリウムホルムアルデヒド縮合物 2重量部
(3)シリコーンオイル 0.2重量部
(4)水 47.8重量部
以上のものを均一に混合、粉砕した原液に更に
(5)ポリカルボン酸ナトリウム 5重量部
(6)無水硫酸ナトリウム 42.8重量部
を加え均一に混合、造粒、乾燥して顆粒水和剤とする。 Formulation Example 5
(1) Compound of the present invention 50 parts by weight (2) Sodium alkylnaphthalene sulfonate formaldehyde condensate 2 parts by weight (3) Silicone oil 0.2 parts by weight (4) Water 47.8 parts by weight or more uniformly mixed (5) 5 parts by weight of sodium polycarboxylate (6) 42.8 parts by weight of anhydrous sodium sulfate are further added to the crushed stock solution, and the mixture is uniformly mixed, granulated and dried to obtain a granulated wettable powder.
製剤例6
(1)本発明化合物 5重量部
(2)ポリオキシエチレンオクチルフェニルエーテル 1重量部
(3)ポリオキシエチレンアルキルエーテルリン酸エステル 0.1重量部
(4)粒状炭酸カルシウム 93.9重量部
(1)~(3)を予め均一に混合し、適量のアセトンで希釈した後、(4)に吹付け、アセトンを除去して粒剤とする。 Formulation Example 6
(1) Compound of the present invention 5 parts by weight (2) Polyoxyethylene octylphenyl ether 1 part by weight (3) Polyoxyethylene alkyl ether phosphate 0.1 part by weight (4) Granular calcium carbonate 93.9 parts by weight (1 ) To (3) are mixed uniformly in advance and diluted with an appropriate amount of acetone, and then sprayed onto (4) to remove acetone and form granules.
(1)本発明化合物 5重量部
(2)ポリオキシエチレンオクチルフェニルエーテル 1重量部
(3)ポリオキシエチレンアルキルエーテルリン酸エステル 0.1重量部
(4)粒状炭酸カルシウム 93.9重量部
(1)~(3)を予め均一に混合し、適量のアセトンで希釈した後、(4)に吹付け、アセトンを除去して粒剤とする。 Formulation Example 6
(1) Compound of the present invention 5 parts by weight (2) Polyoxyethylene octylphenyl ether 1 part by weight (3) Polyoxyethylene alkyl ether phosphate 0.1 part by weight (4) Granular calcium carbonate 93.9 parts by weight (1 ) To (3) are mixed uniformly in advance and diluted with an appropriate amount of acetone, and then sprayed onto (4) to remove acetone and form granules.
製剤例7
(1)本発明化合物 2.5重量部
(2)N,N-ジメチルアセトアミド 2.5重量部
(3)大豆油 95.0重量部
以上のものを均一に混合、溶解して微量散布剤(ultra low volume formulation)とする。 Formulation Example 7
(1) Compound of the present invention 2.5 parts by weight (2) N, N-dimethylacetamide 2.5 parts by weight (3) Soybean oil 95.0 parts by weight or more are uniformly mixed and dissolved to give a trace amount of spray ( ultra low volume formulation).
(1)本発明化合物 2.5重量部
(2)N,N-ジメチルアセトアミド 2.5重量部
(3)大豆油 95.0重量部
以上のものを均一に混合、溶解して微量散布剤(ultra low volume formulation)とする。 Formulation Example 7
(1) Compound of the present invention 2.5 parts by weight (2) N, N-dimethylacetamide 2.5 parts by weight (3) Soybean oil 95.0 parts by weight or more are uniformly mixed and dissolved to give a trace amount of spray ( ultra low volume formulation).
製剤例8
(1)本発明化合物 40重量部
(2)ポリオキシエチレントリスチリルフェニルエーテルリン酸カリウム 4重量部
(3)シリコーンオイル 0.2重量部
(4)キサンタンガム 0.1重量部
(5)エチレングリコール 5重量部
(6)水 50.7重量部
以上のものを均一に混合、粉砕して水性懸濁剤とする。 Formulation Example 8
(1) Compound of the present invention 40 parts by weight (2) Polyoxyethylene tristyryl phenyl ether potassium phosphate 4 parts by weight (3) Silicone oil 0.2 part by weight (4) Xanthan gum 0.1 part by weight (5) Ethylene glycol 5 Part by weight (6) Water 50.7 parts by weight or more are uniformly mixed and pulverized to obtain an aqueous suspension.
(1)本発明化合物 40重量部
(2)ポリオキシエチレントリスチリルフェニルエーテルリン酸カリウム 4重量部
(3)シリコーンオイル 0.2重量部
(4)キサンタンガム 0.1重量部
(5)エチレングリコール 5重量部
(6)水 50.7重量部
以上のものを均一に混合、粉砕して水性懸濁剤とする。 Formulation Example 8
(1) Compound of the present invention 40 parts by weight (2) Polyoxyethylene tristyryl phenyl ether potassium phosphate 4 parts by weight (3) Silicone oil 0.2 part by weight (4) Xanthan gum 0.1 part by weight (5) Ethylene glycol 5 Part by weight (6) Water 50.7 parts by weight or more are uniformly mixed and pulverized to obtain an aqueous suspension.
製剤例9
(1)本発明化合物 10重量部
(2)ジエチレングリコールモノエチルエーテル 80重量部
(3)ポリオキシエチレンアルキルエーテル 10重量部
以上の成分を均一に混合し、水溶性液剤とする。
Formulation Example 9
(1) Compound of the present invention 10 parts by weight (2) 80 parts by weight of diethylene glycol monoethyl ether (3) Polyoxyethylene alkyl ether 10 parts by weight or more of ingredients are mixed uniformly to obtain an aqueous solution.
(1)本発明化合物 10重量部
(2)ジエチレングリコールモノエチルエーテル 80重量部
(3)ポリオキシエチレンアルキルエーテル 10重量部
以上の成分を均一に混合し、水溶性液剤とする。
Formulation Example 9
(1) Compound of the present invention 10 parts by weight (2) 80 parts by weight of diethylene glycol monoethyl ether (3) Polyoxyethylene alkyl ether 10 parts by weight or more of ingredients are mixed uniformly to obtain an aqueous solution.
本発明の新規なピリジル-トリアゾロピリミジン誘導体又はその塩は、有害生物防除剤として有用である。
なお、2008年8月13日に出願された日本特許出願2008-208708号の明細書、特許請求の範囲、及び要約書の全内容をここに引用し、本発明の明細書の開示として、取り入れるものである。 The novel pyridyl-triazolopyrimidine derivatives or salts thereof of the present invention are useful as pest control agents.
The entire contents of the specification, claims, and abstract of Japanese Patent Application No. 2008-208708, filed on August 13, 2008, are incorporated herein as the disclosure of the specification of the present invention. Is.
なお、2008年8月13日に出願された日本特許出願2008-208708号の明細書、特許請求の範囲、及び要約書の全内容をここに引用し、本発明の明細書の開示として、取り入れるものである。 The novel pyridyl-triazolopyrimidine derivatives or salts thereof of the present invention are useful as pest control agents.
The entire contents of the specification, claims, and abstract of Japanese Patent Application No. 2008-208708, filed on August 13, 2008, are incorporated herein as the disclosure of the specification of the present invention. Is.
Claims (10)
- 式(I):
- R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、Aで置換されてもよいアルキニル、ハロゲン原子、アルキルで置換されてもよい複素環基、CH=NOR2、CH=NNR4R5、COR2、COOR2、OR2、S(O)nR3、NR4R5又はCONR4R5であり;Xがアルキル、アリール、ハロゲン原子、ハロアルキル又はOR2であり;Aがハロゲン原子、OR2、S(O)nR3、OS(O)nR3、NR4R5、アルキル、シクロアルキル、複素環基、NHNR4R5、COOR2又はニトロであり;R2が水素原子、アルキル、ハロアルキル又はシアノアルキルであり;R3がアルキルであり;R5が水素原子、アルキル、ハロアルキル、COR2又はCOOR2である請求項1に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。 R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, alkynyl optionally substituted with A, halogen atom, optionally substituted with alkyl heterocyclic group, CH = NOR 2, CH = be NNR 4 R 5, COR 2, COOR 2, oR 2, S (O) n R 3, NR 4 R 5 or CONR 4 R 5; X is an alkyl, aryl , Halogen atom, haloalkyl or OR 2 ; A is a halogen atom, OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 , alkyl, cycloalkyl, heterocyclic group, NHNR 4 R 5 , COOR 2 or nitro; R 2 is a hydrogen atom, alkyl, haloalkyl or cyanoalkyl; R 3 is alkyl; R 5 is a hydrogen atom, alkyl, haloalkyl, COR 2 or COOR 2 Contract The pyridyl-triazolopyrimidine derivative or a salt thereof according to claim 1.
- R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、CH=NOR2、CH=NNR4R5、COR2、COOR2、NR4R5又はCONR4R5であり;AがOR2、S(O)nR3、OS(O)nR3、NR4R5又はニトロである請求項2に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。 R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, CH═NOR 2 , CH═NNR 4 R 5 , COR 2 , COOR 2 , NR The pyridyl-triazolo according to claim 2, which is 4 R 5 or CONR 4 R 5 ; A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro. A pyrimidine derivative or a salt thereof.
- R1がAで置換されてもよいアルキル、Aで置換されてもよいシクロアルキル、Aで置換されてもよいアルケニル、CH=NOR2、CH=NNR4R5、COR2、COOR2、NR4R5又はCONR4R5であり;AがOR2、S(O)nR3、OS(O)nR3、NR4R5又はニトロであり;R5がハロアルキル、COR2又はCOOR2である請求項2に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。 R 1 is alkyl optionally substituted with A, cycloalkyl optionally substituted with A, alkenyl optionally substituted with A, CH═NOR 2 , CH═NNR 4 R 5 , COR 2 , COOR 2 , NR 4 R 5 or CONR 4 R 5 ; A is OR 2 , S (O) n R 3 , OS (O) n R 3 , NR 4 R 5 or nitro; R 5 is haloalkyl, COR 2 or COOR The pyridyl-triazolopyrimidine derivative or a salt thereof according to claim 2, which is 2.
- XがOR2である請求項1に記載のピリジル-トリアゾロピリミジン誘導体又はその塩。 The pyridyl-triazolopyrimidine derivative or a salt thereof according to claim 1, wherein X is OR 2 .
- 前記請求項1のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する有害生物防除剤。 A pest control agent comprising the pyridyl-triazolopyrimidine derivative of claim 1 or a salt thereof as an active ingredient.
- 前記請求項1のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する農園芸用有害生物防除剤。 An agricultural and horticultural pest control agent comprising the pyridyl-triazolopyrimidine derivative or a salt thereof according to claim 1 as an active ingredient.
- 前記請求項1のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する殺虫、殺ダニ、殺線虫又は殺土壌害虫剤。 An insecticide, acaricide, nematicide or soil insecticide containing the pyridyl-triazolopyrimidine derivative or its salt according to claim 1 as an active ingredient.
- 前記請求項1のピリジル-トリアゾロピリミジン誘導体又はその塩を有効成分として含有する殺虫又は殺ダニ剤。 An insecticide or acaricide containing the pyridyl-triazolopyrimidine derivative or its salt according to claim 1 as an active ingredient.
- 前記請求項1のピリジル-トリアゾロピリミジン誘導体又はその塩の有効量を施用して有害生物を防除する方法。 A method for controlling pests by applying an effective amount of the pyridyl-triazolopyrimidine derivative or a salt thereof according to claim 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008208708 | 2008-08-13 | ||
JP2008-208708 | 2008-08-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010018853A1 true WO2010018853A1 (en) | 2010-02-18 |
Family
ID=41668995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/064275 WO2010018853A1 (en) | 2008-08-13 | 2009-08-12 | Pyridyl-triazolopyrimidine derivative or salt thereof, and harmful organism control agent comprising the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2010065026A (en) |
WO (1) | WO2010018853A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106905231A (en) * | 2015-12-23 | 2017-06-30 | 联化科技股份有限公司 | The preparation method of 3- chloro-5-trifluoromethylpyridine class compounds and intermediate |
US10287286B2 (en) | 2015-03-18 | 2019-05-14 | Takeda Pharmaceutical Company Limited | Compounds |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4835456B1 (en) * | 1970-12-28 | 1973-10-27 | ||
JP2002503664A (en) * | 1998-02-11 | 2002-02-05 | アメリカン・サイアナミド・カンパニー | Fungicide 7-alkyl-triazolopyrimidine |
JP2002308879A (en) * | 2001-04-13 | 2002-10-23 | Nippon Soda Co Ltd | 5-haloalkylazolopyrimidine compound, production method, and harmful organism control agent |
WO2004082383A1 (en) * | 2003-03-17 | 2004-09-30 | Basf Aktiengesellschaft | Use of triazolopyrimidines for combating nematode diseases of plants |
WO2006092428A2 (en) * | 2005-03-02 | 2006-09-08 | Basf Aktiengesellschaft | 2-substituted 7-amino-azolopyrimidine, a method for the production and use thereof for controlling pathogenic fungi and agents containing said compound |
WO2008099902A1 (en) * | 2007-02-15 | 2008-08-21 | Ishihara Sangyo Kaisha, Ltd. | Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process |
-
2009
- 2009-08-11 JP JP2009186570A patent/JP2010065026A/en active Pending
- 2009-08-12 WO PCT/JP2009/064275 patent/WO2010018853A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4835456B1 (en) * | 1970-12-28 | 1973-10-27 | ||
JP2002503664A (en) * | 1998-02-11 | 2002-02-05 | アメリカン・サイアナミド・カンパニー | Fungicide 7-alkyl-triazolopyrimidine |
JP2002308879A (en) * | 2001-04-13 | 2002-10-23 | Nippon Soda Co Ltd | 5-haloalkylazolopyrimidine compound, production method, and harmful organism control agent |
WO2004082383A1 (en) * | 2003-03-17 | 2004-09-30 | Basf Aktiengesellschaft | Use of triazolopyrimidines for combating nematode diseases of plants |
WO2006092428A2 (en) * | 2005-03-02 | 2006-09-08 | Basf Aktiengesellschaft | 2-substituted 7-amino-azolopyrimidine, a method for the production and use thereof for controlling pathogenic fungi and agents containing said compound |
WO2008099902A1 (en) * | 2007-02-15 | 2008-08-21 | Ishihara Sangyo Kaisha, Ltd. | Pyridyl-triazolopyrimidine derivative or its salt, pesticide containing it and its production process |
Non-Patent Citations (2)
Title |
---|
"Synth. Chem. Agrochem. III", vol. 504, 1992, ACS SYMPOSIUM SERIES, article SELBY, T.P ET AL.: "7-Phenyl-1, 2, 4-triazolo[l, 5-a]pyrimidines and related heterocycles. A new family of bleaching herbicides", pages: 91 - 102 * |
PETRICH, S.A ET AL.: "The application of unsymmetrical vinylogous iminium salts and related synthons to the preparation of monosubstituted triazolo[l, 5-a]pyrimidines", TETRAHEDRON, vol. 50, no. 42, 1994, pages 12113 - 12124 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10287286B2 (en) | 2015-03-18 | 2019-05-14 | Takeda Pharmaceutical Company Limited | Compounds |
CN106905231A (en) * | 2015-12-23 | 2017-06-30 | 联化科技股份有限公司 | The preparation method of 3- chloro-5-trifluoromethylpyridine class compounds and intermediate |
Also Published As
Publication number | Publication date |
---|---|
JP2010065026A (en) | 2010-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5231829B2 (en) | Pyridyl-triazolopyrimidine derivatives or salts thereof, pest control agents containing them, and methods for producing them | |
WO2010018868A1 (en) | Pest control agent containing triazolopyrimidine derivative or salt thereof | |
KR20090018657A (en) | Pest control agent containing novel pyridyl-methanamine derivative or salt thereof | |
US20100179172A1 (en) | N-phenyl-methanamine derivative and pesticide containing it | |
JP2010138166A (en) | New pyridine derivative or salt thereof, pest-controlling agent containing the same, and method for producing the same | |
JP2012087116A (en) | Benzamide derivative or salt of the same, pesticide, miticide, nematicide or pesticide for soil pest containing the same | |
JP2011144169A (en) | Imidazopyrimidine derivative or salt thereof, and noxious organism control agent comprising the same | |
WO2011090127A1 (en) | Triazolopyridine derivative or salt thereof, process for production of same, and noxious organism control agent comprising same | |
JP2011105700A (en) | Diaryltriazole derivative or salt thereof, insecticide, miticide, nematicide or soil pesticide containing the same and method for producing the same | |
WO2016068301A1 (en) | Pest control agent | |
JP2010195771A (en) | Triazolopyrimidine derivative or salt thereof, process for producing the same and pesticide containing the same | |
WO2010018853A1 (en) | Pyridyl-triazolopyrimidine derivative or salt thereof, and harmful organism control agent comprising the same | |
JP2016050201A (en) | Pest control agent | |
JP2006001914A (en) | Pyrimidine compound, method for producing the same and vermin controlling agent containing the same | |
TWI597267B (en) | Pest control agent | |
WO2017159618A1 (en) | Pest control agent | |
JP2008019222A (en) | Anthranylamide-based compound, method for producing the same, and pest-controlling agent comprising the same | |
JP2008024697A (en) | Pest control agent comprising new pyridyl-methanamine derivative or salt thereof | |
JP2007277206A (en) | Anthranylamide compound, process for producing the same, and pest control agent containing the compound | |
JP2016014016A (en) | Pest control agent | |
JP2016011294A (en) | Pest control agent | |
JP2007051105A (en) | Difluoroalkane amide-based compound, method for producing the same, and noxious organism exterminating agent containing the same | |
JP2007045774A (en) | Fluoroalkene compound, method for producing the same, and vermin controlling agent containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09806744 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09806744 Country of ref document: EP Kind code of ref document: A1 |